AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-19|~|~|~|Benign/Borderline|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632802|Female|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|40632802|Female|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459979|Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|40459979|Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305950|Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|40305950|Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40209737|Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|40209737|Female|All other|2013|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|20|200815055|Female|All other|2013-2017|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|31|200815055|Female|All other|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40151698|Female|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|40151698|Female|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40146685|Female|All other|2015|~|~|~
0-19|~|~|~|Malignant|~|40146685|Female|All other|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165280|Female|All other|2016|~|~|~
0-19|~|~|~|Malignant|~|40165280|Female|All other|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141655|Female|All other|2017|~|~|~
0-19|~|~|~|Malignant|~|40141655|Female|All other|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|39865121|Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39998876|Female|Anaplastic astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40165421|Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40382360|Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|40576293|Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|30|40670476|Female|Anaplastic astrocytoma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40632802|Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40459979|Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40305950|Female|Anaplastic astrocytoma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.2|0.1|Malignant|50|40209737|Female|Anaplastic astrocytoma|2013|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|200815055|Female|Anaplastic astrocytoma|2013-2017|~|~|~
0-19|0.1|0.1|0.1|Malignant|178|200815055|Female|Anaplastic astrocytoma|2013-2017|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40151698|Female|Anaplastic astrocytoma|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|40146685|Female|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Anaplastic astrocytoma|2016|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|40165280|Female|Anaplastic astrocytoma|2016|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Anaplastic astrocytoma|2017|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|40141655|Female|Anaplastic astrocytoma|2017|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40632802|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40459979|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|40305950|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40209737|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|200815055|Female|Anaplastic oligodendroglioma|2013-2017|~|~|~
0-19|~|~|~|Malignant|~|200815055|Female|Anaplastic oligodendroglioma|2013-2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|40151698|Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|40146685|Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|40165280|Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141655|Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|39865121|Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|39998876|Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|89|40165421|Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|40382360|Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|40576293|Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|40670476|Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|40632802|Female|Astrocytoma, NOS|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|40459979|Female|Astrocytoma, NOS|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|84|40305950|Female|Astrocytoma, NOS|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|40209737|Female|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|200815055|Female|Astrocytoma, NOS|2013-2017|~|~|~
0-19|0.2|0.2|0.2|Malignant|425|200815055|Female|Astrocytoma, NOS|2013-2017|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|101|40151698|Female|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Astrocytoma, NOS|2015|~|~|~
0-19|0.1|0.2|0.2|Malignant|74|40146685|Female|Astrocytoma, NOS|2015|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|79|40165280|Female|Astrocytoma, NOS|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Astrocytoma, NOS|2017|~|~|~
0-19|0.1|0.2|0.2|Malignant|72|40141655|Female|Astrocytoma, NOS|2017|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|29|39865121|Female|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Choroid plexus|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|39998876|Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Choroid plexus|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40165421|Female|Choroid plexus|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Choroid plexus|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|40382360|Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|40576293|Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Choroid plexus|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|40670476|Female|Choroid plexus|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Choroid plexus|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40632802|Female|Choroid plexus|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40632802|Female|Choroid plexus|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|40459979|Female|Choroid plexus|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40459979|Female|Choroid plexus|2011|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|40305950|Female|Choroid plexus|2012|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40305950|Female|Choroid plexus|2012|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40209737|Female|Choroid plexus|2013|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40209737|Female|Choroid plexus|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|136|200815055|Female|Choroid plexus|2013-2017|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|44|200815055|Female|Choroid plexus|2013-2017|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|20|40151698|Female|Choroid plexus|2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40151698|Female|Choroid plexus|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|40146685|Female|Choroid plexus|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40146685|Female|Choroid plexus|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|40165280|Female|Choroid plexus|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40165280|Female|Choroid plexus|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|40141655|Female|Choroid plexus|2017|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40141655|Female|Choroid plexus|2017|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|83|39865121|Female|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|39998876|Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|77|40165421|Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|40382360|Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Craniopharyngioma|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|40576293|Female|Craniopharyngioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|40670476|Female|Craniopharyngioma|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|40632802|Female|Craniopharyngioma|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40632802|Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|86|40459979|Female|Craniopharyngioma|2011|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40459979|Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|40305950|Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40305950|Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|40209737|Female|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40209737|Female|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|406|200815055|Female|Craniopharyngioma|2013-2017|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|200815055|Female|Craniopharyngioma|2013-2017|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|40151698|Female|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40151698|Female|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|81|40146685|Female|Craniopharyngioma|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40146685|Female|Craniopharyngioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|40165280|Female|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165280|Female|Craniopharyngioma|2016|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|40141655|Female|Craniopharyngioma|2017|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40141655|Female|Craniopharyngioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|39865121|Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40670476|Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40632802|Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40459979|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Malignant|~|40305950|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|40209737|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|200815055|Female|Diffuse astrocytoma|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|200815055|Female|Diffuse astrocytoma|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|40151698|Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|40146685|Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|40165280|Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141655|Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|215|39865121|Female|Embryonal/primitive/medulloblastoma|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.4|0.5|0.5|Malignant|186|39998876|Female|Embryonal/primitive/medulloblastoma|2005|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.4|0.6|0.5|Malignant|203|40165421|Female|Embryonal/primitive/medulloblastoma|2006|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.5|0.6|0.5|Malignant|220|40382360|Female|Embryonal/primitive/medulloblastoma|2007|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.5|0.6|0.6|Malignant|229|40576293|Female|Embryonal/primitive/medulloblastoma|2008|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.4|0.6|0.5|Malignant|205|40670476|Female|Embryonal/primitive/medulloblastoma|2009|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.4|0.5|0.4|Malignant|175|40632802|Female|Embryonal/primitive/medulloblastoma|2010|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.4|0.6|0.5|Malignant|196|40459979|Female|Embryonal/primitive/medulloblastoma|2011|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.4|0.5|0.4|Malignant|180|40305950|Female|Embryonal/primitive/medulloblastoma|2012|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.4|0.5|0.5|Malignant|186|40209737|Female|Embryonal/primitive/medulloblastoma|2013|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|200815055|Female|Embryonal/primitive/medulloblastoma|2013-2017|~|~|~
0-19|0.4|0.5|0.5|Malignant|933|200815055|Female|Embryonal/primitive/medulloblastoma|2013-2017|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.5|0.6|0.5|Malignant|211|40151698|Female|Embryonal/primitive/medulloblastoma|2014|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.4|0.5|0.5|Malignant|191|40146685|Female|Embryonal/primitive/medulloblastoma|2015|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.4|0.5|0.4|Malignant|179|40165280|Female|Embryonal/primitive/medulloblastoma|2016|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Embryonal/primitive/medulloblastoma|2017|~|~|~
0-19|0.4|0.5|0.4|Malignant|166|40141655|Female|Embryonal/primitive/medulloblastoma|2017|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Ependymoma variants|2010|~|~|~
0-19|~|~|~|Malignant|~|40632802|Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40459979|Female|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40459979|Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40305950|Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40305950|Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40209737|Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40209737|Female|Ependymoma variants|2013|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|65|200815055|Female|Ependymoma variants|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|200815055|Female|Ependymoma variants|2013-2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|40151698|Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Ependymoma variants|2015|~|~|~
0-19|~|~|~|Malignant|~|40146685|Female|Ependymoma variants|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Ependymoma variants|2016|~|~|~
0-19|~|~|~|Malignant|~|40165280|Female|Ependymoma variants|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Ependymoma variants|2017|~|~|~
0-19|~|~|~|Malignant|~|40141655|Female|Ependymoma variants|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|39865121|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|39998876|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|40165421|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40382360|Female|Ependymoma/anaplastic ependymoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|40576293|Female|Ependymoma/anaplastic ependymoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|40670476|Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|40632802|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|40459979|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|88|40305950|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|40209737|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|200815055|Female|Ependymoma/anaplastic ependymoma|2013-2017|~|~|~
0-19|0.2|0.2|0.2|Malignant|442|200815055|Female|Ependymoma/anaplastic ependymoma|2013-2017|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|87|40151698|Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|40146685|Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|78|40165280|Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Ependymoma/anaplastic ependymoma|2017|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|40141655|Female|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Germ Cell Tumors|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|39865121|Female|Germ Cell Tumors|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Germ Cell Tumors|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|47|39998876|Female|Germ Cell Tumors|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Germ Cell Tumors|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|33|40382360|Female|Germ Cell Tumors|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|30|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|40670476|Female|Germ Cell Tumors|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|43|40670476|Female|Germ Cell Tumors|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|40632802|Female|Germ Cell Tumors|2010|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|52|40632802|Female|Germ Cell Tumors|2010|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|22|40459979|Female|Germ Cell Tumors|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|37|40459979|Female|Germ Cell Tumors|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|16|40305950|Female|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|21|40305950|Female|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|40209737|Female|Germ Cell Tumors|2013|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|47|40209737|Female|Germ Cell Tumors|2013|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|97|200815055|Female|Germ Cell Tumors|2013-2017|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|228|200815055|Female|Germ Cell Tumors|2013-2017|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|40151698|Female|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|34|40151698|Female|Germ Cell Tumors|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|40146685|Female|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|46|40146685|Female|Germ Cell Tumors|2015|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|24|40165280|Female|Germ Cell Tumors|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|58|40165280|Female|Germ Cell Tumors|2016|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Germ Cell Tumors|2017|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|40141655|Female|Germ Cell Tumors|2017|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|52|39865121|Female|Glioblastoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|39998876|Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|40165421|Female|Glioblastoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|59|40382360|Female|Glioblastoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|62|40576293|Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40670476|Female|Glioblastoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|51|40632802|Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Glioblastoma|2011|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|40459979|Female|Glioblastoma|2011|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|40305950|Female|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Glioblastoma|2013|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40209737|Female|Glioblastoma|2013|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|200815055|Female|Glioblastoma|2013-2017|~|~|~
0-19|0.1|0.2|0.2|Malignant|324|200815055|Female|Glioblastoma|2013-2017|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|40151698|Female|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Glioblastoma|2015|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|40146685|Female|Glioblastoma|2015|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Glioblastoma|2016|~|~|~
0-19|0.1|0.2|0.1|Malignant|54|40165280|Female|Glioblastoma|2016|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Glioblastoma|2017|~|~|~
0-19|0.1|0.2|0.2|Malignant|64|40141655|Female|Glioblastoma|2017|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.7|0.6|Malignant|233|39865121|Female|Glioma malignant, NOS|2004|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.7|0.6|Malignant|237|39998876|Female|Glioma malignant, NOS|2005|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|245|40165421|Female|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|267|40382360|Female|Glioma malignant, NOS|2007|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.8|0.7|Malignant|281|40576293|Female|Glioma malignant, NOS|2008|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|297|40670476|Female|Glioma malignant, NOS|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.7|0.7|Malignant|263|40632802|Female|Glioma malignant, NOS|2010|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|20|40459979|Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.7|0.9|0.8|Malignant|310|40459979|Female|Glioma malignant, NOS|2011|0.7|0.9|0.8
0-19|0.0|0.1|0.0|Benign/Borderline|17|40305950|Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.5|0.6|0.6|Malignant|226|40305950|Female|Glioma malignant, NOS|2012|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Glioma malignant, NOS|2013|~|~|~
0-19|0.7|0.8|0.7|Malignant|300|40209737|Female|Glioma malignant, NOS|2013|0.7|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|84|200815055|Female|Glioma malignant, NOS|2013-2017|0.0|0.1|0.0
0-19|0.7|0.8|0.7|Malignant|1427|200815055|Female|Glioma malignant, NOS|2013-2017|0.7|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Glioma malignant, NOS|2014|~|~|~
0-19|0.6|0.7|0.7|Malignant|265|40151698|Female|Glioma malignant, NOS|2014|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Glioma malignant, NOS|2015|~|~|~
0-19|0.6|0.8|0.7|Malignant|271|40146685|Female|Glioma malignant, NOS|2015|0.6|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|23|40165280|Female|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.7|0.8|0.7|Malignant|300|40165280|Female|Glioma malignant, NOS|2016|0.7|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|18|40141655|Female|Glioma malignant, NOS|2017|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|291|40141655|Female|Glioma malignant, NOS|2017|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|39998876|Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40382360|Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40670476|Female|Hemangioblastoma|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|40632802|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40459979|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Hemangioblastoma|2012|~|~|~
0-19|~|~|~|Malignant|~|40305950|Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40209737|Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40209737|Female|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|96|200815055|Female|Hemangioblastoma|2013-2017|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|200815055|Female|Hemangioblastoma|2013-2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|30|40151698|Female|Hemangioblastoma|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40151698|Female|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40146685|Female|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40146685|Female|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40165280|Female|Hemangioblastoma|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40165280|Female|Hemangioblastoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Hemangioblastoma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141655|Female|Hemangioblastoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|39998876|Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|40165421|Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|40382360|Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|46|40576293|Female|Hemangioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|40670476|Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|44|40632802|Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40632802|Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|72|40459979|Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40459979|Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40305950|Female|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40305950|Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|62|40209737|Female|Hemangioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40209737|Female|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|298|200815055|Female|Hemangioma|2013-2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|200815055|Female|Hemangioma|2013-2017|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|40151698|Female|Hemangioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40151698|Female|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|73|40146685|Female|Hemangioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40146685|Female|Hemangioma|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40165280|Female|Hemangioma|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40165280|Female|Hemangioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|48|40141655|Female|Hemangioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40141655|Female|Hemangioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|40632802|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|40459979|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|40305950|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|40209737|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|200815055|Female|Local Extensions from Regional Tumors|2013-2017|~|~|~
0-19|~|~|~|Malignant|~|200815055|Female|Local Extensions from Regional Tumors|2013-2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|40151698|Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|40146685|Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|40165280|Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Malignant|~|40141655|Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|40632802|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|40459979|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|40305950|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|40209737|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|200815055|Female|Lymphomas and Hematopoietic Neoplasms|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|200815055|Female|Lymphomas and Hematopoietic Neoplasms|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|40151698|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Malignant|~|40146685|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Malignant|~|40165280|Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Malignant|~|40141655|Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|46|39865121|Female|Meningioma|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|39998876|Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|40165421|Female|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|40382360|Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|40576293|Female|Meningioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|40670476|Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|40632802|Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40632802|Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|40459979|Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40459979|Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|40305950|Female|Meningioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40305950|Female|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|40209737|Female|Meningioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40209737|Female|Meningioma|2013|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|342|200815055|Female|Meningioma|2013-2017|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|21|200815055|Female|Meningioma|2013-2017|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|67|40151698|Female|Meningioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40151698|Female|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40146685|Female|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40146685|Female|Meningioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|40165280|Female|Meningioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165280|Female|Meningioma|2016|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|40141655|Female|Meningioma|2017|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40141655|Female|Meningioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Mixed glioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|39998876|Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Mixed glioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Mixed glioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Mixed glioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40632802|Female|Mixed glioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40459979|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|40305950|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40209737|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|200815055|Female|Mixed glioma|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|32|200815055|Female|Mixed glioma|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Mixed glioma|2014|~|~|~
0-19|~|~|~|Malignant|~|40151698|Female|Mixed glioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|40146685|Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|40165280|Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Mixed glioma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141655|Female|Mixed glioma|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|39865121|Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|57|39998876|Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|39998876|Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|51|40165421|Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|26|40165421|Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|52|40382360|Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|78|40576293|Female|Neoplasm, unspecified|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Neoplasm, unspecified|2008|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|62|40670476|Female|Neoplasm, unspecified|2009|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Neoplasm, unspecified|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|40632802|Female|Neoplasm, unspecified|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40632802|Female|Neoplasm, unspecified|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|40459979|Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|20|40459979|Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|72|40305950|Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|24|40305950|Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|73|40209737|Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|23|40209737|Female|Neoplasm, unspecified|2013|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|337|200815055|Female|Neoplasm, unspecified|2013-2017|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|106|200815055|Female|Neoplasm, unspecified|2013-2017|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|79|40151698|Female|Neoplasm, unspecified|2014|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|40151698|Female|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|81|40146685|Female|Neoplasm, unspecified|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40146685|Female|Neoplasm, unspecified|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|40165280|Female|Neoplasm, unspecified|2016|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|25|40165280|Female|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|51|40141655|Female|Neoplasm, unspecified|2017|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|21|40141655|Female|Neoplasm, unspecified|2017|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|165|39998876|Female|Nerve sheath, benign and malignant|2005|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|157|40165421|Female|Nerve sheath, benign and malignant|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|129|40382360|Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|145|40576293|Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40576293|Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|155|40670476|Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|130|40632802|Female|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40632802|Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|40459979|Female|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40459979|Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|143|40305950|Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40305950|Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|40209737|Female|Nerve sheath, benign and malignant|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40209737|Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|647|200815055|Female|Nerve sheath, benign and malignant|2013-2017|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|200815055|Female|Nerve sheath, benign and malignant|2013-2017|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|102|40151698|Female|Nerve sheath, benign and malignant|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40151698|Female|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|156|40146685|Female|Nerve sheath, benign and malignant|2015|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40146685|Female|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|122|40165280|Female|Nerve sheath, benign and malignant|2016|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40165280|Female|Nerve sheath, benign and malignant|2016|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|117|40141655|Female|Nerve sheath, benign and malignant|2017|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40141655|Female|Nerve sheath, benign and malignant|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|40632802|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|40459979|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|40305950|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|40209737|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|200815055|Female|Neuroepithelial|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|200815055|Female|Neuroepithelial|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|40151698|Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|40146685|Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|40165280|Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Malignant|~|40141655|Female|Neuroepithelial|2017|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Neuronal/glial, neuronal|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|136|39998876|Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|39998876|Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|121|40165421|Female|Neuronal/glial, neuronal|2006|0.2|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|25|40165421|Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|138|40382360|Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|32|40382360|Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|134|40576293|Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|28|40576293|Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|137|40670476|Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|144|40632802|Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|19|40632802|Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|153|40459979|Female|Neuronal/glial, neuronal|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40459979|Female|Neuronal/glial, neuronal|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|40305950|Female|Neuronal/glial, neuronal|2012|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|17|40305950|Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|159|40209737|Female|Neuronal/glial, neuronal|2013|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|23|40209737|Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.4|0.4|0.4|Benign/Borderline|833|200815055|Female|Neuronal/glial, neuronal|2013-2017|0.4|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|113|200815055|Female|Neuronal/glial, neuronal|2013-2017|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|155|40151698|Female|Neuronal/glial, neuronal|2014|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|25|40151698|Female|Neuronal/glial, neuronal|2014|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|170|40146685|Female|Neuronal/glial, neuronal|2015|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|16|40146685|Female|Neuronal/glial, neuronal|2015|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|184|40165280|Female|Neuronal/glial, neuronal|2016|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|29|40165280|Female|Neuronal/glial, neuronal|2016|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|165|40141655|Female|Neuronal/glial, neuronal|2017|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|20|40141655|Female|Neuronal/glial, neuronal|2017|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Oligodendroglioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|39865121|Female|Oligodendroglioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|39998876|Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|40382360|Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40576293|Female|Oligodendroglioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Oligodendroglioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40632802|Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40459979|Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|40305950|Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40209737|Female|Oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|200815055|Female|Oligodendroglioma|2013-2017|~|~|~
0-19|0.0|0.1|0.0|Malignant|86|200815055|Female|Oligodendroglioma|2013-2017|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40151698|Female|Oligodendroglioma|2014|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40146685|Female|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40165280|Female|Oligodendroglioma|2016|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|40141655|Female|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|39998876|Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40165421|Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40165421|Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|40382360|Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40576293|Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40576293|Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40670476|Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|40632802|Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40632802|Female|Other mesenchymal|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|40459979|Female|Other mesenchymal|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40459979|Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40305950|Female|Other mesenchymal|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40305950|Female|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|40209737|Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40209737|Female|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|227|200815055|Female|Other mesenchymal|2013-2017|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|25|200815055|Female|Other mesenchymal|2013-2017|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|41|40151698|Female|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40151698|Female|Other mesenchymal|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|40146685|Female|Other mesenchymal|2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40146685|Female|Other mesenchymal|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40165280|Female|Other mesenchymal|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40165280|Female|Other mesenchymal|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|45|40141655|Female|Other mesenchymal|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40141655|Female|Other mesenchymal|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.7|0.9|0.8|Malignant|329|39865121|Female|Pilocytic astrocytoma|2004|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|321|39998876|Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|318|40165421|Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.8|0.9|0.8|Malignant|338|40382360|Female|Pilocytic astrocytoma|2007|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|335|40576293|Female|Pilocytic astrocytoma|2008|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|1.0|0.9|Malignant|354|40670476|Female|Pilocytic astrocytoma|2009|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.9|1.1|1.0|Malignant|392|40632802|Female|Pilocytic astrocytoma|2010|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|354|40459979|Female|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.8|1.0|0.9|Malignant|379|40305950|Female|Pilocytic astrocytoma|2012|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.8|1.0|0.9|Malignant|365|40209737|Female|Pilocytic astrocytoma|2013|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|200815055|Female|Pilocytic astrocytoma|2013-2017|~|~|~
0-19|0.9|0.9|0.9|Malignant|1811|200815055|Female|Pilocytic astrocytoma|2013-2017|0.9|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Pilocytic astrocytoma|2014|~|~|~
0-19|0.9|1.1|1.0|Malignant|401|40151698|Female|Pilocytic astrocytoma|2014|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|354|40146685|Female|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Pilocytic astrocytoma|2016|~|~|~
0-19|0.7|0.9|0.8|Malignant|314|40165280|Female|Pilocytic astrocytoma|2016|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Pilocytic astrocytoma|2017|~|~|~
0-19|0.8|1.0|0.9|Malignant|377|40141655|Female|Pilocytic astrocytoma|2017|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40576293|Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632802|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|40632802|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40459979|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Malignant|~|40459979|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40305950|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Malignant|~|40305950|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40209737|Female|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Malignant|~|40209737|Female|Pineal parenchymal|2013|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|22|200815055|Female|Pineal parenchymal|2013-2017|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Malignant|83|200815055|Female|Pineal parenchymal|2013-2017|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40151698|Female|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40151698|Female|Pineal parenchymal|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40146685|Female|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40146685|Female|Pineal parenchymal|2015|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165280|Female|Pineal parenchymal|2016|~|~|~
0-19|~|~|~|Malignant|~|40165280|Female|Pineal parenchymal|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40141655|Female|Pineal parenchymal|2017|~|~|~
0-19|~|~|~|Malignant|~|40141655|Female|Pineal parenchymal|2017|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|271|39865121|Female|Pituitary|2004|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|39865121|Female|Pituitary|2004|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|313|39998876|Female|Pituitary|2005|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|39998876|Female|Pituitary|2005|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|356|40165421|Female|Pituitary|2006|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40165421|Female|Pituitary|2006|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|341|40382360|Female|Pituitary|2007|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|40382360|Female|Pituitary|2007|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|398|40576293|Female|Pituitary|2008|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40576293|Female|Pituitary|2008|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|398|40670476|Female|Pituitary|2009|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40670476|Female|Pituitary|2009|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|456|40632802|Female|Pituitary|2010|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40632802|Female|Pituitary|2010|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|460|40459979|Female|Pituitary|2011|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40459979|Female|Pituitary|2011|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|484|40305950|Female|Pituitary|2012|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40305950|Female|Pituitary|2012|~|~|~
0-19|1.0|1.3|1.1|Benign/Borderline|466|40209737|Female|Pituitary|2013|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40209737|Female|Pituitary|2013|~|~|~
0-19|1.2|1.3|1.2|Benign/Borderline|2485|200815055|Female|Pituitary|2013-2017|1.2|1.3|1.2
0-19|~|~|~|Malignant|~|200815055|Female|Pituitary|2013-2017|~|~|~
0-19|1.1|1.4|1.3|Benign/Borderline|509|40151698|Female|Pituitary|2014|1.2|1.4|1.3
0-19|~|~|~|Malignant|~|40151698|Female|Pituitary|2014|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|492|40146685|Female|Pituitary|2015|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40146685|Female|Pituitary|2015|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|527|40165280|Female|Pituitary|2016|1.2|1.4|1.3
0-19|~|~|~|Malignant|~|40165280|Female|Pituitary|2016|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|491|40141655|Female|Pituitary|2017|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40141655|Female|Pituitary|2017|~|~|~
0-19|1.8|2.1|2.0|Benign/Borderline|789|39865121|Female|Total|2004|1.8|2.1|2.0
0-19|3.1|3.5|3.3|Malignant|1305|39865121|Female|Total|2004|3.1|3.5|3.3
0-19|2.2|2.5|2.4|Benign/Borderline|959|39998876|Female|Total|2005|2.2|2.6|2.4
0-19|2.9|3.3|3.1|Malignant|1237|39998876|Female|Total|2005|2.9|3.3|3.1
0-19|2.2|2.5|2.4|Benign/Borderline|970|40165421|Female|Total|2006|2.3|2.6|2.4
0-19|2.9|3.3|3.1|Malignant|1230|40165421|Female|Total|2006|2.9|3.2|3.1
0-19|2.3|2.6|2.4|Benign/Borderline|987|40382360|Female|Total|2007|2.3|2.6|2.4
0-19|3.1|3.4|3.2|Malignant|1300|40382360|Female|Total|2007|3.0|3.4|3.2
0-19|2.4|2.7|2.6|Benign/Borderline|1069|40576293|Female|Total|2008|2.5|2.8|2.6
0-19|3.0|3.4|3.2|Malignant|1287|40576293|Female|Total|2008|3.0|3.3|3.2
0-19|2.5|2.8|2.7|Benign/Borderline|1096|40670476|Female|Total|2009|2.5|2.9|2.7
0-19|3.0|3.4|3.2|Malignant|1297|40670476|Female|Total|2009|3.0|3.4|3.2
0-19|2.7|3.0|2.8|Benign/Borderline|1163|40632802|Female|Total|2010|2.7|3.0|2.9
0-19|3.0|3.4|3.2|Malignant|1301|40632802|Female|Total|2010|3.0|3.4|3.2
0-19|2.8|3.1|2.9|Benign/Borderline|1193|40459979|Female|Total|2011|2.8|3.1|2.9
0-19|3.2|3.5|3.3|Malignant|1348|40459979|Female|Total|2011|3.2|3.5|3.3
0-19|2.9|3.2|3.1|Benign/Borderline|1241|40305950|Female|Total|2012|2.9|3.3|3.1
0-19|2.9|3.2|3.1|Malignant|1236|40305950|Female|Total|2012|2.9|3.2|3.1
0-19|2.9|3.3|3.1|Benign/Borderline|1256|40209737|Female|Total|2013|3.0|3.3|3.1
0-19|3.2|3.5|3.4|Malignant|1351|40209737|Female|Total|2013|3.2|3.5|3.4
0-19|3.0|3.2|3.1|Benign/Borderline|6217|200815055|Female|Total|2013-2017|3.0|3.2|3.1
0-19|3.2|3.3|3.2|Malignant|6487|200815055|Female|Total|2013-2017|3.2|3.3|3.2
0-19|2.9|3.3|3.1|Benign/Borderline|1249|40151698|Female|Total|2014|2.9|3.3|3.1
0-19|3.2|3.6|3.4|Malignant|1366|40151698|Female|Total|2014|3.2|3.6|3.4
0-19|3.0|3.4|3.2|Benign/Borderline|1284|40146685|Female|Total|2015|3.0|3.4|3.2
0-19|3.0|3.4|3.2|Malignant|1273|40146685|Female|Total|2015|3.0|3.3|3.2
0-19|2.9|3.3|3.1|Benign/Borderline|1261|40165280|Female|Total|2016|3.0|3.3|3.1
0-19|2.9|3.3|3.1|Malignant|1244|40165280|Female|Total|2016|2.9|3.3|3.1
0-19|2.7|3.1|2.9|Benign/Borderline|1167|40141655|Female|Total|2017|2.7|3.1|2.9
0-19|3.0|3.3|3.1|Malignant|1253|40141655|Female|Total|2017|3.0|3.3|3.1
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|165|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|157|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|129|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|145|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|155|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|130|40632802|Female|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40632802|Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|40459979|Female|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40459979|Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|143|40305950|Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40305950|Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|40209737|Female|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40209737|Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|647|200815055|Female|Tumors of Cranial and Spinal Nerves|2013-2017|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|200815055|Female|Tumors of Cranial and Spinal Nerves|2013-2017|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|102|40151698|Female|Tumors of Cranial and Spinal Nerves|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40151698|Female|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|156|40146685|Female|Tumors of Cranial and Spinal Nerves|2015|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40146685|Female|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|122|40165280|Female|Tumors of Cranial and Spinal Nerves|2016|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40165280|Female|Tumors of Cranial and Spinal Nerves|2016|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|117|40141655|Female|Tumors of Cranial and Spinal Nerves|2017|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40141655|Female|Tumors of Cranial and Spinal Nerves|2017|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|190|39865121|Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.5
0-19|2.9|3.2|3.0|Malignant|1207|39865121|Female|Tumors of Neuroepthelial Tissue|2004|2.9|3.2|3.0
0-19|0.4|0.6|0.5|Benign/Borderline|197|39998876|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.6|0.5
0-19|2.7|3.0|2.9|Malignant|1146|39998876|Female|Tumors of Neuroepthelial Tissue|2005|2.7|3.0|2.9
0-19|0.4|0.6|0.5|Benign/Borderline|201|40165421|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.6|0.5
0-19|2.7|3.1|2.9|Malignant|1160|40165421|Female|Tumors of Neuroepthelial Tissue|2006|2.7|3.1|2.9
0-19|0.5|0.6|0.6|Benign/Borderline|230|40382360|Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|2.9|3.3|3.1|Malignant|1237|40382360|Female|Tumors of Neuroepthelial Tissue|2007|2.9|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|229|40576293|Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.6
0-19|2.9|3.2|3.0|Malignant|1232|40576293|Female|Tumors of Neuroepthelial Tissue|2008|2.9|3.2|3.0
0-19|0.5|0.6|0.5|Benign/Borderline|215|40670476|Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
0-19|2.8|3.2|3.0|Malignant|1217|40670476|Female|Tumors of Neuroepthelial Tissue|2009|2.8|3.2|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|232|40632802|Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
0-19|2.8|3.2|3.0|Malignant|1221|40632802|Female|Tumors of Neuroepthelial Tissue|2010|2.8|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|247|40459979|Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.7|0.6
0-19|3.0|3.3|3.1|Malignant|1268|40459979|Female|Tumors of Neuroepthelial Tissue|2011|3.0|3.3|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|252|40305950|Female|Tumors of Neuroepthelial Tissue|2012|0.6|0.7|0.6
0-19|2.7|3.1|2.9|Malignant|1172|40305950|Female|Tumors of Neuroepthelial Tissue|2012|2.7|3.1|2.9
0-19|0.6|0.7|0.6|Benign/Borderline|260|40209737|Female|Tumors of Neuroepthelial Tissue|2013|0.6|0.7|0.6
0-19|3.0|3.3|3.1|Malignant|1262|40209737|Female|Tumors of Neuroepthelial Tissue|2013|3.0|3.3|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|1280|200815055|Female|Tumors of Neuroepthelial Tissue|2013-2017|0.6|0.7|0.6
0-19|2.9|3.1|3.0|Malignant|6061|200815055|Female|Tumors of Neuroepthelial Tissue|2013-2017|2.9|3.1|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|243|40151698|Female|Tumors of Neuroepthelial Tissue|2014|0.5|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|1293|40151698|Female|Tumors of Neuroepthelial Tissue|2014|3.0|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|251|40146685|Female|Tumors of Neuroepthelial Tissue|2015|0.6|0.7|0.6
0-19|2.8|3.1|3.0|Malignant|1190|40146685|Female|Tumors of Neuroepthelial Tissue|2015|2.8|3.1|3.0
0-19|0.6|0.8|0.7|Benign/Borderline|276|40165280|Female|Tumors of Neuroepthelial Tissue|2016|0.6|0.8|0.7
0-19|2.7|3.0|2.8|Malignant|1140|40165280|Female|Tumors of Neuroepthelial Tissue|2016|2.7|3.0|2.8
0-19|0.5|0.7|0.6|Benign/Borderline|250|40141655|Female|Tumors of Neuroepthelial Tissue|2017|0.5|0.7|0.6
0-19|2.8|3.1|2.9|Malignant|1176|40141655|Female|Tumors of Neuroepthelial Tissue|2017|2.8|3.1|2.9
0-19|0.8|1.0|0.9|Benign/Borderline|354|39865121|Female|Tumors of Sellar Region|2004|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|391|39998876|Female|Tumors of Sellar Region|2005|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Sellar Region|2005|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|433|40165421|Female|Tumors of Sellar Region|2006|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Sellar Region|2006|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|437|40382360|Female|Tumors of Sellar Region|2007|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Sellar Region|2007|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|462|40576293|Female|Tumors of Sellar Region|2008|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Sellar Region|2008|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|489|40670476|Female|Tumors of Sellar Region|2009|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Sellar Region|2009|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|548|40632802|Female|Tumors of Sellar Region|2010|1.2|1.5|1.3
0-19|~|~|~|Malignant|~|40632802|Female|Tumors of Sellar Region|2010|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|546|40459979|Female|Tumors of Sellar Region|2011|1.2|1.5|1.3
0-19|~|~|~|Malignant|~|40459979|Female|Tumors of Sellar Region|2011|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|562|40305950|Female|Tumors of Sellar Region|2012|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40305950|Female|Tumors of Sellar Region|2012|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|555|40209737|Female|Tumors of Sellar Region|2013|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40209737|Female|Tumors of Sellar Region|2013|~|~|~
0-19|1.4|1.5|1.4|Benign/Borderline|2891|200815055|Female|Tumors of Sellar Region|2013-2017|1.4|1.5|1.4
0-19|~|~|~|Malignant|~|200815055|Female|Tumors of Sellar Region|2013-2017|~|~|~
0-19|1.4|1.6|1.5|Benign/Borderline|600|40151698|Female|Tumors of Sellar Region|2014|1.4|1.6|1.5
0-19|~|~|~|Malignant|~|40151698|Female|Tumors of Sellar Region|2014|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|573|40146685|Female|Tumors of Sellar Region|2015|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40146685|Female|Tumors of Sellar Region|2015|~|~|~
0-19|1.3|1.6|1.5|Benign/Borderline|594|40165280|Female|Tumors of Sellar Region|2016|1.4|1.6|1.5
0-19|~|~|~|Malignant|~|40165280|Female|Tumors of Sellar Region|2016|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|569|40141655|Female|Tumors of Sellar Region|2017|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40141655|Female|Tumors of Sellar Region|2017|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|39865121|Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|111|39998876|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|40165421|Female|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|40382360|Female|Tumors of the Meninges|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|90|40576293|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|103|40670476|Female|Tumors of the Meninges|2009|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|99|40632802|Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40632802|Female|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|107|40459979|Female|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40459979|Female|Tumors of the Meninges|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|130|40305950|Female|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40305950|Female|Tumors of the Meninges|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|135|40209737|Female|Tumors of the Meninges|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40209737|Female|Tumors of the Meninges|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|665|200815055|Female|Tumors of the Meninges|2013-2017|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|48|200815055|Female|Tumors of the Meninges|2013-2017|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|138|40151698|Female|Tumors of the Meninges|2014|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40151698|Female|Tumors of the Meninges|2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|40146685|Female|Tumors of the Meninges|2015|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40146685|Female|Tumors of the Meninges|2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|40165280|Female|Tumors of the Meninges|2016|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40165280|Female|Tumors of the Meninges|2016|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|119|40141655|Female|Tumors of the Meninges|2017|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|40141655|Female|Tumors of the Meninges|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|47|39865121|Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|81|39998876|Female|Unclassified Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|20|39998876|Female|Unclassified Tumors|2005|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|86|40165421|Female|Unclassified Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|83|40382360|Female|Unclassified Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Unclassified Tumors|2007|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|124|40576293|Female|Unclassified Tumors|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Unclassified Tumors|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|40670476|Female|Unclassified Tumors|2009|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|133|40632802|Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40632802|Female|Unclassified Tumors|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|139|40459979|Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|20|40459979|Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|138|40305950|Female|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40305950|Female|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|136|40209737|Female|Unclassified Tumors|2013|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40209737|Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|636|200815055|Female|Unclassified Tumors|2013-2017|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|112|200815055|Female|Unclassified Tumors|2013-2017|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|143|40151698|Female|Unclassified Tumors|2014|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|24|40151698|Female|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|154|40146685|Female|Unclassified Tumors|2015|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|16|40146685|Female|Unclassified Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|104|40165280|Female|Unclassified Tumors|2016|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|26|40165280|Female|Unclassified Tumors|2016|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|99|40141655|Female|Unclassified Tumors|2017|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|22|40141655|Female|Unclassified Tumors|2017|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|24|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|24|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|36|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|35|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|26|40576293|Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Unique astrocytoma variants|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|40670476|Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|40670476|Female|Unique astrocytoma variants|2009|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|29|40632802|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40632802|Female|Unique astrocytoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40459979|Female|Unique astrocytoma variants|2011|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|23|40459979|Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|33|40305950|Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40305950|Female|Unique astrocytoma variants|2012|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|35|40209737|Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|40209737|Female|Unique astrocytoma variants|2013|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|131|200815055|Female|Unique astrocytoma variants|2013-2017|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|100|200815055|Female|Unique astrocytoma variants|2013-2017|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|40|40151698|Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|40151698|Female|Unique astrocytoma variants|2014|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|18|40146685|Female|Unique astrocytoma variants|2015|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|25|40146685|Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|40165280|Female|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|40165280|Female|Unique astrocytoma variants|2016|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|17|40141655|Female|Unique astrocytoma variants|2017|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|23|40141655|Female|Unique astrocytoma variants|2017|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549101|Male|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|42549101|Male|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367731|Male|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|42367731|Male|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42177631|Male|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|42177631|Male|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42037054|Male|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|42037054|Male|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|209799727|Male|All other|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|47|209799727|Male|All other|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41956389|Male|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|41956389|Male|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41936220|Male|All other|2015|~|~|~
0-19|~|~|~|Malignant|~|41936220|Male|All other|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41945689|Male|All other|2016|~|~|~
0-19|~|~|~|Malignant|~|41945689|Male|All other|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41924375|Male|All other|2017|~|~|~
0-19|~|~|~|Malignant|~|41924375|Male|All other|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|41889233|Male|Anaplastic astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|42006384|Male|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|42158997|Male|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|56|42367071|Male|Anaplastic astrocytoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|42541971|Male|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|42609915|Male|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|42549101|Male|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|42367731|Male|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42177631|Male|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|42177631|Male|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42037054|Male|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|45|42037054|Male|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|209799727|Male|Anaplastic astrocytoma|2013-2017|~|~|~
0-19|0.1|0.1|0.1|Malignant|221|209799727|Male|Anaplastic astrocytoma|2013-2017|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.2|0.1|Malignant|58|41956389|Male|Anaplastic astrocytoma|2014|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|41936220|Male|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|46|41936220|Male|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41945689|Male|Anaplastic astrocytoma|2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|41|41945689|Male|Anaplastic astrocytoma|2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41924375|Male|Anaplastic astrocytoma|2017|~|~|~
0-19|0.0|0.1|0.1|Malignant|31|41924375|Male|Anaplastic astrocytoma|2017|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|42549101|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42367731|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42177631|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|42177631|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42037054|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|42037054|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|209799727|Male|Anaplastic oligodendroglioma|2013-2017|~|~|~
0-19|~|~|~|Malignant|~|209799727|Male|Anaplastic oligodendroglioma|2013-2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|41956389|Male|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41936220|Male|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|41936220|Male|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41945689|Male|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|41945689|Male|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41924375|Male|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|41924375|Male|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41889233|Male|Astrocytoma, NOS|2004|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|42006384|Male|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|107|42158997|Male|Astrocytoma, NOS|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|95|42367071|Male|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|42541971|Male|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|108|42609915|Male|Astrocytoma, NOS|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|124|42549101|Male|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|103|42367731|Male|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42177631|Male|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|42177631|Male|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42037054|Male|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|42037054|Male|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|209799727|Male|Astrocytoma, NOS|2013-2017|~|~|~
0-19|0.2|0.3|0.2|Malignant|485|209799727|Male|Astrocytoma, NOS|2013-2017|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|41956389|Male|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41936220|Male|Astrocytoma, NOS|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|41936220|Male|Astrocytoma, NOS|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41945689|Male|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|41945689|Male|Astrocytoma, NOS|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41924375|Male|Astrocytoma, NOS|2017|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|41924375|Male|Astrocytoma, NOS|2017|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|41889233|Male|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Choroid plexus|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42006384|Male|Choroid plexus|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Choroid plexus|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Choroid plexus|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Choroid plexus|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|42367071|Male|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42541971|Male|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Choroid plexus|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|42609915|Male|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|39|42549101|Male|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|17|42549101|Male|Choroid plexus|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|33|42367731|Male|Choroid plexus|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367731|Male|Choroid plexus|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42177631|Male|Choroid plexus|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42177631|Male|Choroid plexus|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42037054|Male|Choroid plexus|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42037054|Male|Choroid plexus|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|173|209799727|Male|Choroid plexus|2013-2017|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|60|209799727|Male|Choroid plexus|2013-2017|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|36|41956389|Male|Choroid plexus|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41956389|Male|Choroid plexus|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|41936220|Male|Choroid plexus|2015|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|41936220|Male|Choroid plexus|2015|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|36|41945689|Male|Choroid plexus|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41945689|Male|Choroid plexus|2016|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|41924375|Male|Choroid plexus|2017|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41924375|Male|Choroid plexus|2017|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|85|41889233|Male|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|42006384|Male|Craniopharyngioma|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|42158997|Male|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|86|42367071|Male|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|42541971|Male|Craniopharyngioma|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|80|42609915|Male|Craniopharyngioma|2009|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|42549101|Male|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42549101|Male|Craniopharyngioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|71|42367731|Male|Craniopharyngioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367731|Male|Craniopharyngioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|79|42177631|Male|Craniopharyngioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42177631|Male|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|42037054|Male|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42037054|Male|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|459|209799727|Male|Craniopharyngioma|2013-2017|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|209799727|Male|Craniopharyngioma|2013-2017|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|105|41956389|Male|Craniopharyngioma|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41956389|Male|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|41936220|Male|Craniopharyngioma|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41936220|Male|Craniopharyngioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|41945689|Male|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41945689|Male|Craniopharyngioma|2016|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|41924375|Male|Craniopharyngioma|2017|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41924375|Male|Craniopharyngioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|41889233|Male|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42006384|Male|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|42367071|Male|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42541971|Male|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42609915|Male|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42549101|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|42367731|Male|Diffuse astrocytoma|2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42177631|Male|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|42177631|Male|Diffuse astrocytoma|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42037054|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|42037054|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|209799727|Male|Diffuse astrocytoma|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|25|209799727|Male|Diffuse astrocytoma|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|41956389|Male|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41936220|Male|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|41936220|Male|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41945689|Male|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|41945689|Male|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41924375|Male|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Malignant|~|41924375|Male|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.8|0.7|Malignant|294|41889233|Male|Embryonal/primitive/medulloblastoma|2004|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.6|0.8|0.7|Malignant|280|42006384|Male|Embryonal/primitive/medulloblastoma|2005|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.8|0.7|Malignant|295|42158997|Male|Embryonal/primitive/medulloblastoma|2006|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|299|42367071|Male|Embryonal/primitive/medulloblastoma|2007|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.7|0.8|0.8|Malignant|321|42541971|Male|Embryonal/primitive/medulloblastoma|2008|0.7|0.8|0.8
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|310|42609915|Male|Embryonal/primitive/medulloblastoma|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.7|0.8|0.7|Malignant|313|42549101|Male|Embryonal/primitive/medulloblastoma|2010|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.6|0.8|0.7|Malignant|301|42367731|Male|Embryonal/primitive/medulloblastoma|2011|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42177631|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.6|0.8|0.7|Malignant|285|42177631|Male|Embryonal/primitive/medulloblastoma|2012|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42037054|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.6|0.7|0.6|Malignant|272|42037054|Male|Embryonal/primitive/medulloblastoma|2013|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|209799727|Male|Embryonal/primitive/medulloblastoma|2013-2017|~|~|~
0-19|0.6|0.7|0.7|Malignant|1429|209799727|Male|Embryonal/primitive/medulloblastoma|2013-2017|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.6|0.8|0.7|Malignant|282|41956389|Male|Embryonal/primitive/medulloblastoma|2014|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41936220|Male|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.6|0.8|0.7|Malignant|296|41936220|Male|Embryonal/primitive/medulloblastoma|2015|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41945689|Male|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.6|0.8|0.7|Malignant|287|41945689|Male|Embryonal/primitive/medulloblastoma|2016|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41924375|Male|Embryonal/primitive/medulloblastoma|2017|~|~|~
0-19|0.6|0.8|0.7|Malignant|292|41924375|Male|Embryonal/primitive/medulloblastoma|2017|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42006384|Male|Ependymoma variants|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Ependymoma variants|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42609915|Male|Ependymoma variants|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42549101|Male|Ependymoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42549101|Male|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42367731|Male|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42367731|Male|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42177631|Male|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42177631|Male|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|42037054|Male|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42037054|Male|Ependymoma variants|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|87|209799727|Male|Ependymoma variants|2013-2017|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|209799727|Male|Ependymoma variants|2013-2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|41956389|Male|Ependymoma variants|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|41936220|Male|Ependymoma variants|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41936220|Male|Ependymoma variants|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|41945689|Male|Ependymoma variants|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41945689|Male|Ependymoma variants|2016|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|41924375|Male|Ependymoma variants|2017|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41924375|Male|Ependymoma variants|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|103|41889233|Male|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|106|42006384|Male|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|42158997|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42367071|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|42541971|Male|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|42609915|Male|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|121|42549101|Male|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|116|42367731|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42177631|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42177631|Male|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42037054|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|42037054|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|209799727|Male|Ependymoma/anaplastic ependymoma|2013-2017|~|~|~
0-19|0.2|0.3|0.3|Malignant|555|209799727|Male|Ependymoma/anaplastic ependymoma|2013-2017|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41956389|Male|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41936220|Male|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|41936220|Male|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41945689|Male|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|102|41945689|Male|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41924375|Male|Ependymoma/anaplastic ependymoma|2017|~|~|~
0-19|0.2|0.3|0.3|Malignant|119|41924375|Male|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|18|41889233|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|106|41889233|Male|Germ Cell Tumors|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|86|42006384|Male|Germ Cell Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|101|42158997|Male|Germ Cell Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|18|42367071|Male|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|100|42367071|Male|Germ Cell Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|116|42541971|Male|Germ Cell Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|28|42609915|Male|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|98|42609915|Male|Germ Cell Tumors|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|22|42549101|Male|Germ Cell Tumors|2010|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|112|42549101|Male|Germ Cell Tumors|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Germ Cell Tumors|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|101|42367731|Male|Germ Cell Tumors|2011|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|23|42177631|Male|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|110|42177631|Male|Germ Cell Tumors|2012|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|26|42037054|Male|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|110|42037054|Male|Germ Cell Tumors|2013|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|120|209799727|Male|Germ Cell Tumors|2013-2017|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|554|209799727|Male|Germ Cell Tumors|2013-2017|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|25|41956389|Male|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|102|41956389|Male|Germ Cell Tumors|2014|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|17|41936220|Male|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|105|41936220|Male|Germ Cell Tumors|2015|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|30|41945689|Male|Germ Cell Tumors|2016|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|108|41945689|Male|Germ Cell Tumors|2016|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|22|41924375|Male|Germ Cell Tumors|2017|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Malignant|129|41924375|Male|Germ Cell Tumors|2017|0.3|0.4|0.3
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|41889233|Male|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioblastoma|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|61|42006384|Male|Glioblastoma|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|42158997|Male|Glioblastoma|2006|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|42367071|Male|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|42541971|Male|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioblastoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|42609915|Male|Glioblastoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|42549101|Male|Glioblastoma|2010|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|84|42367731|Male|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42177631|Male|Glioblastoma|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|80|42177631|Male|Glioblastoma|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42037054|Male|Glioblastoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|42037054|Male|Glioblastoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|209799727|Male|Glioblastoma|2013-2017|~|~|~
0-19|0.2|0.2|0.2|Malignant|401|209799727|Male|Glioblastoma|2013-2017|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|78|41956389|Male|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41936220|Male|Glioblastoma|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|41936220|Male|Glioblastoma|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41945689|Male|Glioblastoma|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|41945689|Male|Glioblastoma|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41924375|Male|Glioblastoma|2017|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|41924375|Male|Glioblastoma|2017|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|228|41889233|Male|Glioma malignant, NOS|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|223|42006384|Male|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|244|42158997|Male|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioma malignant, NOS|2007|~|~|~
0-19|0.5|0.7|0.6|Malignant|244|42367071|Male|Glioma malignant, NOS|2007|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.6|Malignant|273|42541971|Male|Glioma malignant, NOS|2008|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|272|42609915|Male|Glioma malignant, NOS|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.8|0.7|Malignant|283|42549101|Male|Glioma malignant, NOS|2010|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Glioma malignant, NOS|2011|~|~|~
0-19|0.6|0.7|0.7|Malignant|279|42367731|Male|Glioma malignant, NOS|2011|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|18|42177631|Male|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|279|42177631|Male|Glioma malignant, NOS|2012|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|17|42037054|Male|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|271|42037054|Male|Glioma malignant, NOS|2013|0.6|0.7|0.6
0-19|0.0|0.1|0.1|Benign/Borderline|108|209799727|Male|Glioma malignant, NOS|2013-2017|0.0|0.1|0.1
0-19|0.6|0.7|0.7|Malignant|1427|209799727|Male|Glioma malignant, NOS|2013-2017|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|20|41956389|Male|Glioma malignant, NOS|2014|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|262|41956389|Male|Glioma malignant, NOS|2014|0.6|0.7|0.6
0-19|0.0|0.1|0.1|Benign/Borderline|22|41936220|Male|Glioma malignant, NOS|2015|0.0|0.1|0.1
0-19|0.6|0.8|0.7|Malignant|303|41936220|Male|Glioma malignant, NOS|2015|0.6|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|29|41945689|Male|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.6|0.8|0.7|Malignant|289|41945689|Male|Glioma malignant, NOS|2016|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|20|41924375|Male|Glioma malignant, NOS|2017|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|302|41924375|Male|Glioma malignant, NOS|2017|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|17|41889233|Male|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|42158997|Male|Hemangioblastoma|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42549101|Male|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|42367731|Male|Hemangioblastoma|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42367731|Male|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|42177631|Male|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42177631|Male|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42037054|Male|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42037054|Male|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|92|209799727|Male|Hemangioblastoma|2013-2017|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|209799727|Male|Hemangioblastoma|2013-2017|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|41956389|Male|Hemangioblastoma|2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41956389|Male|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|41936220|Male|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41936220|Male|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|41945689|Male|Hemangioblastoma|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41945689|Male|Hemangioblastoma|2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|41924375|Male|Hemangioblastoma|2017|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41924375|Male|Hemangioblastoma|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|41889233|Male|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42006384|Male|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|42158997|Male|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|42367071|Male|Hemangioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|44|42541971|Male|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|42609915|Male|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42549101|Male|Hemangioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42549101|Male|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|42367731|Male|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367731|Male|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|42177631|Male|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42177631|Male|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|57|42037054|Male|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42037054|Male|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|304|209799727|Male|Hemangioma|2013-2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|209799727|Male|Hemangioma|2013-2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|41956389|Male|Hemangioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41956389|Male|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|41936220|Male|Hemangioma|2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41936220|Male|Hemangioma|2015|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|41945689|Male|Hemangioma|2016|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41945689|Male|Hemangioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|41924375|Male|Hemangioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41924375|Male|Hemangioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|42549101|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|42367731|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42177631|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|42177631|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42037054|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|42037054|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|209799727|Male|Local Extensions from Regional Tumors|2013-2017|~|~|~
0-19|~|~|~|Malignant|~|209799727|Male|Local Extensions from Regional Tumors|2013-2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|41956389|Male|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41936220|Male|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|41936220|Male|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41945689|Male|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|41945689|Male|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41924375|Male|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Malignant|~|41924375|Male|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|42549101|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|42367731|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42177631|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|42177631|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42037054|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|42037054|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|209799727|Male|Lymphomas and Hematopoietic Neoplasms|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|47|209799727|Male|Lymphomas and Hematopoietic Neoplasms|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|41956389|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41936220|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Malignant|~|41936220|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41945689|Male|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Malignant|~|41945689|Male|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41924375|Male|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Malignant|~|41924375|Male|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|41889233|Male|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42006384|Male|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|42158997|Male|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42367071|Male|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|42541971|Male|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|42609915|Male|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42549101|Male|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42549101|Male|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|42367731|Male|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367731|Male|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|63|42177631|Male|Meningioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42177631|Male|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|42037054|Male|Meningioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42037054|Male|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|287|209799727|Male|Meningioma|2013-2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|209799727|Male|Meningioma|2013-2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|41956389|Male|Meningioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41956389|Male|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|71|41936220|Male|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41936220|Male|Meningioma|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|41945689|Male|Meningioma|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41945689|Male|Meningioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|41924375|Male|Meningioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41924375|Male|Meningioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42367071|Male|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42549101|Male|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42367731|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42177631|Male|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|42177631|Male|Mixed glioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42037054|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|42037054|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|209799727|Male|Mixed glioma|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|32|209799727|Male|Mixed glioma|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Mixed glioma|2014|~|~|~
0-19|~|~|~|Malignant|~|41956389|Male|Mixed glioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41936220|Male|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|41936220|Male|Mixed glioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41945689|Male|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|41945689|Male|Mixed glioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41924375|Male|Mixed glioma|2017|~|~|~
0-19|~|~|~|Malignant|~|41924375|Male|Mixed glioma|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|41889233|Male|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Neoplasm, unspecified|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|57|42006384|Male|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|53|42158997|Male|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|42158997|Male|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|64|42367071|Male|Neoplasm, unspecified|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|42367071|Male|Neoplasm, unspecified|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|48|42541971|Male|Neoplasm, unspecified|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|42541971|Male|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|87|42609915|Male|Neoplasm, unspecified|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|23|42609915|Male|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|79|42549101|Male|Neoplasm, unspecified|2010|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|42549101|Male|Neoplasm, unspecified|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|70|42367731|Male|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367731|Male|Neoplasm, unspecified|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|42177631|Male|Neoplasm, unspecified|2012|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|29|42177631|Male|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|67|42037054|Male|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|42037054|Male|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|328|209799727|Male|Neoplasm, unspecified|2013-2017|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|113|209799727|Male|Neoplasm, unspecified|2013-2017|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|70|41956389|Male|Neoplasm, unspecified|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|25|41956389|Male|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|59|41936220|Male|Neoplasm, unspecified|2015|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|20|41936220|Male|Neoplasm, unspecified|2015|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|67|41945689|Male|Neoplasm, unspecified|2016|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|41945689|Male|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|65|41924375|Male|Neoplasm, unspecified|2017|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|29|41924375|Male|Neoplasm, unspecified|2017|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|127|41889233|Male|Nerve sheath, benign and malignant|2004|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|124|42006384|Male|Nerve sheath, benign and malignant|2005|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|172|42158997|Male|Nerve sheath, benign and malignant|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|162|42367071|Male|Nerve sheath, benign and malignant|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|148|42541971|Male|Nerve sheath, benign and malignant|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|156|42609915|Male|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|42549101|Male|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42549101|Male|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|148|42367731|Male|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42367731|Male|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|155|42177631|Male|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42177631|Male|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|42037054|Male|Nerve sheath, benign and malignant|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42037054|Male|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|722|209799727|Male|Nerve sheath, benign and malignant|2013-2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|209799727|Male|Nerve sheath, benign and malignant|2013-2017|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|146|41956389|Male|Nerve sheath, benign and malignant|2014|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41956389|Male|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|148|41936220|Male|Nerve sheath, benign and malignant|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41936220|Male|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|171|41945689|Male|Nerve sheath, benign and malignant|2016|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41945689|Male|Nerve sheath, benign and malignant|2016|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|103|41924375|Male|Nerve sheath, benign and malignant|2017|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41924375|Male|Nerve sheath, benign and malignant|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|42549101|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|42367731|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42177631|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|42177631|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42037054|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|42037054|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|209799727|Male|Neuroepithelial|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|209799727|Male|Neuroepithelial|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|41956389|Male|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41936220|Male|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|41936220|Male|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41945689|Male|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|41945689|Male|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41924375|Male|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Malignant|~|41924375|Male|Neuroepithelial|2017|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|41889233|Male|Neuronal/glial, neuronal|2004|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|41889233|Male|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|159|42006384|Male|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|30|42006384|Male|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|158|42158997|Male|Neuronal/glial, neuronal|2006|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|174|42367071|Male|Neuronal/glial, neuronal|2007|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|30|42367071|Male|Neuronal/glial, neuronal|2007|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|177|42541971|Male|Neuronal/glial, neuronal|2008|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|28|42541971|Male|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|160|42609915|Male|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|18|42609915|Male|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|173|42549101|Male|Neuronal/glial, neuronal|2010|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42549101|Male|Neuronal/glial, neuronal|2010|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|188|42367731|Male|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|20|42367731|Male|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.6|0.5|Benign/Borderline|207|42177631|Male|Neuronal/glial, neuronal|2012|0.4|0.6|0.5
0-19|0.0|0.1|0.0|Malignant|19|42177631|Male|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|191|42037054|Male|Neuronal/glial, neuronal|2013|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|23|42037054|Male|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.5|0.5|0.5|Benign/Borderline|1021|209799727|Male|Neuronal/glial, neuronal|2013-2017|0.5|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|120|209799727|Male|Neuronal/glial, neuronal|2013-2017|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|171|41956389|Male|Neuronal/glial, neuronal|2014|0.3|0.5|0.4
0-19|0.1|0.1|0.1|Malignant|31|41956389|Male|Neuronal/glial, neuronal|2014|0.1|0.1|0.1
0-19|0.4|0.6|0.5|Benign/Borderline|213|41936220|Male|Neuronal/glial, neuronal|2015|0.4|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|25|41936220|Male|Neuronal/glial, neuronal|2015|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Benign/Borderline|226|41945689|Male|Neuronal/glial, neuronal|2016|0.5|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|25|41945689|Male|Neuronal/glial, neuronal|2016|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Benign/Borderline|220|41924375|Male|Neuronal/glial, neuronal|2017|0.5|0.6|0.5
0-19|0.0|0.1|0.0|Malignant|16|41924375|Male|Neuronal/glial, neuronal|2017|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|41889233|Male|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|42006384|Male|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|42158997|Male|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Oligodendroglioma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|42541971|Male|Oligodendroglioma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|42609915|Male|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|21|42549101|Male|Oligodendroglioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42367731|Male|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42177631|Male|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|42177631|Male|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42037054|Male|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|42037054|Male|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|209799727|Male|Oligodendroglioma|2013-2017|~|~|~
0-19|0.0|0.1|0.0|Malignant|87|209799727|Male|Oligodendroglioma|2013-2017|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41956389|Male|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41936220|Male|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41936220|Male|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41945689|Male|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|41945689|Male|Oligodendroglioma|2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41924375|Male|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|41924375|Male|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Other mesenchymal|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42158997|Male|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42541971|Male|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42609915|Male|Other mesenchymal|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42609915|Male|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42549101|Male|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42549101|Male|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42367731|Male|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367731|Male|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|42177631|Male|Other mesenchymal|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42177631|Male|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42037054|Male|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42037054|Male|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|195|209799727|Male|Other mesenchymal|2013-2017|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|39|209799727|Male|Other mesenchymal|2013-2017|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|33|41956389|Male|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41956389|Male|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|41936220|Male|Other mesenchymal|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41936220|Male|Other mesenchymal|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|48|41945689|Male|Other mesenchymal|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41945689|Male|Other mesenchymal|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|41924375|Male|Other mesenchymal|2017|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41924375|Male|Other mesenchymal|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|1.0|0.9|Malignant|372|41889233|Male|Pilocytic astrocytoma|2004|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pilocytic astrocytoma|2005|~|~|~
0-19|0.8|0.9|0.8|Malignant|352|42006384|Male|Pilocytic astrocytoma|2005|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.9|Malignant|359|42158997|Male|Pilocytic astrocytoma|2006|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|348|42367071|Male|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|394|42541971|Male|Pilocytic astrocytoma|2008|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|1.0|0.9|Malignant|366|42609915|Male|Pilocytic astrocytoma|2009|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|1.0|0.9|Malignant|377|42549101|Male|Pilocytic astrocytoma|2010|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Pilocytic astrocytoma|2011|~|~|~
0-19|0.9|1.0|0.9|Malignant|397|42367731|Male|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42177631|Male|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.1|1.0|Malignant|422|42177631|Male|Pilocytic astrocytoma|2012|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|42037054|Male|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.1|1.0|Malignant|431|42037054|Male|Pilocytic astrocytoma|2013|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|209799727|Male|Pilocytic astrocytoma|2013-2017|~|~|~
0-19|0.9|1.0|0.9|Malignant|1982|209799727|Male|Pilocytic astrocytoma|2013-2017|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Pilocytic astrocytoma|2014|~|~|~
0-19|0.8|1.0|0.9|Malignant|378|41956389|Male|Pilocytic astrocytoma|2014|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41936220|Male|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|378|41936220|Male|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41945689|Male|Pilocytic astrocytoma|2016|~|~|~
0-19|0.8|1.0|0.9|Malignant|372|41945689|Male|Pilocytic astrocytoma|2016|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41924375|Male|Pilocytic astrocytoma|2017|~|~|~
0-19|0.9|1.1|1.0|Malignant|423|41924375|Male|Pilocytic astrocytoma|2017|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41889233|Male|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42367071|Male|Pineal parenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42541971|Male|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549101|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|42549101|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367731|Male|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42367731|Male|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42177631|Male|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42177631|Male|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42037054|Male|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Malignant|~|42037054|Male|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|209799727|Male|Pineal parenchymal|2013-2017|~|~|~
0-19|0.0|0.1|0.0|Malignant|93|209799727|Male|Pineal parenchymal|2013-2017|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41956389|Male|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|41956389|Male|Pineal parenchymal|2014|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41936220|Male|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41936220|Male|Pineal parenchymal|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41945689|Male|Pineal parenchymal|2016|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|41945689|Male|Pineal parenchymal|2016|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41924375|Male|Pineal parenchymal|2017|~|~|~
0-19|~|~|~|Malignant|~|41924375|Male|Pineal parenchymal|2017|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|85|41889233|Male|Pituitary|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Pituitary|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|121|42006384|Male|Pituitary|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Pituitary|2005|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|95|42158997|Male|Pituitary|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Pituitary|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|42367071|Male|Pituitary|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42367071|Male|Pituitary|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|42541971|Male|Pituitary|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Pituitary|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|157|42609915|Male|Pituitary|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Pituitary|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|139|42549101|Male|Pituitary|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42549101|Male|Pituitary|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|148|42367731|Male|Pituitary|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42367731|Male|Pituitary|2011|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|173|42177631|Male|Pituitary|2012|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42177631|Male|Pituitary|2012|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|172|42037054|Male|Pituitary|2013|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42037054|Male|Pituitary|2013|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|919|209799727|Male|Pituitary|2013-2017|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|209799727|Male|Pituitary|2013-2017|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|194|41956389|Male|Pituitary|2014|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|41956389|Male|Pituitary|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|161|41936220|Male|Pituitary|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41936220|Male|Pituitary|2015|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|187|41945689|Male|Pituitary|2016|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|41945689|Male|Pituitary|2016|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|205|41924375|Male|Pituitary|2017|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|41924375|Male|Pituitary|2017|~|~|~
0-19|1.5|1.8|1.6|Benign/Borderline|684|41889233|Male|Total|2004|1.5|1.8|1.6
0-19|3.4|3.8|3.6|Malignant|1506|41889233|Male|Total|2004|3.4|3.8|3.6
0-19|1.7|2.0|1.9|Benign/Borderline|784|42006384|Male|Total|2005|1.7|2.0|1.9
0-19|3.2|3.6|3.4|Malignant|1431|42006384|Male|Total|2005|3.2|3.6|3.4
0-19|1.8|2.0|1.9|Benign/Borderline|807|42158997|Male|Total|2006|1.8|2.1|1.9
0-19|3.4|3.8|3.6|Malignant|1510|42158997|Male|Total|2006|3.4|3.8|3.6
0-19|1.9|2.1|2.0|Benign/Borderline|849|42367071|Male|Total|2007|1.9|2.1|2.0
0-19|3.4|3.8|3.6|Malignant|1523|42367071|Male|Total|2007|3.4|3.8|3.6
0-19|1.9|2.1|2.0|Benign/Borderline|856|42541971|Male|Total|2008|1.9|2.2|2.0
0-19|3.6|4.0|3.8|Malignant|1605|42541971|Male|Total|2008|3.6|4.0|3.8
0-19|2.0|2.3|2.2|Benign/Borderline|937|42609915|Male|Total|2009|2.1|2.3|2.2
0-19|3.5|3.8|3.7|Malignant|1556|42609915|Male|Total|2009|3.5|3.8|3.7
0-19|2.0|2.2|2.1|Benign/Borderline|893|42549101|Male|Total|2010|2.0|2.2|2.1
0-19|3.6|4.0|3.8|Malignant|1603|42549101|Male|Total|2010|3.6|4.0|3.8
0-19|2.1|2.4|2.2|Benign/Borderline|946|42367731|Male|Total|2011|2.1|2.4|2.2
0-19|3.6|3.9|3.8|Malignant|1590|42367731|Male|Total|2011|3.6|3.9|3.8
0-19|2.2|2.5|2.4|Benign/Borderline|1005|42177631|Male|Total|2012|2.2|2.5|2.4
0-19|3.6|4.0|3.8|Malignant|1613|42177631|Male|Total|2012|3.6|4.0|3.8
0-19|2.2|2.5|2.3|Benign/Borderline|979|42037054|Male|Total|2013|2.2|2.5|2.3
0-19|3.6|4.0|3.8|Malignant|1589|42037054|Male|Total|2013|3.6|4.0|3.8
0-19|2.3|2.4|2.4|Benign/Borderline|5008|209799727|Male|Total|2013-2017|2.3|2.5|2.4
0-19|3.7|3.8|3.8|Malignant|7870|209799727|Male|Total|2013-2017|3.7|3.8|3.8
0-19|2.2|2.5|2.4|Benign/Borderline|996|41956389|Male|Total|2014|2.2|2.5|2.4
0-19|3.5|3.9|3.7|Malignant|1561|41956389|Male|Total|2014|3.5|3.9|3.7
0-19|2.2|2.5|2.3|Benign/Borderline|973|41936220|Male|Total|2015|2.2|2.5|2.3
0-19|3.6|4.0|3.8|Malignant|1592|41936220|Male|Total|2015|3.6|4.0|3.8
0-19|2.4|2.7|2.5|Benign/Borderline|1070|41945689|Male|Total|2016|2.4|2.7|2.6
0-19|3.5|3.9|3.7|Malignant|1536|41945689|Male|Total|2016|3.5|3.8|3.7
0-19|2.2|2.5|2.4|Benign/Borderline|990|41924375|Male|Total|2017|2.2|2.5|2.4
0-19|3.6|4.0|3.8|Malignant|1592|41924375|Male|Total|2017|3.6|4.0|3.8
0-19|0.3|0.4|0.3|Benign/Borderline|127|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|124|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|172|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|162|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|148|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|156|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|42549101|Male|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42549101|Male|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|148|42367731|Male|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42367731|Male|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|155|42177631|Male|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42177631|Male|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|155|42037054|Male|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42037054|Male|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|725|209799727|Male|Tumors of Cranial and Spinal Nerves|2013-2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|209799727|Male|Tumors of Cranial and Spinal Nerves|2013-2017|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|148|41956389|Male|Tumors of Cranial and Spinal Nerves|2014|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41956389|Male|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|148|41936220|Male|Tumors of Cranial and Spinal Nerves|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41936220|Male|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|171|41945689|Male|Tumors of Cranial and Spinal Nerves|2016|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41945689|Male|Tumors of Cranial and Spinal Nerves|2016|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|103|41924375|Male|Tumors of Cranial and Spinal Nerves|2017|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41924375|Male|Tumors of Cranial and Spinal Nerves|2017|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|232|41889233|Male|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.6
0-19|3.1|3.5|3.3|Malignant|1364|41889233|Male|Tumors of Neuroepthelial Tissue|2004|3.1|3.4|3.3
0-19|0.5|0.7|0.6|Benign/Borderline|262|42006384|Male|Tumors of Neuroepthelial Tissue|2005|0.6|0.7|0.6
0-19|2.9|3.3|3.1|Malignant|1297|42006384|Male|Tumors of Neuroepthelial Tissue|2005|2.9|3.3|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|260|42158997|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|1362|42158997|Male|Tumors of Neuroepthelial Tissue|2006|3.1|3.4|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|269|42367071|Male|Tumors of Neuroepthelial Tissue|2007|0.6|0.7|0.6
0-19|3.1|3.4|3.3|Malignant|1375|42367071|Male|Tumors of Neuroepthelial Tissue|2007|3.1|3.4|3.2
0-19|0.6|0.7|0.7|Benign/Borderline|279|42541971|Male|Tumors of Neuroepthelial Tissue|2008|0.6|0.7|0.7
0-19|3.2|3.6|3.4|Malignant|1442|42541971|Male|Tumors of Neuroepthelial Tissue|2008|3.2|3.6|3.4
0-19|0.6|0.7|0.6|Benign/Borderline|273|42609915|Male|Tumors of Neuroepthelial Tissue|2009|0.6|0.7|0.6
0-19|3.2|3.5|3.3|Malignant|1411|42609915|Male|Tumors of Neuroepthelial Tissue|2009|3.1|3.5|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|284|42549101|Male|Tumors of Neuroepthelial Tissue|2010|0.6|0.7|0.7
0-19|3.2|3.6|3.4|Malignant|1447|42549101|Male|Tumors of Neuroepthelial Tissue|2010|3.2|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|303|42367731|Male|Tumors of Neuroepthelial Tissue|2011|0.6|0.8|0.7
0-19|3.3|3.6|3.4|Malignant|1454|42367731|Male|Tumors of Neuroepthelial Tissue|2011|3.3|3.6|3.4
0-19|0.7|0.9|0.8|Benign/Borderline|322|42177631|Male|Tumors of Neuroepthelial Tissue|2012|0.7|0.9|0.8
0-19|3.3|3.6|3.4|Malignant|1445|42177631|Male|Tumors of Neuroepthelial Tissue|2012|3.3|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|305|42037054|Male|Tumors of Neuroepthelial Tissue|2013|0.6|0.8|0.7
0-19|3.2|3.6|3.4|Malignant|1432|42037054|Male|Tumors of Neuroepthelial Tissue|2013|3.2|3.6|3.4
0-19|0.7|0.8|0.8|Benign/Borderline|1577|209799727|Male|Tumors of Neuroepthelial Tissue|2013-2017|0.7|0.8|0.8
0-19|3.3|3.5|3.4|Malignant|7074|209799727|Male|Tumors of Neuroepthelial Tissue|2013-2017|3.3|3.5|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|282|41956389|Male|Tumors of Neuroepthelial Tissue|2014|0.6|0.8|0.7
0-19|3.2|3.5|3.4|Malignant|1410|41956389|Male|Tumors of Neuroepthelial Tissue|2014|3.2|3.5|3.4
0-19|0.7|0.8|0.8|Benign/Borderline|317|41936220|Male|Tumors of Neuroepthelial Tissue|2015|0.7|0.8|0.8
0-19|3.3|3.6|3.4|Malignant|1438|41936220|Male|Tumors of Neuroepthelial Tissue|2015|3.3|3.6|3.4
0-19|0.8|0.9|0.8|Benign/Borderline|352|41945689|Male|Tumors of Neuroepthelial Tissue|2016|0.8|0.9|0.8
0-19|3.1|3.5|3.3|Malignant|1379|41945689|Male|Tumors of Neuroepthelial Tissue|2016|3.1|3.5|3.3
0-19|0.7|0.9|0.8|Benign/Borderline|321|41924375|Male|Tumors of Neuroepthelial Tissue|2017|0.7|0.9|0.8
0-19|3.2|3.6|3.4|Malignant|1415|41924375|Male|Tumors of Neuroepthelial Tissue|2017|3.2|3.6|3.4
0-19|0.3|0.5|0.4|Benign/Borderline|170|41889233|Male|Tumors of Sellar Region|2004|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Sellar Region|2004|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|215|42006384|Male|Tumors of Sellar Region|2005|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Sellar Region|2005|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|176|42158997|Male|Tumors of Sellar Region|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Sellar Region|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|201|42367071|Male|Tumors of Sellar Region|2007|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Sellar Region|2007|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|228|42541971|Male|Tumors of Sellar Region|2008|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Sellar Region|2008|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|237|42609915|Male|Tumors of Sellar Region|2009|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Sellar Region|2009|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|222|42549101|Male|Tumors of Sellar Region|2010|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42549101|Male|Tumors of Sellar Region|2010|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|219|42367731|Male|Tumors of Sellar Region|2011|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42367731|Male|Tumors of Sellar Region|2011|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|252|42177631|Male|Tumors of Sellar Region|2012|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|42177631|Male|Tumors of Sellar Region|2012|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|264|42037054|Male|Tumors of Sellar Region|2013|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|42037054|Male|Tumors of Sellar Region|2013|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|1378|209799727|Male|Tumors of Sellar Region|2013-2017|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|209799727|Male|Tumors of Sellar Region|2013-2017|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|299|41956389|Male|Tumors of Sellar Region|2014|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|41956389|Male|Tumors of Sellar Region|2014|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|255|41936220|Male|Tumors of Sellar Region|2015|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|41936220|Male|Tumors of Sellar Region|2015|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|261|41945689|Male|Tumors of Sellar Region|2016|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|41945689|Male|Tumors of Sellar Region|2016|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|299|41924375|Male|Tumors of Sellar Region|2017|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|41924375|Male|Tumors of Sellar Region|2017|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|41889233|Male|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|85|42006384|Male|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of the Meninges|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|42158997|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|42367071|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|88|42541971|Male|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|42609915|Male|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|42549101|Male|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42549101|Male|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|124|42367731|Male|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42367731|Male|Tumors of the Meninges|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|129|42177631|Male|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42177631|Male|Tumors of the Meninges|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|105|42037054|Male|Tumors of the Meninges|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42037054|Male|Tumors of the Meninges|2013|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|574|209799727|Male|Tumors of the Meninges|2013-2017|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|52|209799727|Male|Tumors of the Meninges|2013-2017|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|114|41956389|Male|Tumors of the Meninges|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41956389|Male|Tumors of the Meninges|2014|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|122|41936220|Male|Tumors of the Meninges|2015|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41936220|Male|Tumors of the Meninges|2015|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|108|41945689|Male|Tumors of the Meninges|2016|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41945689|Male|Tumors of the Meninges|2016|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|125|41924375|Male|Tumors of the Meninges|2017|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|41924375|Male|Tumors of the Meninges|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|41889233|Male|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Unclassified Tumors|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|76|42006384|Male|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|89|42158997|Male|Unclassified Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|24|42158997|Male|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|116|42367071|Male|Unclassified Tumors|2007|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|26|42367071|Male|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|92|42541971|Male|Unclassified Tumors|2008|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|21|42541971|Male|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|147|42609915|Male|Unclassified Tumors|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|23|42609915|Male|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|133|42549101|Male|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|18|42549101|Male|Unclassified Tumors|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|137|42367731|Male|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|16|42367731|Male|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|124|42177631|Male|Unclassified Tumors|2012|0.2|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|32|42177631|Male|Unclassified Tumors|2012|0.1|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|124|42037054|Male|Unclassified Tumors|2013|0.2|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|19|42037054|Male|Unclassified Tumors|2013|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|634|209799727|Male|Unclassified Tumors|2013-2017|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|118|209799727|Male|Unclassified Tumors|2013-2017|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|128|41956389|Male|Unclassified Tumors|2014|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|41956389|Male|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|114|41936220|Male|Unclassified Tumors|2015|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|21|41936220|Male|Unclassified Tumors|2015|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|148|41945689|Male|Unclassified Tumors|2016|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|22|41945689|Male|Unclassified Tumors|2016|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|120|41924375|Male|Unclassified Tumors|2017|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|30|41924375|Male|Unclassified Tumors|2017|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|31|41889233|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Unique astrocytoma variants|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42006384|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Unique astrocytoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|31|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|40|42541971|Male|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42541971|Male|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|42|42609915|Male|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|30|42549101|Male|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|42549101|Male|Unique astrocytoma variants|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|43|42367731|Male|Unique astrocytoma variants|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|28|42367731|Male|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|40|42177631|Male|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|25|42177631|Male|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|38|42037054|Male|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|42037054|Male|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|165|209799727|Male|Unique astrocytoma variants|2013-2017|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|121|209799727|Male|Unique astrocytoma variants|2013-2017|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|43|41956389|Male|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|41956389|Male|Unique astrocytoma variants|2014|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|26|41936220|Male|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|41936220|Male|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|31|41945689|Male|Unique astrocytoma variants|2016|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|41945689|Male|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|27|41924375|Male|Unique astrocytoma variants|2017|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|17|41924375|Male|Unique astrocytoma variants|2017|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|All other|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|83181903|Male and Female|All other|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|82827710|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|82483581|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|82246791|Male and Female|All other|2013|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|34|410614782|Male and Female|All other|2013-2017|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|78|410614782|Male and Female|All other|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|82108087|Male and Female|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|All other|2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82082905|Male and Female|All other|2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|All other|2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82110969|Male and Female|All other|2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|All other|2017|~|~|~
0-19|~|~|~|Malignant|~|82066030|Male and Female|All other|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|70|81754354|Male and Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|61|82005260|Male and Female|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|67|82324418|Male and Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|87|82749431|Male and Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|75|83118264|Male and Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|70|83280391|Male and Female|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|83|83181903|Male and Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|73|82827710|Male and Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|68|82483581|Male and Female|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|95|82246791|Male and Female|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|410614782|Male and Female|Anaplastic astrocytoma|2013-2017|~|~|~
0-19|0.1|0.1|0.1|Malignant|399|410614782|Male and Female|Anaplastic astrocytoma|2013-2017|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|98|82108087|Male and Female|Anaplastic astrocytoma|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|80|82082905|Male and Female|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|Anaplastic astrocytoma|2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|70|82110969|Male and Female|Anaplastic astrocytoma|2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|Anaplastic astrocytoma|2017|~|~|~
0-19|0.1|0.1|0.1|Malignant|56|82066030|Male and Female|Anaplastic astrocytoma|2017|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Anaplastic oligodendroglioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|83181903|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|82827710|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|82483581|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|82246791|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|410614782|Male and Female|Anaplastic oligodendroglioma|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|410614782|Male and Female|Anaplastic oligodendroglioma|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|82108087|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|82082905|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|82110969|Male and Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|82066030|Male and Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|202|81754354|Male and Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|191|82005260|Male and Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|196|82324418|Male and Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|180|82749431|Male and Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|178|83118264|Male and Female|Astrocytoma, NOS|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|204|83280391|Male and Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|217|83181903|Male and Female|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|184|82827710|Male and Female|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|166|82483581|Male and Female|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|189|82246791|Male and Female|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|410614782|Male and Female|Astrocytoma, NOS|2013-2017|~|~|~
0-19|0.2|0.2|0.2|Malignant|910|410614782|Male and Female|Astrocytoma, NOS|2013-2017|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|212|82108087|Male and Female|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|Astrocytoma, NOS|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|171|82082905|Male and Female|Astrocytoma, NOS|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|169|82110969|Male and Female|Astrocytoma, NOS|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|Astrocytoma, NOS|2017|~|~|~
0-19|0.2|0.2|0.2|Malignant|169|82066030|Male and Female|Astrocytoma, NOS|2017|0.2|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|56|81754354|Male and Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|81754354|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|55|82005260|Male and Female|Choroid plexus|2005|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|24|82005260|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|68|82324418|Male and Female|Choroid plexus|2006|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|20|82324418|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|65|82749431|Male and Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82749431|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|79|83118264|Male and Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|83118264|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|83280391|Male and Female|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|68|83181903|Male and Female|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|23|83181903|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|82827710|Male and Female|Choroid plexus|2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82827710|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|61|82483581|Male and Female|Choroid plexus|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|18|82483581|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|66|82246791|Male and Female|Choroid plexus|2013|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|82246791|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|309|410614782|Male and Female|Choroid plexus|2013-2017|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|104|410614782|Male and Female|Choroid plexus|2013-2017|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|56|82108087|Male and Female|Choroid plexus|2014|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|28|82108087|Male and Female|Choroid plexus|2014|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|66|82082905|Male and Female|Choroid plexus|2015|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|23|82082905|Male and Female|Choroid plexus|2015|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|59|82110969|Male and Female|Choroid plexus|2016|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82110969|Male and Female|Choroid plexus|2016|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|62|82066030|Male and Female|Choroid plexus|2017|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|82066030|Male and Female|Choroid plexus|2017|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|168|81754354|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81754354|Male and Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|172|82005260|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|158|82324418|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82324418|Male and Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|182|82749431|Male and Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82749431|Male and Female|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|160|83118264|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|171|83280391|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83280391|Male and Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|175|83181903|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83181903|Male and Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|157|82827710|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82827710|Male and Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|157|82483581|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82483581|Male and Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|181|82246791|Male and Female|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82246791|Male and Female|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|865|410614782|Male and Female|Craniopharyngioma|2013-2017|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|410614782|Male and Female|Craniopharyngioma|2013-2017|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|196|82108087|Male and Female|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82108087|Male and Female|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|175|82082905|Male and Female|Craniopharyngioma|2015|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82082905|Male and Female|Craniopharyngioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|141|82110969|Male and Female|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82110969|Male and Female|Craniopharyngioma|2016|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|172|82066030|Male and Female|Craniopharyngioma|2017|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82066030|Male and Female|Craniopharyngioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|81754354|Male and Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|82005260|Male and Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82324418|Male and Female|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|42|82749431|Male and Female|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|83118264|Male and Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|83181903|Male and Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|82827710|Male and Female|Diffuse astrocytoma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82483581|Male and Female|Diffuse astrocytoma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|Diffuse astrocytoma|2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|82246791|Male and Female|Diffuse astrocytoma|2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|410614782|Male and Female|Diffuse astrocytoma|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|45|410614782|Male and Female|Diffuse astrocytoma|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|82108087|Male and Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|82082905|Male and Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|82110969|Male and Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Malignant|~|82066030|Male and Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.7|0.6|Malignant|509|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|466|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|498|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|519|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|550|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|515|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.5|0.6|0.6|Malignant|488|83181903|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.5|0.7|0.6|Malignant|497|82827710|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.5|0.6|0.6|Malignant|465|82483581|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.5|0.6|0.6|Malignant|458|82246791|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|410614782|Male and Female|Embryonal/primitive/medulloblastoma|2013-2017|~|~|~
0-19|0.6|0.6|0.6|Malignant|2362|410614782|Male and Female|Embryonal/primitive/medulloblastoma|2013-2017|0.6|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.6|0.7|0.6|Malignant|493|82108087|Male and Female|Embryonal/primitive/medulloblastoma|2014|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.5|0.6|0.6|Malignant|487|82082905|Male and Female|Embryonal/primitive/medulloblastoma|2015|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.5|0.6|0.6|Malignant|466|82110969|Male and Female|Embryonal/primitive/medulloblastoma|2016|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|Embryonal/primitive/medulloblastoma|2017|~|~|~
0-19|0.5|0.6|0.6|Malignant|458|82066030|Male and Female|Embryonal/primitive/medulloblastoma|2017|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|25|81754354|Male and Female|Ependymoma variants|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Ependymoma variants|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|82005260|Male and Female|Ependymoma variants|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|82324418|Male and Female|Ependymoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Ependymoma variants|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83118264|Male and Female|Ependymoma variants|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Ependymoma variants|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83280391|Male and Female|Ependymoma variants|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|83181903|Male and Female|Ependymoma variants|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83181903|Male and Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|43|82827710|Male and Female|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82827710|Male and Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|82483581|Male and Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82483581|Male and Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82246791|Male and Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82246791|Male and Female|Ependymoma variants|2013|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|152|410614782|Male and Female|Ependymoma variants|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|410614782|Male and Female|Ependymoma variants|2013-2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|82108087|Male and Female|Ependymoma variants|2014|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|27|82082905|Male and Female|Ependymoma variants|2015|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82082905|Male and Female|Ependymoma variants|2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82110969|Male and Female|Ependymoma variants|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82110969|Male and Female|Ependymoma variants|2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|34|82066030|Male and Female|Ependymoma variants|2017|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82066030|Male and Female|Ependymoma variants|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|200|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|217|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|210|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|186|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|172|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|195|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|214|83181903|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|215|82827710|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|203|82483581|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|204|82246791|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|410614782|Male and Female|Ependymoma/anaplastic ependymoma|2013-2017|~|~|~
0-19|0.2|0.3|0.2|Malignant|997|410614782|Male and Female|Ependymoma/anaplastic ependymoma|2013-2017|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|196|82108087|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|202|82082905|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|180|82110969|Male and Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|Ependymoma/anaplastic ependymoma|2017|~|~|~
0-19|0.2|0.3|0.3|Malignant|215|82066030|Male and Female|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|31|81754354|Male and Female|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|148|81754354|Male and Female|Germ Cell Tumors|2004|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|36|82005260|Male and Female|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|133|82005260|Male and Female|Germ Cell Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|44|82324418|Male and Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|125|82324418|Male and Female|Germ Cell Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|33|82749431|Male and Female|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|133|82749431|Male and Female|Germ Cell Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|83118264|Male and Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|146|83118264|Male and Female|Germ Cell Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|47|83280391|Male and Female|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|141|83280391|Male and Female|Germ Cell Tumors|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|43|83181903|Male and Female|Germ Cell Tumors|2010|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|164|83181903|Male and Female|Germ Cell Tumors|2010|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|82827710|Male and Female|Germ Cell Tumors|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|138|82827710|Male and Female|Germ Cell Tumors|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|39|82483581|Male and Female|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|131|82483581|Male and Female|Germ Cell Tumors|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|45|82246791|Male and Female|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|157|82246791|Male and Female|Germ Cell Tumors|2013|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|217|410614782|Male and Female|Germ Cell Tumors|2013-2017|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|782|410614782|Male and Female|Germ Cell Tumors|2013-2017|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|48|82108087|Male and Female|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|136|82108087|Male and Female|Germ Cell Tumors|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|35|82082905|Male and Female|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|151|82082905|Male and Female|Germ Cell Tumors|2015|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|54|82110969|Male and Female|Germ Cell Tumors|2016|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|166|82110969|Male and Female|Germ Cell Tumors|2016|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|35|82066030|Male and Female|Germ Cell Tumors|2017|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|172|82066030|Male and Female|Germ Cell Tumors|2017|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|128|81754354|Male and Female|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|100|82005260|Male and Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.1|Malignant|112|82324418|Male and Female|Glioblastoma|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|128|82749431|Male and Female|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|129|83118264|Male and Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.2|0.1|Malignant|121|83280391|Male and Female|Glioblastoma|2009|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|118|83181903|Male and Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|159|82827710|Male and Female|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|Glioblastoma|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|155|82483581|Male and Female|Glioblastoma|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|Glioblastoma|2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|162|82246791|Male and Female|Glioblastoma|2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|410614782|Male and Female|Glioblastoma|2013-2017|~|~|~
0-19|0.2|0.2|0.2|Malignant|725|410614782|Male and Female|Glioblastoma|2013-2017|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|145|82108087|Male and Female|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|Glioblastoma|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|150|82082905|Male and Female|Glioblastoma|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|Glioblastoma|2016|~|~|~
0-19|0.1|0.2|0.2|Malignant|135|82110969|Male and Female|Glioblastoma|2016|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|Glioblastoma|2017|~|~|~
0-19|0.1|0.2|0.2|Malignant|133|82066030|Male and Female|Glioblastoma|2017|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|461|81754354|Male and Female|Glioma malignant, NOS|2004|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|460|82005260|Male and Female|Glioma malignant, NOS|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|489|82324418|Male and Female|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|511|82749431|Male and Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|554|83118264|Male and Female|Glioma malignant, NOS|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.7|Malignant|569|83280391|Male and Female|Glioma malignant, NOS|2009|0.6|0.7|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|21|83181903|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
0-19|0.6|0.7|0.7|Malignant|546|83181903|Male and Female|Glioma malignant, NOS|2010|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|32|82827710|Male and Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.7|0.8|0.7|Malignant|589|82827710|Male and Female|Glioma malignant, NOS|2011|0.7|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|35|82483581|Male and Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|505|82483581|Male and Female|Glioma malignant, NOS|2012|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|30|82246791|Male and Female|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|571|82246791|Male and Female|Glioma malignant, NOS|2013|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|192|410614782|Male and Female|Glioma malignant, NOS|2013-2017|0.0|0.1|0.0
0-19|0.7|0.7|0.7|Malignant|2854|410614782|Male and Female|Glioma malignant, NOS|2013-2017|0.7|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|35|82108087|Male and Female|Glioma malignant, NOS|2014|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|527|82108087|Male and Female|Glioma malignant, NOS|2014|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|37|82082905|Male and Female|Glioma malignant, NOS|2015|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|574|82082905|Male and Female|Glioma malignant, NOS|2015|0.6|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|52|82110969|Male and Female|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.7|0.8|0.7|Malignant|589|82110969|Male and Female|Glioma malignant, NOS|2016|0.7|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|38|82066030|Male and Female|Glioma malignant, NOS|2017|0.0|0.1|0.0
0-19|0.7|0.8|0.7|Malignant|593|82066030|Male and Female|Glioma malignant, NOS|2017|0.7|0.8|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|29|81754354|Male and Female|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|82005260|Male and Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|82324418|Male and Female|Hemangioblastoma|2006|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82749431|Male and Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioblastoma|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|23|83118264|Male and Female|Hemangioblastoma|2008|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|31|83280391|Male and Female|Hemangioblastoma|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|26|83181903|Male and Female|Hemangioblastoma|2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83181903|Male and Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82827710|Male and Female|Hemangioblastoma|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82827710|Male and Female|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|36|82483581|Male and Female|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82483581|Male and Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|36|82246791|Male and Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82246791|Male and Female|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|188|410614782|Male and Female|Hemangioblastoma|2013-2017|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|410614782|Male and Female|Hemangioblastoma|2013-2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|50|82108087|Male and Female|Hemangioblastoma|2014|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82108087|Male and Female|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|32|82082905|Male and Female|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82082905|Male and Female|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82110969|Male and Female|Hemangioblastoma|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82110969|Male and Female|Hemangioblastoma|2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|31|82066030|Male and Female|Hemangioblastoma|2017|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82066030|Male and Female|Hemangioblastoma|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|45|81754354|Male and Female|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|43|82005260|Male and Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|71|82324418|Male and Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|83|82749431|Male and Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|90|83118264|Male and Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|113|83280391|Male and Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|97|83181903|Male and Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83181903|Male and Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|139|82827710|Male and Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82827710|Male and Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|131|82483581|Male and Female|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82483581|Male and Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|119|82246791|Male and Female|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82246791|Male and Female|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|602|410614782|Male and Female|Hemangioma|2013-2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|410614782|Male and Female|Hemangioma|2013-2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|122|82108087|Male and Female|Hemangioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82108087|Male and Female|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|126|82082905|Male and Female|Hemangioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82082905|Male and Female|Hemangioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|132|82110969|Male and Female|Hemangioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82110969|Male and Female|Hemangioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|103|82066030|Male and Female|Hemangioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82066030|Male and Female|Hemangioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|83181903|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|82827710|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|82483581|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|82246791|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|410614782|Male and Female|Local Extensions from Regional Tumors|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|410614782|Male and Female|Local Extensions from Regional Tumors|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|82108087|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|82082905|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|82110969|Male and Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Malignant|~|82066030|Male and Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|83181903|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|82827710|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82483581|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|82246791|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|410614782|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|69|410614782|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|82108087|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82082905|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|82110969|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Malignant|~|82066030|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|91|81754354|Male and Female|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|127|82005260|Male and Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|100|82324418|Male and Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|108|82749431|Male and Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|116|83118264|Male and Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|119|83280391|Male and Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|113|83181903|Male and Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83181903|Male and Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|133|82827710|Male and Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82827710|Male and Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|127|82483581|Male and Female|Meningioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82483581|Male and Female|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|130|82246791|Male and Female|Meningioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82246791|Male and Female|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|629|410614782|Male and Female|Meningioma|2013-2017|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|34|410614782|Male and Female|Meningioma|2013-2017|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|128|82108087|Male and Female|Meningioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82108087|Male and Female|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|137|82082905|Male and Female|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82082905|Male and Female|Meningioma|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|111|82110969|Male and Female|Meningioma|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82110969|Male and Female|Meningioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|123|82066030|Male and Female|Meningioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82066030|Male and Female|Meningioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|81754354|Male and Female|Mixed glioma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82005260|Male and Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Mixed glioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|82324418|Male and Female|Mixed glioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|82749431|Male and Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Mixed glioma|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|83181903|Male and Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|Mixed glioma|2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82827710|Male and Female|Mixed glioma|2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|Mixed glioma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|25|82483581|Male and Female|Mixed glioma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|Mixed glioma|2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82246791|Male and Female|Mixed glioma|2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|410614782|Male and Female|Mixed glioma|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|64|410614782|Male and Female|Mixed glioma|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Mixed glioma|2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|82108087|Male and Female|Mixed glioma|2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|82082905|Male and Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|82110969|Male and Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|Mixed glioma|2017|~|~|~
0-19|~|~|~|Malignant|~|82066030|Male and Female|Mixed glioma|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|63|81754354|Male and Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|114|82005260|Male and Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|38|82005260|Male and Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|104|82324418|Male and Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|50|82324418|Male and Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|116|82749431|Male and Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|38|82749431|Male and Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|126|83118264|Male and Female|Neoplasm, unspecified|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|32|83118264|Male and Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|149|83280391|Male and Female|Neoplasm, unspecified|2009|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|168|83181903|Male and Female|Neoplasm, unspecified|2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|27|83181903|Male and Female|Neoplasm, unspecified|2010|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|137|82827710|Male and Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|35|82827710|Male and Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|131|82483581|Male and Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|53|82483581|Male and Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|140|82246791|Male and Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|40|82246791|Male and Female|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|665|410614782|Male and Female|Neoplasm, unspecified|2013-2017|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|219|410614782|Male and Female|Neoplasm, unspecified|2013-2017|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|149|82108087|Male and Female|Neoplasm, unspecified|2014|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|47|82108087|Male and Female|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|140|82082905|Male and Female|Neoplasm, unspecified|2015|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|35|82082905|Male and Female|Neoplasm, unspecified|2015|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|120|82110969|Male and Female|Neoplasm, unspecified|2016|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|47|82110969|Male and Female|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|116|82066030|Male and Female|Neoplasm, unspecified|2017|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|50|82066030|Male and Female|Neoplasm, unspecified|2017|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|242|81754354|Male and Female|Nerve sheath, benign and malignant|2004|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|289|82005260|Male and Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82005260|Male and Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.4|0.4|0.4|Benign/Borderline|329|82324418|Male and Female|Nerve sheath, benign and malignant|2006|0.4|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|291|82749431|Male and Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82749431|Male and Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|293|83118264|Male and Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83118264|Male and Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|311|83280391|Male and Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83280391|Male and Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|270|83181903|Male and Female|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83181903|Male and Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|280|82827710|Male and Female|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82827710|Male and Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|298|82483581|Male and Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82483581|Male and Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|304|82246791|Male and Female|Nerve sheath, benign and malignant|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82246791|Male and Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|1369|410614782|Male and Female|Nerve sheath, benign and malignant|2013-2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|410614782|Male and Female|Nerve sheath, benign and malignant|2013-2017|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|248|82108087|Male and Female|Nerve sheath, benign and malignant|2014|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82108087|Male and Female|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|304|82082905|Male and Female|Nerve sheath, benign and malignant|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82082905|Male and Female|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|293|82110969|Male and Female|Nerve sheath, benign and malignant|2016|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82110969|Male and Female|Nerve sheath, benign and malignant|2016|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|220|82066030|Male and Female|Nerve sheath, benign and malignant|2017|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82066030|Male and Female|Nerve sheath, benign and malignant|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|83181903|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|82827710|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|82483581|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|82246791|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|410614782|Male and Female|Neuroepithelial|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|43|410614782|Male and Female|Neuroepithelial|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|82108087|Male and Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|82082905|Male and Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|82110969|Male and Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Malignant|~|82066030|Male and Female|Neuroepithelial|2017|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|265|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|51|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|295|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|56|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|279|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|53|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|312|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|62|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|311|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|56|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|297|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|35|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|317|83181903|Male and Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|34|83181903|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|341|82827710|Male and Female|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|34|82827710|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|361|82483581|Male and Female|Neuronal/glial, neuronal|2012|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|36|82483581|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|350|82246791|Male and Female|Neuronal/glial, neuronal|2013|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|46|82246791|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|1854|410614782|Male and Female|Neuronal/glial, neuronal|2013-2017|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|233|410614782|Male and Female|Neuronal/glial, neuronal|2013-2017|0.0|0.1|0.1
0-19|0.4|0.4|0.4|Benign/Borderline|326|82108087|Male and Female|Neuronal/glial, neuronal|2014|0.4|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|56|82108087|Male and Female|Neuronal/glial, neuronal|2014|0.1|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|383|82082905|Male and Female|Neuronal/glial, neuronal|2015|0.4|0.5|0.5
0-19|0.0|0.1|0.0|Malignant|41|82082905|Male and Female|Neuronal/glial, neuronal|2015|0.0|0.1|0.0
0-19|0.5|0.5|0.5|Benign/Borderline|410|82110969|Male and Female|Neuronal/glial, neuronal|2016|0.5|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|54|82110969|Male and Female|Neuronal/glial, neuronal|2016|0.0|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|385|82066030|Male and Female|Neuronal/glial, neuronal|2017|0.4|0.5|0.5
0-19|0.0|0.1|0.0|Malignant|36|82066030|Male and Female|Neuronal/glial, neuronal|2017|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|62|81754354|Male and Female|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82005260|Male and Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|54|82324418|Male and Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82749431|Male and Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|50|83118264|Male and Female|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|83280391|Male and Female|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|45|83181903|Male and Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|82827710|Male and Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|48|82483581|Male and Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|82246791|Male and Female|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|410614782|Male and Female|Oligodendroglioma|2013-2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|173|410614782|Male and Female|Oligodendroglioma|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|39|82108087|Male and Female|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|82082905|Male and Female|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|82110969|Male and Female|Oligodendroglioma|2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|Oligodendroglioma|2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|82066030|Male and Female|Oligodendroglioma|2017|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|26|81754354|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|82005260|Male and Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|82324418|Male and Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|83118264|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|49|83280391|Male and Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|52|83181903|Male and Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83181903|Male and Female|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|60|82827710|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82827710|Male and Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|96|82483581|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|17|82483581|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|74|82246791|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82246791|Male and Female|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|422|410614782|Male and Female|Other mesenchymal|2013-2017|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|64|410614782|Male and Female|Other mesenchymal|2013-2017|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|74|82108087|Male and Female|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82108087|Male and Female|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|85|82082905|Male and Female|Other mesenchymal|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82082905|Male and Female|Other mesenchymal|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|99|82110969|Male and Female|Other mesenchymal|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82110969|Male and Female|Other mesenchymal|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|90|82066030|Male and Female|Other mesenchymal|2017|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82066030|Male and Female|Other mesenchymal|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|0.9|0.9|Malignant|701|81754354|Male and Female|Pilocytic astrocytoma|2004|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.8|0.9|0.8|Malignant|673|82005260|Male and Female|Pilocytic astrocytoma|2005|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|677|82324418|Male and Female|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.8|0.9|0.8|Malignant|686|82749431|Male and Female|Pilocytic astrocytoma|2007|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|0.9|0.9|Malignant|729|83118264|Male and Female|Pilocytic astrocytoma|2008|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.9|Malignant|720|83280391|Male and Female|Pilocytic astrocytoma|2009|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.9|1.0|0.9|Malignant|769|83181903|Male and Female|Pilocytic astrocytoma|2010|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|751|82827710|Male and Female|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.0|1.0|Malignant|801|82483581|Male and Female|Pilocytic astrocytoma|2012|0.9|1.0|1.0
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.0|1.0|Malignant|796|82246791|Male and Female|Pilocytic astrocytoma|2013|0.9|1.0|1.0
0-19|~|~|~|Benign/Borderline|~|410614782|Male and Female|Pilocytic astrocytoma|2013-2017|~|~|~
0-19|0.9|1.0|0.9|Malignant|3793|410614782|Male and Female|Pilocytic astrocytoma|2013-2017|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Pilocytic astrocytoma|2014|~|~|~
0-19|0.9|1.0|1.0|Malignant|779|82108087|Male and Female|Pilocytic astrocytoma|2014|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|732|82082905|Male and Female|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|Pilocytic astrocytoma|2016|~|~|~
0-19|0.8|0.9|0.8|Malignant|686|82110969|Male and Female|Pilocytic astrocytoma|2016|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|Pilocytic astrocytoma|2017|~|~|~
0-19|0.9|1.0|1.0|Malignant|800|82066030|Male and Female|Pilocytic astrocytoma|2017|0.9|1.0|1.0
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pineal parenchymal|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|82005260|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pineal parenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|82324418|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82749431|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pineal parenchymal|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83181903|Male and Female|Pineal parenchymal|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83181903|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82827710|Male and Female|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|82827710|Male and Female|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82483581|Male and Female|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|82483581|Male and Female|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82246791|Male and Female|Pineal parenchymal|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|30|82246791|Male and Female|Pineal parenchymal|2013|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|37|410614782|Male and Female|Pineal parenchymal|2013-2017|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|176|410614782|Male and Female|Pineal parenchymal|2013-2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82108087|Male and Female|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|39|82108087|Male and Female|Pineal parenchymal|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82082905|Male and Female|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|82082905|Male and Female|Pineal parenchymal|2015|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82110969|Male and Female|Pineal parenchymal|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|82110969|Male and Female|Pineal parenchymal|2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82066030|Male and Female|Pineal parenchymal|2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|82066030|Male and Female|Pineal parenchymal|2017|0.0|0.0|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|356|81754354|Male and Female|Pituitary|2004|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|81754354|Male and Female|Pituitary|2004|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|434|82005260|Male and Female|Pituitary|2005|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82005260|Male and Female|Pituitary|2005|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|451|82324418|Male and Female|Pituitary|2006|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82324418|Male and Female|Pituitary|2006|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|456|82749431|Male and Female|Pituitary|2007|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|82749431|Male and Female|Pituitary|2007|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|530|83118264|Male and Female|Pituitary|2008|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|83118264|Male and Female|Pituitary|2008|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|555|83280391|Male and Female|Pituitary|2009|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|83280391|Male and Female|Pituitary|2009|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|595|83181903|Male and Female|Pituitary|2010|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|83181903|Male and Female|Pituitary|2010|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|608|82827710|Male and Female|Pituitary|2011|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82827710|Male and Female|Pituitary|2011|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|657|82483581|Male and Female|Pituitary|2012|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|82483581|Male and Female|Pituitary|2012|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|638|82246791|Male and Female|Pituitary|2013|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|82246791|Male and Female|Pituitary|2013|~|~|~
0-19|0.8|0.8|0.8|Benign/Borderline|3404|410614782|Male and Female|Pituitary|2013-2017|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|410614782|Male and Female|Pituitary|2013-2017|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|703|82108087|Male and Female|Pituitary|2014|0.8|0.9|0.9
0-19|~|~|~|Malignant|~|82108087|Male and Female|Pituitary|2014|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|653|82082905|Male and Female|Pituitary|2015|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|82082905|Male and Female|Pituitary|2015|~|~|~
0-19|0.8|0.9|0.9|Benign/Borderline|714|82110969|Male and Female|Pituitary|2016|0.8|0.9|0.9
0-19|~|~|~|Malignant|~|82110969|Male and Female|Pituitary|2016|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|696|82066030|Male and Female|Pituitary|2017|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|82066030|Male and Female|Pituitary|2017|~|~|~
0-19|1.7|1.9|1.8|Benign/Borderline|1473|81754354|Male and Female|Total|2004|1.7|1.9|1.8
0-19|3.3|3.6|3.5|Malignant|2811|81754354|Male and Female|Total|2004|3.3|3.6|3.4
0-19|2.0|2.2|2.1|Benign/Borderline|1743|82005260|Male and Female|Total|2005|2.0|2.2|2.1
0-19|3.1|3.4|3.3|Malignant|2668|82005260|Male and Female|Total|2005|3.1|3.4|3.3
0-19|2.0|2.2|2.1|Benign/Borderline|1777|82324418|Male and Female|Total|2006|2.1|2.3|2.2
0-19|3.2|3.5|3.3|Malignant|2740|82324418|Male and Female|Total|2006|3.2|3.5|3.3
0-19|2.1|2.3|2.2|Benign/Borderline|1836|82749431|Male and Female|Total|2007|2.1|2.3|2.2
0-19|3.3|3.6|3.4|Malignant|2823|82749431|Male and Female|Total|2007|3.3|3.5|3.4
0-19|2.2|2.4|2.3|Benign/Borderline|1925|83118264|Male and Female|Total|2008|2.2|2.4|2.3
0-19|3.4|3.6|3.5|Malignant|2892|83118264|Male and Female|Total|2008|3.4|3.6|3.5
0-19|2.3|2.5|2.4|Benign/Borderline|2033|83280391|Male and Female|Total|2009|2.3|2.5|2.4
0-19|3.3|3.6|3.4|Malignant|2853|83280391|Male and Female|Total|2009|3.3|3.6|3.4
0-19|2.3|2.6|2.4|Benign/Borderline|2056|83181903|Male and Female|Total|2010|2.4|2.6|2.5
0-19|3.4|3.6|3.5|Malignant|2904|83181903|Male and Female|Total|2010|3.4|3.6|3.5
0-19|2.5|2.7|2.6|Benign/Borderline|2139|82827710|Male and Female|Total|2011|2.5|2.7|2.6
0-19|3.4|3.7|3.6|Malignant|2938|82827710|Male and Female|Total|2011|3.4|3.7|3.5
0-19|2.6|2.8|2.7|Benign/Borderline|2246|82483581|Male and Female|Total|2012|2.6|2.8|2.7
0-19|3.3|3.6|3.5|Malignant|2849|82483581|Male and Female|Total|2012|3.3|3.6|3.5
0-19|2.6|2.8|2.7|Benign/Borderline|2235|82246791|Male and Female|Total|2013|2.6|2.8|2.7
0-19|3.5|3.7|3.6|Malignant|2940|82246791|Male and Female|Total|2013|3.4|3.7|3.6
0-19|2.7|2.8|2.7|Benign/Borderline|11225|410614782|Male and Female|Total|2013-2017|2.7|2.8|2.7
0-19|3.4|3.6|3.5|Malignant|14357|410614782|Male and Female|Total|2013-2017|3.4|3.6|3.5
0-19|2.6|2.8|2.7|Benign/Borderline|2245|82108087|Male and Female|Total|2014|2.6|2.8|2.7
0-19|3.4|3.7|3.6|Malignant|2927|82108087|Male and Female|Total|2014|3.4|3.7|3.6
0-19|2.6|2.9|2.7|Benign/Borderline|2257|82082905|Male and Female|Total|2015|2.6|2.9|2.7
0-19|3.4|3.6|3.5|Malignant|2865|82082905|Male and Female|Total|2015|3.4|3.6|3.5
0-19|2.7|2.9|2.8|Benign/Borderline|2331|82110969|Male and Female|Total|2016|2.7|3.0|2.8
0-19|3.3|3.5|3.4|Malignant|2780|82110969|Male and Female|Total|2016|3.3|3.5|3.4
0-19|2.5|2.7|2.6|Benign/Borderline|2157|82066030|Male and Female|Total|2017|2.5|2.7|2.6
0-19|3.3|3.6|3.5|Malignant|2845|82066030|Male and Female|Total|2017|3.3|3.6|3.5
0-19|0.3|0.3|0.3|Benign/Borderline|242|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|289|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.4|0.4|0.4|Benign/Borderline|329|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.4|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|291|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|293|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|311|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|270|83181903|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83181903|Male and Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|280|82827710|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82827710|Male and Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|298|82483581|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82483581|Male and Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|305|82246791|Male and Female|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82246791|Male and Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|1372|410614782|Male and Female|Tumors of Cranial and Spinal Nerves|2013-2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|410614782|Male and Female|Tumors of Cranial and Spinal Nerves|2013-2017|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|250|82108087|Male and Female|Tumors of Cranial and Spinal Nerves|2014|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82108087|Male and Female|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|304|82082905|Male and Female|Tumors of Cranial and Spinal Nerves|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82082905|Male and Female|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|293|82110969|Male and Female|Tumors of Cranial and Spinal Nerves|2016|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82110969|Male and Female|Tumors of Cranial and Spinal Nerves|2016|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|220|82066030|Male and Female|Tumors of Cranial and Spinal Nerves|2017|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82066030|Male and Female|Tumors of Cranial and Spinal Nerves|2017|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|422|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.0|3.3|3.2|Malignant|2571|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|3.0|3.3|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|459|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.6
0-19|2.9|3.1|3.0|Malignant|2443|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|2.9|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|461|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.6
0-19|3.0|3.2|3.1|Malignant|2522|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|2.9|3.2|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|499|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.6|0.7|0.6
0-19|3.1|3.3|3.2|Malignant|2612|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|3.0|3.3|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|508|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.6|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|2674|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|3.1|3.3|3.2
0-19|0.5|0.6|0.6|Benign/Borderline|488|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.6
0-19|3.0|3.3|3.2|Malignant|2628|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|3.0|3.3|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|516|83181903|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.6|0.7|0.6
0-19|3.1|3.3|3.2|Malignant|2668|83181903|Male and Female|Tumors of Neuroepthelial Tissue|2010|3.1|3.3|3.2
0-19|0.6|0.7|0.7|Benign/Borderline|550|82827710|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.6|0.7|0.7
0-19|3.2|3.4|3.3|Malignant|2722|82827710|Male and Female|Tumors of Neuroepthelial Tissue|2011|3.2|3.4|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|574|82483581|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.6|0.8|0.7
0-19|3.1|3.3|3.2|Malignant|2617|82483581|Male and Female|Tumors of Neuroepthelial Tissue|2012|3.1|3.3|3.2
0-19|0.6|0.7|0.7|Benign/Borderline|565|82246791|Male and Female|Tumors of Neuroepthelial Tissue|2013|0.6|0.7|0.7
0-19|3.2|3.4|3.3|Malignant|2694|82246791|Male and Female|Tumors of Neuroepthelial Tissue|2013|3.2|3.4|3.3
0-19|0.7|0.7|0.7|Benign/Borderline|2857|410614782|Male and Female|Tumors of Neuroepthelial Tissue|2013-2017|0.7|0.7|0.7
0-19|3.1|3.3|3.2|Malignant|13135|410614782|Male and Female|Tumors of Neuroepthelial Tissue|2013-2017|3.1|3.3|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|525|82108087|Male and Female|Tumors of Neuroepthelial Tissue|2014|0.6|0.7|0.6
0-19|3.2|3.4|3.3|Malignant|2703|82108087|Male and Female|Tumors of Neuroepthelial Tissue|2014|3.2|3.4|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|568|82082905|Male and Female|Tumors of Neuroepthelial Tissue|2015|0.6|0.8|0.7
0-19|3.1|3.3|3.2|Malignant|2628|82082905|Male and Female|Tumors of Neuroepthelial Tissue|2015|3.1|3.3|3.2
0-19|0.7|0.8|0.8|Benign/Borderline|628|82110969|Male and Female|Tumors of Neuroepthelial Tissue|2016|0.7|0.8|0.8
0-19|3.0|3.2|3.1|Malignant|2519|82110969|Male and Female|Tumors of Neuroepthelial Tissue|2016|2.9|3.2|3.1
0-19|0.6|0.8|0.7|Benign/Borderline|571|82066030|Male and Female|Tumors of Neuroepthelial Tissue|2017|0.6|0.8|0.7
0-19|3.0|3.3|3.2|Malignant|2591|82066030|Male and Female|Tumors of Neuroepthelial Tissue|2017|3.0|3.3|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|524|81754354|Male and Female|Tumors of Sellar Region|2004|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|606|82005260|Male and Female|Tumors of Sellar Region|2005|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|609|82324418|Male and Female|Tumors of Sellar Region|2006|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|638|82749431|Male and Female|Tumors of Sellar Region|2007|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|690|83118264|Male and Female|Tumors of Sellar Region|2008|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Sellar Region|2008|~|~|~
0-19|0.8|0.9|0.9|Benign/Borderline|726|83280391|Male and Female|Tumors of Sellar Region|2009|0.8|0.9|0.9
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Sellar Region|2009|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|770|83181903|Male and Female|Tumors of Sellar Region|2010|0.9|1.0|0.9
0-19|~|~|~|Malignant|~|83181903|Male and Female|Tumors of Sellar Region|2010|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|765|82827710|Male and Female|Tumors of Sellar Region|2011|0.9|1.0|0.9
0-19|~|~|~|Malignant|~|82827710|Male and Female|Tumors of Sellar Region|2011|~|~|~
0-19|0.9|1.0|1.0|Benign/Borderline|814|82483581|Male and Female|Tumors of Sellar Region|2012|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|82483581|Male and Female|Tumors of Sellar Region|2012|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|819|82246791|Male and Female|Tumors of Sellar Region|2013|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|82246791|Male and Female|Tumors of Sellar Region|2013|~|~|~
0-19|1.0|1.1|1.0|Benign/Borderline|4269|410614782|Male and Female|Tumors of Sellar Region|2013-2017|1.0|1.1|1.0
0-19|~|~|~|Malignant|~|410614782|Male and Female|Tumors of Sellar Region|2013-2017|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|899|82108087|Male and Female|Tumors of Sellar Region|2014|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|82108087|Male and Female|Tumors of Sellar Region|2014|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|828|82082905|Male and Female|Tumors of Sellar Region|2015|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|82082905|Male and Female|Tumors of Sellar Region|2015|~|~|~
0-19|1.0|1.1|1.0|Benign/Borderline|855|82110969|Male and Female|Tumors of Sellar Region|2016|1.0|1.1|1.0
0-19|~|~|~|Malignant|~|82110969|Male and Female|Tumors of Sellar Region|2016|~|~|~
0-19|1.0|1.1|1.0|Benign/Borderline|868|82066030|Male and Female|Tumors of Sellar Region|2017|1.0|1.1|1.1
0-19|~|~|~|Malignant|~|82066030|Male and Female|Tumors of Sellar Region|2017|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|146|81754354|Male and Female|Tumors of the Meninges|2004|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|20|81754354|Male and Female|Tumors of the Meninges|2004|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|196|82005260|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|82005260|Male and Female|Tumors of the Meninges|2005|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|159|82324418|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Tumors of the Meninges|2006|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|176|82749431|Male and Female|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|17|82749431|Male and Female|Tumors of the Meninges|2007|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|178|83118264|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|199|83280391|Male and Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|22|83280391|Male and Female|Tumors of the Meninges|2009|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|191|83181903|Male and Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|83181903|Male and Female|Tumors of the Meninges|2010|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|231|82827710|Male and Female|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|16|82827710|Male and Female|Tumors of the Meninges|2011|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|259|82483581|Male and Female|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|21|82483581|Male and Female|Tumors of the Meninges|2012|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|240|82246791|Male and Female|Tumors of the Meninges|2013|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|22|82246791|Male and Female|Tumors of the Meninges|2013|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|1239|410614782|Male and Female|Tumors of the Meninges|2013-2017|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|100|410614782|Male and Female|Tumors of the Meninges|2013-2017|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|252|82108087|Male and Female|Tumors of the Meninges|2014|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|18|82108087|Male and Female|Tumors of the Meninges|2014|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|254|82082905|Male and Female|Tumors of the Meninges|2015|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|23|82082905|Male and Female|Tumors of the Meninges|2015|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|249|82110969|Male and Female|Tumors of the Meninges|2016|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|22|82110969|Male and Female|Tumors of the Meninges|2016|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|244|82066030|Male and Female|Tumors of the Meninges|2017|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82066030|Male and Female|Tumors of the Meninges|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|108|81754354|Male and Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|157|82005260|Male and Female|Unclassified Tumors|2005|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|39|82005260|Male and Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|175|82324418|Male and Female|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|51|82324418|Male and Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|199|82749431|Male and Female|Unclassified Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|42|82749431|Male and Female|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|216|83118264|Male and Female|Unclassified Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|262|83280391|Male and Female|Unclassified Tumors|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|40|83280391|Male and Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|266|83181903|Male and Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|28|83181903|Male and Female|Unclassified Tumors|2010|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|276|82827710|Male and Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|36|82827710|Male and Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|262|82483581|Male and Female|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|56|82483581|Male and Female|Unclassified Tumors|2012|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|260|82246791|Male and Female|Unclassified Tumors|2013|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|43|82246791|Male and Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|1270|410614782|Male and Female|Unclassified Tumors|2013-2017|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|230|410614782|Male and Female|Unclassified Tumors|2013-2017|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|271|82108087|Male and Female|Unclassified Tumors|2014|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|50|82108087|Male and Female|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|268|82082905|Male and Female|Unclassified Tumors|2015|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|37|82082905|Male and Female|Unclassified Tumors|2015|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|252|82110969|Male and Female|Unclassified Tumors|2016|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|48|82110969|Male and Female|Unclassified Tumors|2016|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|219|82066030|Male and Female|Unclassified Tumors|2017|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|52|82066030|Male and Female|Unclassified Tumors|2017|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|52|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|61|82005260|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|30|82005260|Male and Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|50|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|38|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|67|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|58|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|66|83118264|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|31|83118264|Male and Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|78|83280391|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|44|83280391|Male and Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|59|83181903|Male and Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|26|83181903|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|61|82827710|Male and Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|51|82827710|Male and Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|73|82483581|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|44|82483581|Male and Female|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|73|82246791|Male and Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|42|82246791|Male and Female|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|296|410614782|Male and Female|Unique astrocytoma variants|2013-2017|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|221|410614782|Male and Female|Unique astrocytoma variants|2013-2017|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|83|82108087|Male and Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|42|82108087|Male and Female|Unique astrocytoma variants|2014|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|44|82082905|Male and Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|51|82082905|Male and Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|52|82110969|Male and Female|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|46|82110969|Male and Female|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|44|82066030|Male and Female|Unique astrocytoma variants|2017|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|40|82066030|Male and Female|Unique astrocytoma variants|2017|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|All other|2004|~|~|~
20+|~|~|~|Malignant|~|109112165|Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|110320645|Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|23|111567226|Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|19|112783993|Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|All other|2007|~|~|~
20+|~|~|~|Benign/Borderline|~|114027722|Female|All other|2008|~|~|~
20+|~|~|~|Malignant|~|114027722|Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|115293599|Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|20|116616265|Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|116616265|Female|All other|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117908205|Female|All other|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|21|117908205|Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|20|119171985|Female|All other|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119171985|Female|All other|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|120333643|Female|All other|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|22|120333643|Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|107|613253733|Female|All other|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|127|613253733|Female|All other|2013-2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|121537081|Female|All other|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|22|121537081|Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|20|122685213|Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|122685213|Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|30|123817960|Female|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|123817960|Female|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|28|124879836|Female|All other|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|30|124879836|Female|All other|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|566|109112165|Female|Anaplastic astrocytoma|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|514|110320645|Female|Anaplastic astrocytoma|2005|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|511|111567226|Female|Anaplastic astrocytoma|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|529|112783993|Female|Anaplastic astrocytoma|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|503|114027722|Female|Anaplastic astrocytoma|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|501|115293599|Female|Anaplastic astrocytoma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116616265|Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|572|116616265|Female|Anaplastic astrocytoma|2010|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|117908205|Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.4|0.5|0.5|Malignant|571|117908205|Female|Anaplastic astrocytoma|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|119171985|Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|586|119171985|Female|Anaplastic astrocytoma|2012|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|120333643|Female|Anaplastic astrocytoma|2013|~|~|~
20+|0.5|0.6|0.5|Malignant|639|120333643|Female|Anaplastic astrocytoma|2013|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|613253733|Female|Anaplastic astrocytoma|2013-2017|~|~|~
20+|0.5|0.5|0.5|Malignant|3247|613253733|Female|Anaplastic astrocytoma|2013-2017|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|121537081|Female|Anaplastic astrocytoma|2014|~|~|~
20+|0.4|0.5|0.5|Malignant|612|121537081|Female|Anaplastic astrocytoma|2014|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|122685213|Female|Anaplastic astrocytoma|2015|~|~|~
20+|0.5|0.6|0.6|Malignant|699|122685213|Female|Anaplastic astrocytoma|2015|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|123817960|Female|Anaplastic astrocytoma|2016|~|~|~
20+|0.5|0.5|0.5|Malignant|637|123817960|Female|Anaplastic astrocytoma|2016|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|124879836|Female|Anaplastic astrocytoma|2017|~|~|~
20+|0.5|0.6|0.5|Malignant|660|124879836|Female|Anaplastic astrocytoma|2017|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.1|0.2|0.2|Malignant|183|109112165|Female|Anaplastic oligodendroglioma|2004|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|166|110320645|Female|Anaplastic oligodendroglioma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|137|111567226|Female|Anaplastic oligodendroglioma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|158|112783993|Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|170|114027722|Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|145|115293599|Female|Anaplastic oligodendroglioma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116616265|Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|134|116616265|Female|Anaplastic oligodendroglioma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117908205|Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|153|117908205|Female|Anaplastic oligodendroglioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|119171985|Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|169|119171985|Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|120333643|Female|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.1|0.2|0.1|Malignant|153|120333643|Female|Anaplastic oligodendroglioma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|613253733|Female|Anaplastic oligodendroglioma|2013-2017|~|~|~
20+|0.1|0.1|0.1|Malignant|815|613253733|Female|Anaplastic oligodendroglioma|2013-2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121537081|Female|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|151|121537081|Female|Anaplastic oligodendroglioma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122685213|Female|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.1|Malignant|164|122685213|Female|Anaplastic oligodendroglioma|2015|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|123817960|Female|Anaplastic oligodendroglioma|2016|~|~|~
20+|0.1|0.2|0.1|Malignant|168|123817960|Female|Anaplastic oligodendroglioma|2016|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|124879836|Female|Anaplastic oligodendroglioma|2017|~|~|~
20+|0.1|0.2|0.1|Malignant|179|124879836|Female|Anaplastic oligodendroglioma|2017|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|570|109112165|Female|Astrocytoma, NOS|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.5|0.5|Malignant|564|110320645|Female|Astrocytoma, NOS|2005|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Astrocytoma, NOS|2006|~|~|~
20+|0.4|0.5|0.5|Malignant|539|111567226|Female|Astrocytoma, NOS|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Astrocytoma, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|534|112783993|Female|Astrocytoma, NOS|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Astrocytoma, NOS|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|494|114027722|Female|Astrocytoma, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|480|115293599|Female|Astrocytoma, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116616265|Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|477|116616265|Female|Astrocytoma, NOS|2010|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|117908205|Female|Astrocytoma, NOS|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|461|117908205|Female|Astrocytoma, NOS|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|119171985|Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.5|0.4|Malignant|492|119171985|Female|Astrocytoma, NOS|2012|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|120333643|Female|Astrocytoma, NOS|2013|~|~|~
20+|0.3|0.4|0.4|Malignant|447|120333643|Female|Astrocytoma, NOS|2013|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|613253733|Female|Astrocytoma, NOS|2013-2017|~|~|~
20+|0.4|0.4|0.4|Malignant|2510|613253733|Female|Astrocytoma, NOS|2013-2017|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|121537081|Female|Astrocytoma, NOS|2014|~|~|~
20+|0.4|0.4|0.4|Malignant|487|121537081|Female|Astrocytoma, NOS|2014|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|122685213|Female|Astrocytoma, NOS|2015|~|~|~
20+|0.4|0.5|0.4|Malignant|515|122685213|Female|Astrocytoma, NOS|2015|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|123817960|Female|Astrocytoma, NOS|2016|~|~|~
20+|0.4|0.5|0.4|Malignant|565|123817960|Female|Astrocytoma, NOS|2016|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|124879836|Female|Astrocytoma, NOS|2017|~|~|~
20+|0.4|0.4|0.4|Malignant|496|124879836|Female|Astrocytoma, NOS|2017|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|39|109112165|Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|110320645|Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Choroid plexus|2005|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|42|111567226|Female|Choroid plexus|2006|0.0|0.1|0.0
20+|~|~|~|Malignant|~|111567226|Female|Choroid plexus|2006|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|55|112783993|Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|112783993|Female|Choroid plexus|2007|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|49|114027722|Female|Choroid plexus|2008|0.0|0.1|0.0
20+|~|~|~|Malignant|~|114027722|Female|Choroid plexus|2008|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|45|115293599|Female|Choroid plexus|2009|0.0|0.1|0.0
20+|~|~|~|Malignant|~|115293599|Female|Choroid plexus|2009|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|50|116616265|Female|Choroid plexus|2010|0.0|0.1|0.0
20+|~|~|~|Malignant|~|116616265|Female|Choroid plexus|2010|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|52|117908205|Female|Choroid plexus|2011|0.0|0.1|0.0
20+|~|~|~|Malignant|~|117908205|Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|40|119171985|Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119171985|Female|Choroid plexus|2012|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|48|120333643|Female|Choroid plexus|2013|0.0|0.1|0.0
20+|~|~|~|Malignant|~|120333643|Female|Choroid plexus|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|220|613253733|Female|Choroid plexus|2013-2017|0.0|0.0|0.0
20+|~|~|~|Malignant|~|613253733|Female|Choroid plexus|2013-2017|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|47|121537081|Female|Choroid plexus|2014|0.0|0.1|0.0
20+|~|~|~|Malignant|~|121537081|Female|Choroid plexus|2014|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|46|122685213|Female|Choroid plexus|2015|0.0|0.1|0.0
20+|~|~|~|Malignant|~|122685213|Female|Choroid plexus|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|41|123817960|Female|Choroid plexus|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|123817960|Female|Choroid plexus|2016|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|124879836|Female|Choroid plexus|2017|0.0|0.0|0.0
20+|~|~|~|Malignant|~|124879836|Female|Choroid plexus|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|204|109112165|Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Craniopharyngioma|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|185|110320645|Female|Craniopharyngioma|2005|0.1|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|201|111567226|Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|220|112783993|Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|225|114027722|Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|230|115293599|Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|238|116616265|Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116616265|Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|221|117908205|Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117908205|Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|224|119171985|Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|119171985|Female|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|244|120333643|Female|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|120333643|Female|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1148|613253733|Female|Craniopharyngioma|2013-2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|613253733|Female|Craniopharyngioma|2013-2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|223|121537081|Female|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121537081|Female|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|235|122685213|Female|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122685213|Female|Craniopharyngioma|2015|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|215|123817960|Female|Craniopharyngioma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|123817960|Female|Craniopharyngioma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|231|124879836|Female|Craniopharyngioma|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|124879836|Female|Craniopharyngioma|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|113|109112165|Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|130|110320645|Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|94|111567226|Female|Diffuse astrocytoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|133|112783993|Female|Diffuse astrocytoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|130|114027722|Female|Diffuse astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|161|115293599|Female|Diffuse astrocytoma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116616265|Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|162|116616265|Female|Diffuse astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|117908205|Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|114|117908205|Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119171985|Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|94|119171985|Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120333643|Female|Diffuse astrocytoma|2013|~|~|~
20+|0.0|0.1|0.1|Malignant|71|120333643|Female|Diffuse astrocytoma|2013|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|613253733|Female|Diffuse astrocytoma|2013-2017|~|~|~
20+|0.0|0.0|0.0|Malignant|192|613253733|Female|Diffuse astrocytoma|2013-2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|121537081|Female|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.0|Malignant|63|121537081|Female|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122685213|Female|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|35|122685213|Female|Diffuse astrocytoma|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|123817960|Female|Diffuse astrocytoma|2016|~|~|~
20+|~|~|~|Malignant|~|123817960|Female|Diffuse astrocytoma|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|124879836|Female|Diffuse astrocytoma|2017|~|~|~
20+|~|~|~|Malignant|~|124879836|Female|Diffuse astrocytoma|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|69|109112165|Female|Embryonal/primitive/medulloblastoma|2004|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|85|110320645|Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|74|111567226|Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|92|112783993|Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|89|114027722|Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|104|115293599|Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116616265|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|73|116616265|Female|Embryonal/primitive/medulloblastoma|2010|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117908205|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.0|0.1|0.1|Malignant|69|117908205|Female|Embryonal/primitive/medulloblastoma|2011|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119171985|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|81|119171985|Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120333643|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|88|120333643|Female|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|613253733|Female|Embryonal/primitive/medulloblastoma|2013-2017|~|~|~
20+|0.1|0.1|0.1|Malignant|355|613253733|Female|Embryonal/primitive/medulloblastoma|2013-2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121537081|Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|73|121537081|Female|Embryonal/primitive/medulloblastoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122685213|Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.0|0.1|0.1|Malignant|68|122685213|Female|Embryonal/primitive/medulloblastoma|2015|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|123817960|Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
20+|0.0|0.1|0.1|Malignant|63|123817960|Female|Embryonal/primitive/medulloblastoma|2016|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|124879836|Female|Embryonal/primitive/medulloblastoma|2017|~|~|~
20+|0.0|0.1|0.1|Malignant|63|124879836|Female|Embryonal/primitive/medulloblastoma|2017|0.0|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|105|109112165|Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|109112165|Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|120|110320645|Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|110320645|Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|149|111567226|Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|111567226|Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|114|112783993|Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|112783993|Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|110|114027722|Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|114027722|Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|113|115293599|Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|115293599|Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|122|116616265|Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|116616265|Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|118|117908205|Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|117908205|Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|130|119171985|Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|119171985|Female|Ependymoma variants|2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|118|120333643|Female|Ependymoma variants|2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|120333643|Female|Ependymoma variants|2013|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|615|613253733|Female|Ependymoma variants|2013-2017|0.1|0.1|0.1
20+|~|~|~|Malignant|~|613253733|Female|Ependymoma variants|2013-2017|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|131|121537081|Female|Ependymoma variants|2014|0.1|0.1|0.1
20+|~|~|~|Malignant|~|121537081|Female|Ependymoma variants|2014|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|133|122685213|Female|Ependymoma variants|2015|0.1|0.1|0.1
20+|~|~|~|Malignant|~|122685213|Female|Ependymoma variants|2015|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|122|123817960|Female|Ependymoma variants|2016|0.1|0.1|0.1
20+|~|~|~|Malignant|~|123817960|Female|Ependymoma variants|2016|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|111|124879836|Female|Ependymoma variants|2017|0.1|0.1|0.1
20+|~|~|~|Malignant|~|124879836|Female|Ependymoma variants|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|293|109112165|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|302|110320645|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|294|111567226|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|295|112783993|Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|313|114027722|Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|345|115293599|Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116616265|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|296|116616265|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117908205|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|297|117908205|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|119171985|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|303|119171985|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|120333643|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.2|Malignant|275|120333643|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|39|613253733|Female|Ependymoma/anaplastic ependymoma|2013-2017|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|1335|613253733|Female|Ependymoma/anaplastic ependymoma|2013-2017|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|121537081|Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|243|121537081|Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|122685213|Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
20+|0.2|0.3|0.2|Malignant|274|122685213|Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|123817960|Female|Ependymoma/anaplastic ependymoma|2016|~|~|~
20+|0.2|0.2|0.2|Malignant|268|123817960|Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|124879836|Female|Ependymoma/anaplastic ependymoma|2017|~|~|~
20+|0.2|0.3|0.2|Malignant|275|124879836|Female|Ependymoma/anaplastic ependymoma|2017|0.2|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|17|109112165|Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Germ Cell Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|110320645|Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Germ Cell Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|111567226|Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|Germ Cell Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|112783993|Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|Germ Cell Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|33|114027722|Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114027722|Female|Germ Cell Tumors|2008|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|43|115293599|Female|Germ Cell Tumors|2009|0.0|0.1|0.0
20+|~|~|~|Malignant|~|115293599|Female|Germ Cell Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|116616265|Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116616265|Female|Germ Cell Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|117908205|Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|117908205|Female|Germ Cell Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|119171985|Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119171985|Female|Germ Cell Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|25|120333643|Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|120333643|Female|Germ Cell Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|139|613253733|Female|Germ Cell Tumors|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|613253733|Female|Germ Cell Tumors|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|121537081|Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|121537081|Female|Germ Cell Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|122685213|Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|122685213|Female|Germ Cell Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|123817960|Female|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|123817960|Female|Germ Cell Tumors|2016|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|21|124879836|Female|Germ Cell Tumors|2017|0.0|0.0|0.0
20+|~|~|~|Malignant|~|124879836|Female|Germ Cell Tumors|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioblastoma|2004|~|~|~
20+|3.4|3.6|3.5|Malignant|4095|109112165|Female|Glioblastoma|2004|3.6|3.9|3.8
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioblastoma|2005|~|~|~
20+|3.4|3.6|3.5|Malignant|4161|110320645|Female|Glioblastoma|2005|3.7|3.9|3.8
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioblastoma|2006|~|~|~
20+|3.5|3.7|3.6|Malignant|4293|111567226|Female|Glioblastoma|2006|3.7|4.0|3.8
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioblastoma|2007|~|~|~
20+|3.5|3.7|3.6|Malignant|4371|112783993|Female|Glioblastoma|2007|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioblastoma|2008|~|~|~
20+|3.4|3.6|3.5|Malignant|4404|114027722|Female|Glioblastoma|2008|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioblastoma|2009|~|~|~
20+|3.4|3.6|3.5|Malignant|4481|115293599|Female|Glioblastoma|2009|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|116616265|Female|Glioblastoma|2010|~|~|~
20+|3.4|3.6|3.5|Malignant|4616|116616265|Female|Glioblastoma|2010|3.8|4.1|4.0
20+|~|~|~|Benign/Borderline|~|117908205|Female|Glioblastoma|2011|~|~|~
20+|3.4|3.6|3.5|Malignant|4587|117908205|Female|Glioblastoma|2011|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|119171985|Female|Glioblastoma|2012|~|~|~
20+|3.5|3.7|3.6|Malignant|4865|119171985|Female|Glioblastoma|2012|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|120333643|Female|Glioblastoma|2013|~|~|~
20+|3.4|3.6|3.5|Malignant|4915|120333643|Female|Glioblastoma|2013|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|613253733|Female|Glioblastoma|2013-2017|~|~|~
20+|3.5|3.5|3.5|Malignant|25162|613253733|Female|Glioblastoma|2013-2017|4.1|4.2|4.1
20+|~|~|~|Benign/Borderline|~|121537081|Female|Glioblastoma|2014|~|~|~
20+|3.3|3.5|3.4|Malignant|4790|121537081|Female|Glioblastoma|2014|3.8|4.1|3.9
20+|~|~|~|Benign/Borderline|~|122685213|Female|Glioblastoma|2015|~|~|~
20+|3.5|3.7|3.6|Malignant|5119|122685213|Female|Glioblastoma|2015|4.1|4.3|4.2
20+|~|~|~|Benign/Borderline|~|123817960|Female|Glioblastoma|2016|~|~|~
20+|3.4|3.6|3.5|Malignant|5193|123817960|Female|Glioblastoma|2016|4.1|4.3|4.2
20+|~|~|~|Benign/Borderline|~|124879836|Female|Glioblastoma|2017|~|~|~
20+|3.3|3.5|3.4|Malignant|5145|124879836|Female|Glioblastoma|2017|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioma malignant, NOS|2004|~|~|~
20+|0.3|0.4|0.4|Malignant|423|109112165|Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioma malignant, NOS|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|392|110320645|Female|Glioma malignant, NOS|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioma malignant, NOS|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|398|111567226|Female|Glioma malignant, NOS|2006|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioma malignant, NOS|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|413|112783993|Female|Glioma malignant, NOS|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioma malignant, NOS|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|445|114027722|Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|512|115293599|Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116616265|Female|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|411|116616265|Female|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|117908205|Female|Glioma malignant, NOS|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|450|117908205|Female|Glioma malignant, NOS|2011|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|17|119171985|Female|Glioma malignant, NOS|2012|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|437|119171985|Female|Glioma malignant, NOS|2012|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|18|120333643|Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|457|120333643|Female|Glioma malignant, NOS|2013|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|117|613253733|Female|Glioma malignant, NOS|2013-2017|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|2453|613253733|Female|Glioma malignant, NOS|2013-2017|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|25|121537081|Female|Glioma malignant, NOS|2014|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|444|121537081|Female|Glioma malignant, NOS|2014|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|27|122685213|Female|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|514|122685213|Female|Glioma malignant, NOS|2015|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|19|123817960|Female|Glioma malignant, NOS|2016|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|520|123817960|Female|Glioma malignant, NOS|2016|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|28|124879836|Female|Glioma malignant, NOS|2017|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|518|124879836|Female|Glioma malignant, NOS|2017|0.4|0.5|0.4
20+|0.2|0.2|0.2|Benign/Borderline|206|109112165|Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|230|110320645|Female|Hemangioblastoma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|222|111567226|Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|217|112783993|Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|239|114027722|Female|Hemangioblastoma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|237|115293599|Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|225|116616265|Female|Hemangioblastoma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116616265|Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|246|117908205|Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117908205|Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|257|119171985|Female|Hemangioblastoma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|119171985|Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|235|120333643|Female|Hemangioblastoma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|120333643|Female|Hemangioblastoma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1167|613253733|Female|Hemangioblastoma|2013-2017|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|613253733|Female|Hemangioblastoma|2013-2017|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|217|121537081|Female|Hemangioblastoma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121537081|Female|Hemangioblastoma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|243|122685213|Female|Hemangioblastoma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122685213|Female|Hemangioblastoma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|261|123817960|Female|Hemangioblastoma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|123817960|Female|Hemangioblastoma|2016|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|211|124879836|Female|Hemangioblastoma|2017|0.1|0.2|0.2
20+|~|~|~|Malignant|~|124879836|Female|Hemangioblastoma|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|235|109112165|Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|286|110320645|Female|Hemangioma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|110320645|Female|Hemangioma|2005|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|319|111567226|Female|Hemangioma|2006|0.3|0.3|0.3
20+|~|~|~|Malignant|~|111567226|Female|Hemangioma|2006|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|368|112783993|Female|Hemangioma|2007|0.3|0.4|0.3
20+|~|~|~|Malignant|~|112783993|Female|Hemangioma|2007|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|469|114027722|Female|Hemangioma|2008|0.4|0.5|0.4
20+|~|~|~|Malignant|~|114027722|Female|Hemangioma|2008|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|526|115293599|Female|Hemangioma|2009|0.4|0.5|0.5
20+|~|~|~|Malignant|~|115293599|Female|Hemangioma|2009|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|655|116616265|Female|Hemangioma|2010|0.5|0.6|0.6
20+|~|~|~|Malignant|~|116616265|Female|Hemangioma|2010|~|~|~
20+|0.6|0.6|0.6|Benign/Borderline|715|117908205|Female|Hemangioma|2011|0.6|0.7|0.6
20+|~|~|~|Malignant|~|117908205|Female|Hemangioma|2011|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|715|119171985|Female|Hemangioma|2012|0.6|0.6|0.6
20+|~|~|~|Malignant|~|119171985|Female|Hemangioma|2012|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|723|120333643|Female|Hemangioma|2013|0.6|0.6|0.6
20+|~|~|~|Malignant|~|120333643|Female|Hemangioma|2013|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|2937|613253733|Female|Hemangioma|2013-2017|0.5|0.5|0.5
20+|~|~|~|Malignant|~|613253733|Female|Hemangioma|2013-2017|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|648|121537081|Female|Hemangioma|2014|0.5|0.6|0.5
20+|~|~|~|Malignant|~|121537081|Female|Hemangioma|2014|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|566|122685213|Female|Hemangioma|2015|0.4|0.5|0.5
20+|~|~|~|Malignant|~|122685213|Female|Hemangioma|2015|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|526|123817960|Female|Hemangioma|2016|0.4|0.5|0.4
20+|~|~|~|Malignant|~|123817960|Female|Hemangioma|2016|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|474|124879836|Female|Hemangioma|2017|0.3|0.4|0.4
20+|~|~|~|Malignant|~|124879836|Female|Hemangioma|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|25|112783993|Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|24|115293599|Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116616265|Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|24|116616265|Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117908205|Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|20|117908205|Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|119171985|Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|20|119171985|Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|120333643|Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|~|~|~|Malignant|~|120333643|Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|613253733|Female|Local Extensions from Regional Tumors|2013-2017|~|~|~
20+|0.0|0.0|0.0|Malignant|90|613253733|Female|Local Extensions from Regional Tumors|2013-2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|121537081|Female|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|26|121537081|Female|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|122685213|Female|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|19|122685213|Female|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|123817960|Female|Local Extensions from Regional Tumors|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|16|123817960|Female|Local Extensions from Regional Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|124879836|Female|Local Extensions from Regional Tumors|2017|~|~|~
20+|~|~|~|Malignant|~|124879836|Female|Local Extensions from Regional Tumors|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|591|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|662|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|674|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|640|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|701|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|665|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|116616265|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|749|116616265|Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|117908205|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.5|0.6|0.6|Malignant|718|117908205|Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|119171985|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.5|0.6|0.5|Malignant|705|119171985|Female|Lymphomas and Hematopoietic Neoplasms|2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|120333643|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.5|0.6|0.6|Malignant|741|120333643|Female|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|613253733|Female|Lymphomas and Hematopoietic Neoplasms|2013-2017|~|~|~
20+|0.5|0.6|0.6|Malignant|3973|613253733|Female|Lymphomas and Hematopoietic Neoplasms|2013-2017|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|121537081|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.5|0.6|0.6|Malignant|816|121537081|Female|Lymphomas and Hematopoietic Neoplasms|2014|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|122685213|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.5|0.6|0.5|Malignant|757|122685213|Female|Lymphomas and Hematopoietic Neoplasms|2015|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|123817960|Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
20+|0.5|0.6|0.6|Malignant|831|123817960|Female|Lymphomas and Hematopoietic Neoplasms|2016|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|124879836|Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
20+|0.5|0.6|0.6|Malignant|828|124879836|Female|Lymphomas and Hematopoietic Neoplasms|2017|0.6|0.7|0.7
20+|12.0|12.4|12.2|Benign/Borderline|14154|109112165|Female|Meningioma|2004|12.8|13.2|13.0
20+|0.2|0.3|0.2|Malignant|272|109112165|Female|Meningioma|2004|0.2|0.3|0.2
20+|13.5|13.9|13.7|Benign/Borderline|16224|110320645|Female|Meningioma|2005|14.5|14.9|14.7
20+|0.2|0.3|0.2|Malignant|280|110320645|Female|Meningioma|2005|0.2|0.3|0.3
20+|14.1|14.6|14.4|Benign/Borderline|17268|111567226|Female|Meningioma|2006|15.2|15.7|15.5
20+|0.2|0.2|0.2|Malignant|252|111567226|Female|Meningioma|2006|0.2|0.3|0.2
20+|14.7|15.1|14.9|Benign/Borderline|18179|112783993|Female|Meningioma|2007|15.9|16.4|16.1
20+|0.2|0.2|0.2|Malignant|270|112783993|Female|Meningioma|2007|0.2|0.3|0.2
20+|15.4|15.9|15.6|Benign/Borderline|19444|114027722|Female|Meningioma|2008|16.8|17.3|17.1
20+|0.2|0.2|0.2|Malignant|217|114027722|Female|Meningioma|2008|0.2|0.2|0.2
20+|16.4|16.9|16.6|Benign/Borderline|21050|115293599|Female|Meningioma|2009|18.0|18.5|18.3
20+|0.1|0.2|0.2|Malignant|200|115293599|Female|Meningioma|2009|0.2|0.2|0.2
20+|15.8|16.3|16.0|Benign/Borderline|20634|116616265|Female|Meningioma|2010|17.5|17.9|17.7
20+|0.1|0.2|0.2|Malignant|206|116616265|Female|Meningioma|2010|0.2|0.2|0.2
20+|15.9|16.4|16.1|Benign/Borderline|21018|117908205|Female|Meningioma|2011|17.6|18.1|17.8
20+|0.1|0.2|0.1|Malignant|186|117908205|Female|Meningioma|2011|0.1|0.2|0.2
20+|16.2|16.6|16.4|Benign/Borderline|21787|119171985|Female|Meningioma|2012|18.0|18.5|18.3
20+|0.1|0.2|0.2|Malignant|202|119171985|Female|Meningioma|2012|0.1|0.2|0.2
20+|16.3|16.7|16.5|Benign/Borderline|22189|120333643|Female|Meningioma|2013|18.2|18.7|18.4
20+|0.1|0.2|0.2|Malignant|223|120333643|Female|Meningioma|2013|0.2|0.2|0.2
20+|16.7|16.9|16.8|Benign/Borderline|117335|613253733|Female|Meningioma|2013-2017|19.0|19.2|19.1
20+|0.1|0.1|0.1|Malignant|974|613253733|Female|Meningioma|2013-2017|0.1|0.2|0.2
20+|16.5|17.0|16.8|Benign/Borderline|22992|121537081|Female|Meningioma|2014|18.7|19.2|18.9
20+|0.1|0.2|0.2|Malignant|218|121537081|Female|Meningioma|2014|0.2|0.2|0.2
20+|16.9|17.3|17.1|Benign/Borderline|23841|122685213|Female|Meningioma|2015|19.2|19.7|19.4
20+|0.1|0.2|0.1|Malignant|196|122685213|Female|Meningioma|2015|0.1|0.2|0.2
20+|16.9|17.4|17.1|Benign/Borderline|24189|123817960|Female|Meningioma|2016|19.3|19.8|19.5
20+|0.1|0.1|0.1|Malignant|164|123817960|Female|Meningioma|2016|0.1|0.2|0.1
20+|16.5|17.0|16.7|Benign/Borderline|24124|124879836|Female|Meningioma|2017|19.1|19.6|19.3
20+|0.1|0.1|0.1|Malignant|173|124879836|Female|Meningioma|2017|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|197|109112165|Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Mixed glioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|236|110320645|Female|Mixed glioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Mixed glioma|2006|~|~|~
20+|0.2|0.3|0.2|Malignant|273|111567226|Female|Mixed glioma|2006|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|112783993|Female|Mixed glioma|2007|~|~|~
20+|0.2|0.2|0.2|Malignant|239|112783993|Female|Mixed glioma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114027722|Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.2|Malignant|263|114027722|Female|Mixed glioma|2008|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|115293599|Female|Mixed glioma|2009|~|~|~
20+|0.2|0.3|0.3|Malignant|286|115293599|Female|Mixed glioma|2009|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|116616265|Female|Mixed glioma|2010|~|~|~
20+|0.2|0.3|0.2|Malignant|270|116616265|Female|Mixed glioma|2010|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|117908205|Female|Mixed glioma|2011|~|~|~
20+|0.2|0.3|0.2|Malignant|272|117908205|Female|Mixed glioma|2011|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|119171985|Female|Mixed glioma|2012|~|~|~
20+|0.2|0.2|0.2|Malignant|242|119171985|Female|Mixed glioma|2012|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|120333643|Female|Mixed glioma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|248|120333643|Female|Mixed glioma|2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|613253733|Female|Mixed glioma|2013-2017|~|~|~
20+|0.1|0.1|0.1|Malignant|650|613253733|Female|Mixed glioma|2013-2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121537081|Female|Mixed glioma|2014|~|~|~
20+|0.1|0.2|0.2|Malignant|199|121537081|Female|Mixed glioma|2014|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|122685213|Female|Mixed glioma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|130|122685213|Female|Mixed glioma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|123817960|Female|Mixed glioma|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|42|123817960|Female|Mixed glioma|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|124879836|Female|Mixed glioma|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|31|124879836|Female|Mixed glioma|2017|0.0|0.0|0.0
20+|0.5|0.6|0.6|Benign/Borderline|687|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|703|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.8|0.7|Benign/Borderline|869|110320645|Female|Neoplasm, unspecified|2005|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|719|110320645|Female|Neoplasm, unspecified|2005|0.6|0.7|0.7
20+|0.6|0.7|0.7|Benign/Borderline|803|111567226|Female|Neoplasm, unspecified|2006|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|721|111567226|Female|Neoplasm, unspecified|2006|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|836|112783993|Female|Neoplasm, unspecified|2007|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|652|112783993|Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|835|114027722|Female|Neoplasm, unspecified|2008|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|751|114027722|Female|Neoplasm, unspecified|2008|0.6|0.7|0.7
20+|0.7|0.8|0.7|Benign/Borderline|919|115293599|Female|Neoplasm, unspecified|2009|0.7|0.9|0.8
20+|0.5|0.6|0.6|Malignant|785|115293599|Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.7|0.6|Benign/Borderline|819|116616265|Female|Neoplasm, unspecified|2010|0.7|0.8|0.7
20+|0.4|0.5|0.5|Malignant|650|116616265|Female|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|839|117908205|Female|Neoplasm, unspecified|2011|0.7|0.8|0.7
20+|0.4|0.5|0.5|Malignant|647|117908205|Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.7|0.7|Benign/Borderline|872|119171985|Female|Neoplasm, unspecified|2012|0.7|0.8|0.7
20+|0.4|0.5|0.5|Malignant|654|119171985|Female|Neoplasm, unspecified|2012|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|797|120333643|Female|Neoplasm, unspecified|2013|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|664|120333643|Female|Neoplasm, unspecified|2013|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|3958|613253733|Female|Neoplasm, unspecified|2013-2017|0.6|0.7|0.6
20+|0.4|0.5|0.4|Malignant|3382|613253733|Female|Neoplasm, unspecified|2013-2017|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|868|121537081|Female|Neoplasm, unspecified|2014|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|738|121537081|Female|Neoplasm, unspecified|2014|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|837|122685213|Female|Neoplasm, unspecified|2015|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|726|122685213|Female|Neoplasm, unspecified|2015|0.5|0.6|0.6
20+|0.5|0.6|0.5|Benign/Borderline|757|123817960|Female|Neoplasm, unspecified|2016|0.6|0.7|0.6
20+|0.4|0.4|0.4|Malignant|601|123817960|Female|Neoplasm, unspecified|2016|0.4|0.5|0.5
20+|0.5|0.5|0.5|Benign/Borderline|699|124879836|Female|Neoplasm, unspecified|2017|0.5|0.6|0.6
20+|0.4|0.5|0.4|Malignant|653|124879836|Female|Neoplasm, unspecified|2017|0.5|0.6|0.5
20+|2.2|2.4|2.3|Benign/Borderline|2555|109112165|Female|Nerve sheath, benign and malignant|2004|2.3|2.4|2.3
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2827|110320645|Female|Nerve sheath, benign and malignant|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|2949|111567226|Female|Nerve sheath, benign and malignant|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2953|112783993|Female|Nerve sheath, benign and malignant|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3079|114027722|Female|Nerve sheath, benign and malignant|2008|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|3235|115293599|Female|Nerve sheath, benign and malignant|2009|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3034|116616265|Female|Nerve sheath, benign and malignant|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|116616265|Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3278|117908205|Female|Nerve sheath, benign and malignant|2011|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|20|117908205|Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3472|119171985|Female|Nerve sheath, benign and malignant|2012|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|26|119171985|Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3626|120333643|Female|Nerve sheath, benign and malignant|2013|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|22|120333643|Female|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.7|2.8|2.8|Benign/Borderline|18191|613253733|Female|Nerve sheath, benign and malignant|2013-2017|2.9|3.0|3.0
20+|0.0|0.0|0.0|Malignant|106|613253733|Female|Nerve sheath, benign and malignant|2013-2017|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3747|121537081|Female|Nerve sheath, benign and malignant|2014|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|17|121537081|Female|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3772|122685213|Female|Nerve sheath, benign and malignant|2015|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|23|122685213|Female|Nerve sheath, benign and malignant|2015|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|3644|123817960|Female|Nerve sheath, benign and malignant|2016|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|25|123817960|Female|Nerve sheath, benign and malignant|2016|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3402|124879836|Female|Nerve sheath, benign and malignant|2017|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|19|124879836|Female|Nerve sheath, benign and malignant|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|16|111567226|Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|27|114027722|Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116616265|Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|116616265|Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117908205|Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|23|117908205|Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|119171985|Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|27|119171985|Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|120333643|Female|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|21|120333643|Female|Neuroepithelial|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|18|613253733|Female|Neuroepithelial|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|117|613253733|Female|Neuroepithelial|2013-2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|121537081|Female|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|22|121537081|Female|Neuroepithelial|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|122685213|Female|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|37|122685213|Female|Neuroepithelial|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|123817960|Female|Neuroepithelial|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|22|123817960|Female|Neuroepithelial|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|124879836|Female|Neuroepithelial|2017|~|~|~
20+|~|~|~|Malignant|~|124879836|Female|Neuroepithelial|2017|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|154|109112165|Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109112165|Female|Neuronal/glial, neuronal|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|184|110320645|Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|110320645|Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|187|111567226|Female|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|205|112783993|Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|112783993|Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|203|114027722|Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|114027722|Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|222|115293599|Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.3|0.2|Benign/Borderline|248|116616265|Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|116616265|Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|239|117908205|Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|117908205|Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|211|119171985|Female|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|119171985|Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|182|120333643|Female|Neuronal/glial, neuronal|2013|0.1|0.2|0.2
20+|~|~|~|Malignant|~|120333643|Female|Neuronal/glial, neuronal|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1128|613253733|Female|Neuronal/glial, neuronal|2013-2017|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|88|613253733|Female|Neuronal/glial, neuronal|2013-2017|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|234|121537081|Female|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121537081|Female|Neuronal/glial, neuronal|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|226|122685213|Female|Neuronal/glial, neuronal|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122685213|Female|Neuronal/glial, neuronal|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|236|123817960|Female|Neuronal/glial, neuronal|2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|27|123817960|Female|Neuronal/glial, neuronal|2016|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|250|124879836|Female|Neuronal/glial, neuronal|2017|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|124879836|Female|Neuronal/glial, neuronal|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Oligodendroglioma|2004|~|~|~
20+|0.3|0.4|0.3|Malignant|355|109112165|Female|Oligodendroglioma|2004|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|361|110320645|Female|Oligodendroglioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Oligodendroglioma|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|379|111567226|Female|Oligodendroglioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|373|112783993|Female|Oligodendroglioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|364|114027722|Female|Oligodendroglioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.4|0.3|Malignant|364|115293599|Female|Oligodendroglioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116616265|Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|330|116616265|Female|Oligodendroglioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117908205|Female|Oligodendroglioma|2011|~|~|~
20+|0.3|0.3|0.3|Malignant|321|117908205|Female|Oligodendroglioma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|119171985|Female|Oligodendroglioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|296|119171985|Female|Oligodendroglioma|2012|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|120333643|Female|Oligodendroglioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|343|120333643|Female|Oligodendroglioma|2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|613253733|Female|Oligodendroglioma|2013-2017|~|~|~
20+|0.3|0.3|0.3|Malignant|1592|613253733|Female|Oligodendroglioma|2013-2017|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|121537081|Female|Oligodendroglioma|2014|~|~|~
20+|0.2|0.3|0.3|Malignant|305|121537081|Female|Oligodendroglioma|2014|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|122685213|Female|Oligodendroglioma|2015|~|~|~
20+|0.2|0.3|0.3|Malignant|307|122685213|Female|Oligodendroglioma|2015|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|123817960|Female|Oligodendroglioma|2016|~|~|~
20+|0.3|0.3|0.3|Malignant|329|123817960|Female|Oligodendroglioma|2016|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|124879836|Female|Oligodendroglioma|2017|~|~|~
20+|0.2|0.3|0.3|Malignant|308|124879836|Female|Oligodendroglioma|2017|0.2|0.3|0.2
20+|0.0|0.1|0.1|Benign/Borderline|68|109112165|Female|Other mesenchymal|2004|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|109112165|Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|110320645|Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|110320645|Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|87|111567226|Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|28|111567226|Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|112783993|Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|112783993|Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|103|114027722|Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|51|114027722|Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|96|115293599|Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|25|115293599|Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|95|116616265|Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|116616265|Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|92|117908205|Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|117908205|Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|108|119171985|Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|39|119171985|Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|104|120333643|Female|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|40|120333643|Female|Other mesenchymal|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|470|613253733|Female|Other mesenchymal|2013-2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|209|613253733|Female|Other mesenchymal|2013-2017|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|94|121537081|Female|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|33|121537081|Female|Other mesenchymal|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|91|122685213|Female|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|37|122685213|Female|Other mesenchymal|2015|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|78|123817960|Female|Other mesenchymal|2016|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|39|123817960|Female|Other mesenchymal|2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|103|124879836|Female|Other mesenchymal|2017|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|60|124879836|Female|Other mesenchymal|2017|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|125|109112165|Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|150|110320645|Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|148|111567226|Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|165|112783993|Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|145|114027722|Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|135|115293599|Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116616265|Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|166|116616265|Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|117908205|Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|161|117908205|Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|119171985|Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|122|119171985|Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120333643|Female|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.2|0.1|Malignant|156|120333643|Female|Pilocytic astrocytoma|2013|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|613253733|Female|Pilocytic astrocytoma|2013-2017|~|~|~
20+|0.1|0.1|0.1|Malignant|708|613253733|Female|Pilocytic astrocytoma|2013-2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121537081|Female|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|147|121537081|Female|Pilocytic astrocytoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122685213|Female|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|145|122685213|Female|Pilocytic astrocytoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|123817960|Female|Pilocytic astrocytoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|136|123817960|Female|Pilocytic astrocytoma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|124879836|Female|Pilocytic astrocytoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|124|124879836|Female|Pilocytic astrocytoma|2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|18|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|34|110320645|Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|45|114027722|Female|Pineal parenchymal|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|42|116616265|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|23|116616265|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|46|117908205|Female|Pineal parenchymal|2011|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|26|117908205|Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|36|119171985|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|119171985|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|54|120333643|Female|Pineal parenchymal|2013|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|34|120333643|Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|220|613253733|Female|Pineal parenchymal|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|136|613253733|Female|Pineal parenchymal|2013-2017|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|44|121537081|Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|121537081|Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|51|122685213|Female|Pineal parenchymal|2015|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|31|122685213|Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|35|123817960|Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|28|123817960|Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|36|124879836|Female|Pineal parenchymal|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|25|124879836|Female|Pineal parenchymal|2017|0.0|0.0|0.0
20+|3.7|3.9|3.8|Benign/Borderline|4127|109112165|Female|Pituitary|2004|3.7|3.9|3.8
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Pituitary|2004|0.0|0.0|0.0
20+|4.3|4.5|4.4|Benign/Borderline|4808|110320645|Female|Pituitary|2005|4.2|4.5|4.4
20+|0.0|0.0|0.0|Malignant|24|110320645|Female|Pituitary|2005|0.0|0.0|0.0
20+|4.7|4.9|4.8|Benign/Borderline|5291|111567226|Female|Pituitary|2006|4.6|4.9|4.7
20+|~|~|~|Malignant|~|111567226|Female|Pituitary|2006|~|~|~
20+|4.8|5.1|4.9|Benign/Borderline|5493|112783993|Female|Pituitary|2007|4.7|5.0|4.9
20+|~|~|~|Malignant|~|112783993|Female|Pituitary|2007|~|~|~
20+|5.1|5.4|5.3|Benign/Borderline|5923|114027722|Female|Pituitary|2008|5.1|5.3|5.2
20+|~|~|~|Malignant|~|114027722|Female|Pituitary|2008|~|~|~
20+|5.6|5.9|5.7|Benign/Borderline|6520|115293599|Female|Pituitary|2009|5.5|5.8|5.7
20+|0.0|0.0|0.0|Malignant|17|115293599|Female|Pituitary|2009|0.0|0.0|0.0
20+|5.5|5.8|5.7|Benign/Borderline|6516|116616265|Female|Pituitary|2010|5.5|5.7|5.6
20+|0.0|0.0|0.0|Malignant|16|116616265|Female|Pituitary|2010|0.0|0.0|0.0
20+|5.7|5.9|5.8|Benign/Borderline|6703|117908205|Female|Pituitary|2011|5.5|5.8|5.7
20+|~|~|~|Malignant|~|117908205|Female|Pituitary|2011|~|~|~
20+|6.0|6.3|6.1|Benign/Borderline|7126|119171985|Female|Pituitary|2012|5.8|6.1|6.0
20+|~|~|~|Malignant|~|119171985|Female|Pituitary|2012|~|~|~
20+|5.8|6.1|5.9|Benign/Borderline|7051|120333643|Female|Pituitary|2013|5.7|6.0|5.9
20+|~|~|~|Malignant|~|120333643|Female|Pituitary|2013|~|~|~
20+|6.0|6.1|6.0|Benign/Borderline|36279|613253733|Female|Pituitary|2013-2017|5.9|6.0|5.9
20+|0.0|0.0|0.0|Malignant|54|613253733|Female|Pituitary|2013-2017|0.0|0.0|0.0
20+|5.9|6.2|6.0|Benign/Borderline|7169|121537081|Female|Pituitary|2014|5.8|6.0|5.9
20+|~|~|~|Malignant|~|121537081|Female|Pituitary|2014|~|~|~
20+|6.0|6.3|6.2|Benign/Borderline|7408|122685213|Female|Pituitary|2015|5.9|6.2|6.0
20+|~|~|~|Malignant|~|122685213|Female|Pituitary|2015|~|~|~
20+|5.9|6.2|6.0|Benign/Borderline|7331|123817960|Female|Pituitary|2016|5.8|6.1|5.9
20+|~|~|~|Malignant|~|123817960|Female|Pituitary|2016|~|~|~
20+|5.8|6.1|6.0|Benign/Borderline|7320|124879836|Female|Pituitary|2017|5.7|6.0|5.9
20+|~|~|~|Malignant|~|124879836|Female|Pituitary|2017|~|~|~
20+|19.6|20.1|19.9|Benign/Borderline|22639|109112165|Female|Total|2004|20.5|21.0|20.7
20+|7.5|7.8|7.6|Malignant|8739|109112165|Female|Total|2004|7.8|8.2|8.0
20+|22.2|22.8|22.5|Benign/Borderline|25999|110320645|Female|Total|2005|23.3|23.9|23.6
20+|7.5|7.8|7.7|Malignant|8919|110320645|Female|Total|2005|7.9|8.3|8.1
20+|23.3|23.9|23.6|Benign/Borderline|27669|111567226|Female|Total|2006|24.5|25.1|24.8
20+|7.5|7.8|7.6|Malignant|8983|111567226|Female|Total|2006|7.9|8.2|8.1
20+|24.0|24.5|24.2|Benign/Borderline|28875|112783993|Female|Total|2007|25.3|25.9|25.6
20+|7.4|7.7|7.6|Malignant|9077|112783993|Female|Total|2007|7.9|8.2|8.0
20+|25.2|25.8|25.5|Benign/Borderline|30848|114027722|Female|Total|2008|26.8|27.4|27.1
20+|7.4|7.7|7.6|Malignant|9227|114027722|Female|Total|2008|7.9|8.3|8.1
20+|26.9|27.5|27.2|Benign/Borderline|33375|115293599|Female|Total|2009|28.6|29.3|28.9
20+|7.4|7.7|7.6|Malignant|9372|115293599|Female|Total|2009|8.0|8.3|8.1
20+|26.1|26.7|26.4|Benign/Borderline|32802|116616265|Female|Total|2010|27.8|28.4|28.1
20+|7.2|7.5|7.4|Malignant|9317|116616265|Female|Total|2010|7.8|8.2|8.0
20+|26.5|27.1|26.8|Benign/Borderline|33715|117908205|Female|Total|2011|28.3|28.9|28.6
20+|7.0|7.3|7.2|Malignant|9207|117908205|Female|Total|2011|7.6|8.0|7.8
20+|27.2|27.8|27.5|Benign/Borderline|35139|119171985|Female|Total|2012|29.2|29.8|29.5
20+|7.1|7.4|7.3|Malignant|9471|119171985|Female|Total|2012|7.8|8.1|7.9
20+|27.1|27.7|27.4|Benign/Borderline|35524|120333643|Female|Total|2013|29.2|29.8|29.5
20+|7.1|7.4|7.3|Malignant|9627|120333643|Female|Total|2013|7.8|8.2|8.0
20+|27.5|27.8|27.6|Benign/Borderline|184511|613253733|Female|Total|2013-2017|30.0|30.2|30.1
20+|7.0|7.1|7.1|Malignant|48410|613253733|Female|Total|2013-2017|7.8|8.0|7.9
20+|27.5|28.1|27.8|Benign/Borderline|36590|121537081|Female|Total|2014|29.8|30.4|30.1
20+|6.9|7.2|7.0|Malignant|9492|121537081|Female|Total|2014|7.7|8.0|7.8
20+|27.9|28.5|28.2|Benign/Borderline|37634|122685213|Female|Total|2015|30.4|31.0|30.7
20+|7.1|7.4|7.2|Malignant|9867|122685213|Female|Total|2015|7.9|8.2|8.0
20+|27.5|28.1|27.8|Benign/Borderline|37607|123817960|Female|Total|2016|30.1|30.7|30.4
20+|6.8|7.1|7.0|Malignant|9752|123817960|Female|Total|2016|7.7|8.0|7.9
20+|26.7|27.3|27.0|Benign/Borderline|37156|124879836|Female|Total|2017|29.5|30.1|29.8
20+|6.7|7.0|6.8|Malignant|9672|124879836|Female|Total|2017|7.6|7.9|7.7
20+|2.2|2.4|2.3|Benign/Borderline|2555|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|2.3|2.4|2.3
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2830|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|2950|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2954|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3081|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|3238|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3037|116616265|Female|Tumors of Cranial and Spinal Nerves|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|116616265|Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3280|117908205|Female|Tumors of Cranial and Spinal Nerves|2011|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|20|117908205|Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3472|119171985|Female|Tumors of Cranial and Spinal Nerves|2012|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|26|119171985|Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3627|120333643|Female|Tumors of Cranial and Spinal Nerves|2013|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|22|120333643|Female|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.7|2.8|2.8|Benign/Borderline|18206|613253733|Female|Tumors of Cranial and Spinal Nerves|2013-2017|2.9|3.0|3.0
20+|0.0|0.0|0.0|Malignant|106|613253733|Female|Tumors of Cranial and Spinal Nerves|2013-2017|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3753|121537081|Female|Tumors of Cranial and Spinal Nerves|2014|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|17|121537081|Female|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3775|122685213|Female|Tumors of Cranial and Spinal Nerves|2015|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|23|122685213|Female|Tumors of Cranial and Spinal Nerves|2015|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|3648|123817960|Female|Tumors of Cranial and Spinal Nerves|2016|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|25|123817960|Female|Tumors of Cranial and Spinal Nerves|2016|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3403|124879836|Female|Tumors of Cranial and Spinal Nerves|2017|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|19|124879836|Female|Tumors of Cranial and Spinal Nerves|2017|0.0|0.0|0.0
20+|0.3|0.4|0.4|Benign/Borderline|381|109112165|Female|Tumors of Neuroepthelial Tissue|2004|0.3|0.4|0.3
20+|6.1|6.4|6.2|Malignant|7059|109112165|Female|Tumors of Neuroepthelial Tissue|2004|6.3|6.6|6.5
20+|0.4|0.4|0.4|Benign/Borderline|442|110320645|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.4|0.4
20+|6.0|6.3|6.2|Malignant|7147|110320645|Female|Tumors of Neuroepthelial Tissue|2005|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|484|111567226|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7230|111567226|Female|Tumors of Neuroepthelial Tissue|2006|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|484|112783993|Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.4
20+|6.1|6.4|6.2|Malignant|7394|112783993|Female|Tumors of Neuroepthelial Tissue|2007|6.4|6.7|6.6
20+|0.4|0.5|0.4|Benign/Borderline|489|114027722|Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7422|114027722|Female|Tumors of Neuroepthelial Tissue|2008|6.4|6.7|6.5
20+|0.4|0.5|0.5|Benign/Borderline|513|115293599|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.4
20+|6.1|6.3|6.2|Malignant|7622|115293599|Female|Tumors of Neuroepthelial Tissue|2009|6.5|6.8|6.6
20+|0.4|0.5|0.5|Benign/Borderline|547|116616265|Female|Tumors of Neuroepthelial Tissue|2010|0.4|0.5|0.5
20+|5.9|6.2|6.1|Malignant|7600|116616265|Female|Tumors of Neuroepthelial Tissue|2010|6.4|6.7|6.5
20+|0.4|0.5|0.5|Benign/Borderline|560|117908205|Female|Tumors of Neuroepthelial Tissue|2011|0.4|0.5|0.5
20+|5.8|6.1|5.9|Malignant|7556|117908205|Female|Tumors of Neuroepthelial Tissue|2011|6.3|6.6|6.4
20+|0.4|0.5|0.5|Benign/Borderline|541|119171985|Female|Tumors of Neuroepthelial Tissue|2012|0.4|0.5|0.5
20+|5.9|6.2|6.0|Malignant|7795|119171985|Female|Tumors of Neuroepthelial Tissue|2012|6.4|6.7|6.5
20+|0.4|0.5|0.4|Benign/Borderline|525|120333643|Female|Tumors of Neuroepthelial Tissue|2013|0.4|0.5|0.4
20+|5.9|6.1|6.0|Malignant|7892|120333643|Female|Tumors of Neuroepthelial Tissue|2013|6.4|6.7|6.6
20+|0.5|0.5|0.5|Benign/Borderline|2857|613253733|Female|Tumors of Neuroepthelial Tissue|2013-2017|0.4|0.5|0.5
20+|5.8|5.9|5.8|Malignant|39536|613253733|Female|Tumors of Neuroepthelial Tissue|2013-2017|6.4|6.5|6.4
20+|0.5|0.5|0.5|Benign/Borderline|593|121537081|Female|Tumors of Neuroepthelial Tissue|2014|0.4|0.5|0.5
20+|5.6|5.8|5.7|Malignant|7611|121537081|Female|Tumors of Neuroepthelial Tissue|2014|6.1|6.4|6.3
20+|0.5|0.6|0.5|Benign/Borderline|602|122685213|Female|Tumors of Neuroepthelial Tissue|2015|0.5|0.5|0.5
20+|5.9|6.1|6.0|Malignant|8078|122685213|Female|Tumors of Neuroepthelial Tissue|2015|6.4|6.7|6.6
20+|0.4|0.5|0.5|Benign/Borderline|570|123817960|Female|Tumors of Neuroepthelial Tissue|2016|0.4|0.5|0.5
20+|5.7|5.9|5.8|Malignant|8050|123817960|Female|Tumors of Neuroepthelial Tissue|2016|6.4|6.6|6.5
20+|0.4|0.5|0.5|Benign/Borderline|567|124879836|Female|Tumors of Neuroepthelial Tissue|2017|0.4|0.5|0.5
20+|5.5|5.8|5.6|Malignant|7905|124879836|Female|Tumors of Neuroepthelial Tissue|2017|6.2|6.5|6.3
20+|3.9|4.1|4.0|Benign/Borderline|4331|109112165|Female|Tumors of Sellar Region|2004|3.9|4.1|4.0
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.4|4.7|4.6|Benign/Borderline|4993|110320645|Female|Tumors of Sellar Region|2005|4.4|4.7|4.5
20+|0.0|0.0|0.0|Malignant|25|110320645|Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.8|5.1|5.0|Benign/Borderline|5492|111567226|Female|Tumors of Sellar Region|2006|4.8|5.1|4.9
20+|~|~|~|Malignant|~|111567226|Female|Tumors of Sellar Region|2006|~|~|~
20+|5.0|5.3|5.1|Benign/Borderline|5713|112783993|Female|Tumors of Sellar Region|2007|4.9|5.2|5.1
20+|~|~|~|Malignant|~|112783993|Female|Tumors of Sellar Region|2007|~|~|~
20+|5.3|5.6|5.5|Benign/Borderline|6148|114027722|Female|Tumors of Sellar Region|2008|5.3|5.5|5.4
20+|~|~|~|Malignant|~|114027722|Female|Tumors of Sellar Region|2008|~|~|~
20+|5.8|6.1|5.9|Benign/Borderline|6750|115293599|Female|Tumors of Sellar Region|2009|5.7|6.0|5.9
20+|0.0|0.0|0.0|Malignant|18|115293599|Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|5.7|6.0|5.9|Benign/Borderline|6754|116616265|Female|Tumors of Sellar Region|2010|5.7|5.9|5.8
20+|0.0|0.0|0.0|Malignant|16|116616265|Female|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|5.8|6.1|6.0|Benign/Borderline|6924|117908205|Female|Tumors of Sellar Region|2011|5.7|6.0|5.9
20+|~|~|~|Malignant|~|117908205|Female|Tumors of Sellar Region|2011|~|~|~
20+|6.2|6.5|6.3|Benign/Borderline|7350|119171985|Female|Tumors of Sellar Region|2012|6.0|6.3|6.2
20+|~|~|~|Malignant|~|119171985|Female|Tumors of Sellar Region|2012|~|~|~
20+|6.0|6.3|6.1|Benign/Borderline|7295|120333643|Female|Tumors of Sellar Region|2013|5.9|6.2|6.1
20+|0.0|0.0|0.0|Malignant|16|120333643|Female|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|6.1|6.3|6.2|Benign/Borderline|37427|613253733|Female|Tumors of Sellar Region|2013-2017|6.0|6.2|6.1
20+|0.0|0.0|0.0|Malignant|58|613253733|Female|Tumors of Sellar Region|2013-2017|0.0|0.0|0.0
20+|6.1|6.4|6.2|Benign/Borderline|7392|121537081|Female|Tumors of Sellar Region|2014|5.9|6.2|6.1
20+|~|~|~|Malignant|~|121537081|Female|Tumors of Sellar Region|2014|~|~|~
20+|6.2|6.5|6.4|Benign/Borderline|7643|122685213|Female|Tumors of Sellar Region|2015|6.1|6.4|6.2
20+|~|~|~|Malignant|~|122685213|Female|Tumors of Sellar Region|2015|~|~|~
20+|6.0|6.3|6.2|Benign/Borderline|7546|123817960|Female|Tumors of Sellar Region|2016|6.0|6.2|6.1
20+|~|~|~|Malignant|~|123817960|Female|Tumors of Sellar Region|2016|~|~|~
20+|6.0|6.3|6.1|Benign/Borderline|7551|124879836|Female|Tumors of Sellar Region|2017|5.9|6.2|6.0
20+|~|~|~|Malignant|~|124879836|Female|Tumors of Sellar Region|2017|~|~|~
20+|12.2|12.6|12.4|Benign/Borderline|14428|109112165|Female|Tumors of the Meninges|2004|13.0|13.4|13.2
20+|0.2|0.3|0.3|Malignant|298|109112165|Female|Tumors of the Meninges|2004|0.2|0.3|0.3
20+|13.8|14.2|14.0|Benign/Borderline|16537|110320645|Female|Tumors of the Meninges|2005|14.8|15.2|15.0
20+|0.2|0.3|0.3|Malignant|307|110320645|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
20+|14.4|14.9|14.6|Benign/Borderline|17577|111567226|Female|Tumors of the Meninges|2006|15.5|16.0|15.8
20+|0.2|0.3|0.2|Malignant|283|111567226|Female|Tumors of the Meninges|2006|0.2|0.3|0.3
20+|14.9|15.4|15.2|Benign/Borderline|18479|112783993|Female|Tumors of the Meninges|2007|16.1|16.6|16.4
20+|0.2|0.3|0.3|Malignant|310|112783993|Female|Tumors of the Meninges|2007|0.2|0.3|0.3
20+|15.7|16.2|15.9|Benign/Borderline|19786|114027722|Female|Tumors of the Meninges|2008|17.1|17.6|17.4
20+|0.2|0.2|0.2|Malignant|269|114027722|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
20+|16.7|17.2|16.9|Benign/Borderline|21383|115293599|Female|Tumors of the Meninges|2009|18.3|18.8|18.5
20+|0.2|0.2|0.2|Malignant|227|115293599|Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|16.1|16.5|16.3|Benign/Borderline|20954|116616265|Female|Tumors of the Meninges|2010|17.7|18.2|18.0
20+|0.2|0.2|0.2|Malignant|241|116616265|Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|16.2|16.6|16.4|Benign/Borderline|21356|117908205|Female|Tumors of the Meninges|2011|17.9|18.4|18.1
20+|0.1|0.2|0.2|Malignant|217|117908205|Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|16.5|17.0|16.7|Benign/Borderline|22152|119171985|Female|Tumors of the Meninges|2012|18.3|18.8|18.6
20+|0.2|0.2|0.2|Malignant|241|119171985|Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|16.6|17.0|16.8|Benign/Borderline|22528|120333643|Female|Tumors of the Meninges|2013|18.5|19.0|18.7
20+|0.2|0.2|0.2|Malignant|267|120333643|Female|Tumors of the Meninges|2013|0.2|0.3|0.2
20+|17.0|17.2|17.1|Benign/Borderline|118972|613253733|Female|Tumors of the Meninges|2013-2017|19.3|19.5|19.4
20+|0.2|0.2|0.2|Malignant|1201|613253733|Female|Tumors of the Meninges|2013-2017|0.2|0.2|0.2
20+|16.8|17.2|17.0|Benign/Borderline|23303|121537081|Female|Tumors of the Meninges|2014|18.9|19.4|19.2
20+|0.2|0.2|0.2|Malignant|256|121537081|Female|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|17.1|17.6|17.3|Benign/Borderline|24175|122685213|Female|Tumors of the Meninges|2015|19.5|20.0|19.7
20+|0.2|0.2|0.2|Malignant|237|122685213|Female|Tumors of the Meninges|2015|0.2|0.2|0.2
20+|17.2|17.6|17.4|Benign/Borderline|24528|123817960|Female|Tumors of the Meninges|2016|19.6|20.1|19.8
20+|0.1|0.2|0.1|Malignant|206|123817960|Female|Tumors of the Meninges|2016|0.1|0.2|0.2
20+|16.8|17.2|17.0|Benign/Borderline|24438|124879836|Female|Tumors of the Meninges|2017|19.3|19.8|19.6
20+|0.1|0.2|0.2|Malignant|235|124879836|Female|Tumors of the Meninges|2017|0.2|0.2|0.2
20+|0.8|0.9|0.8|Benign/Borderline|926|109112165|Female|Unclassified Tumors|2004|0.8|0.9|0.8
20+|0.5|0.6|0.6|Malignant|709|109112165|Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.1|1.0|Benign/Borderline|1159|110320645|Female|Unclassified Tumors|2005|1.0|1.1|1.1
20+|0.5|0.6|0.6|Malignant|723|110320645|Female|Unclassified Tumors|2005|0.6|0.7|0.7
20+|0.9|1.0|1.0|Benign/Borderline|1130|111567226|Female|Unclassified Tumors|2006|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|726|111567226|Female|Unclassified Tumors|2006|0.6|0.7|0.7
20+|0.9|1.1|1.0|Benign/Borderline|1208|112783993|Female|Unclassified Tumors|2007|1.0|1.1|1.1
20+|0.5|0.5|0.5|Malignant|655|112783993|Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|1310|114027722|Female|Unclassified Tumors|2008|1.1|1.2|1.1
20+|0.5|0.6|0.6|Malignant|765|114027722|Female|Unclassified Tumors|2008|0.6|0.7|0.7
20+|1.1|1.3|1.2|Benign/Borderline|1446|115293599|Female|Unclassified Tumors|2009|1.2|1.3|1.3
20+|0.5|0.6|0.6|Malignant|792|115293599|Female|Unclassified Tumors|2009|0.6|0.7|0.7
20+|1.1|1.3|1.2|Benign/Borderline|1477|116616265|Female|Unclassified Tumors|2010|1.2|1.3|1.3
20+|0.4|0.5|0.5|Malignant|657|116616265|Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.2|1.3|1.3|Benign/Borderline|1558|117908205|Female|Unclassified Tumors|2011|1.3|1.4|1.3
20+|0.4|0.5|0.5|Malignant|653|117908205|Female|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.2|1.3|1.2|Benign/Borderline|1588|119171985|Female|Unclassified Tumors|2012|1.3|1.4|1.3
20+|0.4|0.5|0.5|Malignant|659|119171985|Female|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.1|1.3|1.2|Benign/Borderline|1524|120333643|Female|Unclassified Tumors|2013|1.2|1.3|1.3
20+|0.4|0.5|0.5|Malignant|668|120333643|Female|Unclassified Tumors|2013|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|6907|613253733|Female|Unclassified Tumors|2013-2017|1.1|1.2|1.1
20+|0.4|0.5|0.5|Malignant|3415|613253733|Female|Unclassified Tumors|2013-2017|0.5|0.6|0.6
20+|1.1|1.2|1.2|Benign/Borderline|1517|121537081|Female|Unclassified Tumors|2014|1.2|1.3|1.2
20+|0.5|0.5|0.5|Malignant|745|121537081|Female|Unclassified Tumors|2014|0.6|0.7|0.6
20+|1.0|1.1|1.1|Benign/Borderline|1406|122685213|Female|Unclassified Tumors|2015|1.1|1.2|1.1
20+|0.5|0.5|0.5|Malignant|734|122685213|Female|Unclassified Tumors|2015|0.6|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1285|123817960|Female|Unclassified Tumors|2016|1.0|1.1|1.0
20+|0.4|0.4|0.4|Malignant|607|123817960|Female|Unclassified Tumors|2016|0.5|0.5|0.5
20+|0.8|0.9|0.9|Benign/Borderline|1175|124879836|Female|Unclassified Tumors|2017|0.9|1.0|0.9
20+|0.4|0.5|0.4|Malignant|661|124879836|Female|Unclassified Tumors|2017|0.5|0.6|0.5
20+|0.0|0.1|0.0|Benign/Borderline|54|109112165|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|18|109112165|Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|43|110320645|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|49|111567226|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|24|111567226|Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|62|112783993|Female|Unique astrocytoma variants|2007|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|19|112783993|Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|59|114027722|Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|75|115293599|Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|70|116616265|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|20|116616265|Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|81|117908205|Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|117908205|Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|101|119171985|Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|119171985|Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|96|120333643|Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|120333643|Female|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|490|613253733|Female|Unique astrocytoma variants|2013-2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|155|613253733|Female|Unique astrocytoma variants|2013-2017|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|100|121537081|Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|121537081|Female|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|103|122685213|Female|Unique astrocytoma variants|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|23|122685213|Female|Unique astrocytoma variants|2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|104|123817960|Female|Unique astrocytoma variants|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|123817960|Female|Unique astrocytoma variants|2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|87|124879836|Female|Unique astrocytoma variants|2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|28|124879836|Female|Unique astrocytoma variants|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|All other|2005|~|~|~
20+|~|~|~|Malignant|~|103190694|Male|All other|2005|~|~|~
20+|~|~|~|Benign/Borderline|~|104488268|Male|All other|2006|~|~|~
20+|~|~|~|Malignant|~|104488268|Male|All other|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|105697783|Male|All other|2007|~|~|~
20+|~|~|~|Malignant|~|105697783|Male|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|22|106947980|Male|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|All other|2008|~|~|~
20+|~|~|~|Benign/Borderline|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Malignant|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|109527917|Male|All other|2010|~|~|~
20+|~|~|~|Malignant|~|109527917|Male|All other|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|110844094|Male|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|24|110844094|Male|All other|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112218652|Male|All other|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|21|112218652|Male|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|19|113477293|Male|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|28|113477293|Male|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|138|579536769|Male|All other|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|130|579536769|Male|All other|2013-2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114741253|Male|All other|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|27|114741253|Male|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|115974555|Male|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|115974555|Male|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|43|117142413|Male|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|117142413|Male|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|38|118201255|Male|All other|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|23|118201255|Male|All other|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.7|0.7|Malignant|671|101938779|Male|Anaplastic astrocytoma|2004|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic astrocytoma|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|700|103190694|Male|Anaplastic astrocytoma|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic astrocytoma|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|699|104488268|Male|Anaplastic astrocytoma|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic astrocytoma|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|673|105697783|Male|Anaplastic astrocytoma|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic astrocytoma|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|709|106947980|Male|Anaplastic astrocytoma|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic astrocytoma|2009|~|~|~
20+|0.6|0.7|0.7|Malignant|713|108197539|Male|Anaplastic astrocytoma|2009|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109527917|Male|Anaplastic astrocytoma|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|707|109527917|Male|Anaplastic astrocytoma|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|110844094|Male|Anaplastic astrocytoma|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|709|110844094|Male|Anaplastic astrocytoma|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|112218652|Male|Anaplastic astrocytoma|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|751|112218652|Male|Anaplastic astrocytoma|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|113477293|Male|Anaplastic astrocytoma|2013|~|~|~
20+|0.6|0.7|0.7|Malignant|789|113477293|Male|Anaplastic astrocytoma|2013|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|579536769|Male|Anaplastic astrocytoma|2013-2017|~|~|~
20+|0.7|0.7|0.7|Malignant|3947|579536769|Male|Anaplastic astrocytoma|2013-2017|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|114741253|Male|Anaplastic astrocytoma|2014|~|~|~
20+|0.6|0.7|0.7|Malignant|787|114741253|Male|Anaplastic astrocytoma|2014|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|115974555|Male|Anaplastic astrocytoma|2015|~|~|~
20+|0.6|0.7|0.7|Malignant|778|115974555|Male|Anaplastic astrocytoma|2015|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|117142413|Male|Anaplastic astrocytoma|2016|~|~|~
20+|0.6|0.7|0.7|Malignant|823|117142413|Male|Anaplastic astrocytoma|2016|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|118201255|Male|Anaplastic astrocytoma|2017|~|~|~
20+|0.6|0.7|0.6|Malignant|770|118201255|Male|Anaplastic astrocytoma|2017|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|211|101938779|Male|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|210|103190694|Male|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|217|104488268|Male|Anaplastic oligodendroglioma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|183|105697783|Male|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|189|106947980|Male|Anaplastic oligodendroglioma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|189|108197539|Male|Anaplastic oligodendroglioma|2009|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109527917|Male|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.2|0.2|0.2|Malignant|194|109527917|Male|Anaplastic oligodendroglioma|2010|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110844094|Male|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|182|110844094|Male|Anaplastic oligodendroglioma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|112218652|Male|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.2|Malignant|188|112218652|Male|Anaplastic oligodendroglioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|113477293|Male|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|220|113477293|Male|Anaplastic oligodendroglioma|2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|579536769|Male|Anaplastic oligodendroglioma|2013-2017|~|~|~
20+|0.2|0.2|0.2|Malignant|1042|579536769|Male|Anaplastic oligodendroglioma|2013-2017|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114741253|Male|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|202|114741253|Male|Anaplastic oligodendroglioma|2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|115974555|Male|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.2|Malignant|189|115974555|Male|Anaplastic oligodendroglioma|2015|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|117142413|Male|Anaplastic oligodendroglioma|2016|~|~|~
20+|0.2|0.2|0.2|Malignant|201|117142413|Male|Anaplastic oligodendroglioma|2016|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|118201255|Male|Anaplastic oligodendroglioma|2017|~|~|~
20+|0.2|0.2|0.2|Malignant|230|118201255|Male|Anaplastic oligodendroglioma|2017|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|101938779|Male|Astrocytoma, NOS|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|637|101938779|Male|Astrocytoma, NOS|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|103190694|Male|Astrocytoma, NOS|2005|~|~|~
20+|0.6|0.7|0.6|Malignant|634|103190694|Male|Astrocytoma, NOS|2005|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|104488268|Male|Astrocytoma, NOS|2006|~|~|~
20+|0.6|0.7|0.6|Malignant|649|104488268|Male|Astrocytoma, NOS|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|105697783|Male|Astrocytoma, NOS|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|625|105697783|Male|Astrocytoma, NOS|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|626|106947980|Male|Astrocytoma, NOS|2008|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Astrocytoma, NOS|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|574|108197539|Male|Astrocytoma, NOS|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|109527917|Male|Astrocytoma, NOS|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|615|109527917|Male|Astrocytoma, NOS|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|110844094|Male|Astrocytoma, NOS|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|581|110844094|Male|Astrocytoma, NOS|2011|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|112218652|Male|Astrocytoma, NOS|2012|~|~|~
20+|0.5|0.5|0.5|Malignant|558|112218652|Male|Astrocytoma, NOS|2012|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|113477293|Male|Astrocytoma, NOS|2013|~|~|~
20+|0.5|0.5|0.5|Malignant|564|113477293|Male|Astrocytoma, NOS|2013|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|579536769|Male|Astrocytoma, NOS|2013-2017|~|~|~
20+|0.5|0.6|0.5|Malignant|3205|579536769|Male|Astrocytoma, NOS|2013-2017|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|114741253|Male|Astrocytoma, NOS|2014|~|~|~
20+|0.5|0.6|0.5|Malignant|599|114741253|Male|Astrocytoma, NOS|2014|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|115974555|Male|Astrocytoma, NOS|2015|~|~|~
20+|0.5|0.6|0.6|Malignant|673|115974555|Male|Astrocytoma, NOS|2015|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|117142413|Male|Astrocytoma, NOS|2016|~|~|~
20+|0.5|0.6|0.6|Malignant|680|117142413|Male|Astrocytoma, NOS|2016|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|118201255|Male|Astrocytoma, NOS|2017|~|~|~
20+|0.5|0.6|0.6|Malignant|689|118201255|Male|Astrocytoma, NOS|2017|0.5|0.6|0.6
20+|0.0|0.0|0.0|Benign/Borderline|24|101938779|Male|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|101938779|Male|Choroid plexus|2004|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|37|103190694|Male|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|103190694|Male|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|104488268|Male|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104488268|Male|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|34|105697783|Male|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|27|106947980|Male|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|108197539|Male|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108197539|Male|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|109527917|Male|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109527917|Male|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|110844094|Male|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110844094|Male|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|34|112218652|Male|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112218652|Male|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|113477293|Male|Choroid plexus|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|113477293|Male|Choroid plexus|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|187|579536769|Male|Choroid plexus|2013-2017|0.0|0.0|0.0
20+|~|~|~|Malignant|~|579536769|Male|Choroid plexus|2013-2017|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|41|114741253|Male|Choroid plexus|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114741253|Male|Choroid plexus|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|115974555|Male|Choroid plexus|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115974555|Male|Choroid plexus|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|117142413|Male|Choroid plexus|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|117142413|Male|Choroid plexus|2016|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|48|118201255|Male|Choroid plexus|2017|0.0|0.1|0.0
20+|~|~|~|Malignant|~|118201255|Male|Choroid plexus|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|185|101938779|Male|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|101938779|Male|Craniopharyngioma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|231|103190694|Male|Craniopharyngioma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|103190694|Male|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|191|104488268|Male|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|200|105697783|Male|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|105697783|Male|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|198|106947980|Male|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106947980|Male|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|202|108197539|Male|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|108197539|Male|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|202|109527917|Male|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109527917|Male|Craniopharyngioma|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|196|110844094|Male|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110844094|Male|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|216|112218652|Male|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112218652|Male|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|227|113477293|Male|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|113477293|Male|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1128|579536769|Male|Craniopharyngioma|2013-2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|579536769|Male|Craniopharyngioma|2013-2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|203|114741253|Male|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114741253|Male|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|221|115974555|Male|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115974555|Male|Craniopharyngioma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|240|117142413|Male|Craniopharyngioma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117142413|Male|Craniopharyngioma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|237|118201255|Male|Craniopharyngioma|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|118201255|Male|Craniopharyngioma|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|145|101938779|Male|Diffuse astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|150|103190694|Male|Diffuse astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Diffuse astrocytoma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|200|104488268|Male|Diffuse astrocytoma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Diffuse astrocytoma|2007|~|~|~
20+|0.2|0.2|0.2|Malignant|185|105697783|Male|Diffuse astrocytoma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Diffuse astrocytoma|2008|~|~|~
20+|0.2|0.2|0.2|Malignant|210|106947980|Male|Diffuse astrocytoma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Diffuse astrocytoma|2009|~|~|~
20+|0.2|0.2|0.2|Malignant|208|108197539|Male|Diffuse astrocytoma|2009|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109527917|Male|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|187|109527917|Male|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110844094|Male|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|137|110844094|Male|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112218652|Male|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|113|112218652|Male|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113477293|Male|Diffuse astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|103|113477293|Male|Diffuse astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|579536769|Male|Diffuse astrocytoma|2013-2017|~|~|~
20+|0.0|0.0|0.0|Malignant|257|579536769|Male|Diffuse astrocytoma|2013-2017|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|114741253|Male|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|69|114741253|Male|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115974555|Male|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.1|0.0|Malignant|49|115974555|Male|Diffuse astrocytoma|2015|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|117142413|Male|Diffuse astrocytoma|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|23|117142413|Male|Diffuse astrocytoma|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118201255|Male|Diffuse astrocytoma|2017|~|~|~
20+|~|~|~|Malignant|~|118201255|Male|Diffuse astrocytoma|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|98|101938779|Male|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|105|103190694|Male|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|97|104488268|Male|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|105697783|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|124|105697783|Male|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|123|106947980|Male|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|133|108197539|Male|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109527917|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|125|109527917|Male|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110844094|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|118|110844094|Male|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112218652|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|93|112218652|Male|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113477293|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|97|113477293|Male|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|579536769|Male|Embryonal/primitive/medulloblastoma|2013-2017|~|~|~
20+|0.1|0.1|0.1|Malignant|518|579536769|Male|Embryonal/primitive/medulloblastoma|2013-2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114741253|Male|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|106|114741253|Male|Embryonal/primitive/medulloblastoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115974555|Male|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|99|115974555|Male|Embryonal/primitive/medulloblastoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117142413|Male|Embryonal/primitive/medulloblastoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|119|117142413|Male|Embryonal/primitive/medulloblastoma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|118201255|Male|Embryonal/primitive/medulloblastoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|97|118201255|Male|Embryonal/primitive/medulloblastoma|2017|0.1|0.1|0.1
20+|0.1|0.2|0.1|Benign/Borderline|141|101938779|Male|Ependymoma variants|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Ependymoma variants|2004|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|150|103190694|Male|Ependymoma variants|2005|0.1|0.2|0.1
20+|~|~|~|Malignant|~|103190694|Male|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|161|104488268|Male|Ependymoma variants|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|136|105697783|Male|Ependymoma variants|2007|0.1|0.2|0.1
20+|~|~|~|Malignant|~|105697783|Male|Ependymoma variants|2007|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|145|106947980|Male|Ependymoma variants|2008|0.1|0.2|0.1
20+|~|~|~|Malignant|~|106947980|Male|Ependymoma variants|2008|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|147|108197539|Male|Ependymoma variants|2009|0.1|0.2|0.1
20+|~|~|~|Malignant|~|108197539|Male|Ependymoma variants|2009|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|155|109527917|Male|Ependymoma variants|2010|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109527917|Male|Ependymoma variants|2010|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|151|110844094|Male|Ependymoma variants|2011|0.1|0.2|0.1
20+|~|~|~|Malignant|~|110844094|Male|Ependymoma variants|2011|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|163|112218652|Male|Ependymoma variants|2012|0.1|0.2|0.1
20+|~|~|~|Malignant|~|112218652|Male|Ependymoma variants|2012|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|157|113477293|Male|Ependymoma variants|2013|0.1|0.2|0.1
20+|~|~|~|Malignant|~|113477293|Male|Ependymoma variants|2013|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|803|579536769|Male|Ependymoma variants|2013-2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|18|579536769|Male|Ependymoma variants|2013-2017|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|167|114741253|Male|Ependymoma variants|2014|0.1|0.2|0.1
20+|~|~|~|Malignant|~|114741253|Male|Ependymoma variants|2014|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|158|115974555|Male|Ependymoma variants|2015|0.1|0.2|0.1
20+|~|~|~|Malignant|~|115974555|Male|Ependymoma variants|2015|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|169|117142413|Male|Ependymoma variants|2016|0.1|0.2|0.1
20+|~|~|~|Malignant|~|117142413|Male|Ependymoma variants|2016|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|152|118201255|Male|Ependymoma variants|2017|0.1|0.2|0.1
20+|~|~|~|Malignant|~|118201255|Male|Ependymoma variants|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|302|101938779|Male|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|300|103190694|Male|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|291|104488268|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|289|105697783|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|320|106947980|Male|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|337|108197539|Male|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109527917|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|331|109527917|Male|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110844094|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|297|110844094|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112218652|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|327|112218652|Male|Ependymoma/anaplastic ependymoma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113477293|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.3|Malignant|301|113477293|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|69|579536769|Male|Ependymoma/anaplastic ependymoma|2013-2017|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|1542|579536769|Male|Ependymoma/anaplastic ependymoma|2013-2017|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|22|114741253|Male|Ependymoma/anaplastic ependymoma|2014|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|322|114741253|Male|Ependymoma/anaplastic ependymoma|2014|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115974555|Male|Ependymoma/anaplastic ependymoma|2015|~|~|~
20+|0.2|0.3|0.3|Malignant|306|115974555|Male|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117142413|Male|Ependymoma/anaplastic ependymoma|2016|~|~|~
20+|0.2|0.3|0.3|Malignant|319|117142413|Male|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|118201255|Male|Ependymoma/anaplastic ependymoma|2017|~|~|~
20+|0.2|0.3|0.2|Malignant|294|118201255|Male|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|21|101938779|Male|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|42|101938779|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|103190694|Male|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|54|103190694|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|29|104488268|Male|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|46|104488268|Male|Germ Cell Tumors|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|34|105697783|Male|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|76|105697783|Male|Germ Cell Tumors|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|33|106947980|Male|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|53|106947980|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|35|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|36|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|109527917|Male|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|56|109527917|Male|Germ Cell Tumors|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|24|110844094|Male|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|60|110844094|Male|Germ Cell Tumors|2011|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|32|112218652|Male|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|112218652|Male|Germ Cell Tumors|2012|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|113477293|Male|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|46|113477293|Male|Germ Cell Tumors|2013|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|136|579536769|Male|Germ Cell Tumors|2013-2017|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|289|579536769|Male|Germ Cell Tumors|2013-2017|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|114741253|Male|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|62|114741253|Male|Germ Cell Tumors|2014|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|28|115974555|Male|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|55|115974555|Male|Germ Cell Tumors|2015|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|30|117142413|Male|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|67|117142413|Male|Germ Cell Tumors|2016|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|27|118201255|Male|Germ Cell Tumors|2017|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|59|118201255|Male|Germ Cell Tumors|2017|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioblastoma|2004|~|~|~
20+|5.5|5.8|5.6|Malignant|5467|101938779|Male|Glioblastoma|2004|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioblastoma|2005|~|~|~
20+|5.5|5.8|5.6|Malignant|5544|103190694|Male|Glioblastoma|2005|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioblastoma|2006|~|~|~
20+|5.3|5.6|5.4|Malignant|5508|104488268|Male|Glioblastoma|2006|5.1|5.4|5.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioblastoma|2007|~|~|~
20+|5.5|5.7|5.6|Malignant|5820|105697783|Male|Glioblastoma|2007|5.4|5.6|5.5
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioblastoma|2008|~|~|~
20+|5.5|5.8|5.7|Malignant|6009|106947980|Male|Glioblastoma|2008|5.5|5.8|5.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioblastoma|2009|~|~|~
20+|5.4|5.7|5.6|Malignant|6014|108197539|Male|Glioblastoma|2009|5.4|5.7|5.6
20+|~|~|~|Benign/Borderline|~|109527917|Male|Glioblastoma|2010|~|~|~
20+|5.4|5.6|5.5|Malignant|6122|109527917|Male|Glioblastoma|2010|5.5|5.7|5.6
20+|~|~|~|Benign/Borderline|~|110844094|Male|Glioblastoma|2011|~|~|~
20+|5.4|5.7|5.5|Malignant|6304|110844094|Male|Glioblastoma|2011|5.5|5.8|5.7
20+|~|~|~|Benign/Borderline|~|112218652|Male|Glioblastoma|2012|~|~|~
20+|5.5|5.7|5.6|Malignant|6525|112218652|Male|Glioblastoma|2012|5.7|6.0|5.8
20+|~|~|~|Benign/Borderline|~|113477293|Male|Glioblastoma|2013|~|~|~
20+|5.4|5.7|5.6|Malignant|6639|113477293|Male|Glioblastoma|2013|5.7|6.0|5.9
20+|~|~|~|Benign/Borderline|~|579536769|Male|Glioblastoma|2013-2017|~|~|~
20+|5.5|5.6|5.6|Malignant|34714|579536769|Male|Glioblastoma|2013-2017|5.9|6.1|6.0
20+|~|~|~|Benign/Borderline|~|114741253|Male|Glioblastoma|2014|~|~|~
20+|5.5|5.7|5.6|Malignant|6794|114741253|Male|Glioblastoma|2014|5.8|6.1|5.9
20+|~|~|~|Benign/Borderline|~|115974555|Male|Glioblastoma|2015|~|~|~
20+|5.4|5.7|5.5|Malignant|6881|115974555|Male|Glioblastoma|2015|5.8|6.1|5.9
20+|~|~|~|Benign/Borderline|~|117142413|Male|Glioblastoma|2016|~|~|~
20+|5.5|5.8|5.6|Malignant|7174|117142413|Male|Glioblastoma|2016|6.0|6.3|6.1
20+|~|~|~|Benign/Borderline|~|118201255|Male|Glioblastoma|2017|~|~|~
20+|5.4|5.7|5.6|Malignant|7226|118201255|Male|Glioblastoma|2017|6.0|6.3|6.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|422|101938779|Male|Glioma malignant, NOS|2004|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|442|103190694|Male|Glioma malignant, NOS|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|445|104488268|Male|Glioma malignant, NOS|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|463|105697783|Male|Glioma malignant, NOS|2007|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|16|106947980|Male|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|478|106947980|Male|Glioma malignant, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|456|108197539|Male|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109527917|Male|Glioma malignant, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|409|109527917|Male|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|17|110844094|Male|Glioma malignant, NOS|2011|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|490|110844094|Male|Glioma malignant, NOS|2011|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|112218652|Male|Glioma malignant, NOS|2012|~|~|~
20+|0.4|0.5|0.4|Malignant|486|112218652|Male|Glioma malignant, NOS|2012|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|113477293|Male|Glioma malignant, NOS|2013|~|~|~
20+|0.4|0.5|0.4|Malignant|459|113477293|Male|Glioma malignant, NOS|2013|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|93|579536769|Male|Glioma malignant, NOS|2013-2017|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|2534|579536769|Male|Glioma malignant, NOS|2013-2017|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|114741253|Male|Glioma malignant, NOS|2014|~|~|~
20+|0.4|0.5|0.4|Malignant|496|114741253|Male|Glioma malignant, NOS|2014|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|21|115974555|Male|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|481|115974555|Male|Glioma malignant, NOS|2015|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|29|117142413|Male|Glioma malignant, NOS|2016|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|525|117142413|Male|Glioma malignant, NOS|2016|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|16|118201255|Male|Glioma malignant, NOS|2017|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|573|118201255|Male|Glioma malignant, NOS|2017|0.4|0.5|0.5
20+|0.2|0.3|0.2|Benign/Borderline|250|101938779|Male|Hemangioblastoma|2004|0.2|0.3|0.2
20+|~|~|~|Malignant|~|101938779|Male|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|286|103190694|Male|Hemangioblastoma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|103190694|Male|Hemangioblastoma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|276|104488268|Male|Hemangioblastoma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|104488268|Male|Hemangioblastoma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|257|105697783|Male|Hemangioblastoma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|288|106947980|Male|Hemangioblastoma|2008|0.2|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioblastoma|2008|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|273|108197539|Male|Hemangioblastoma|2009|0.2|0.3|0.3
20+|~|~|~|Malignant|~|108197539|Male|Hemangioblastoma|2009|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|304|109527917|Male|Hemangioblastoma|2010|0.2|0.3|0.3
20+|~|~|~|Malignant|~|109527917|Male|Hemangioblastoma|2010|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|277|110844094|Male|Hemangioblastoma|2011|0.2|0.3|0.2
20+|~|~|~|Malignant|~|110844094|Male|Hemangioblastoma|2011|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|282|112218652|Male|Hemangioblastoma|2012|0.2|0.3|0.3
20+|~|~|~|Malignant|~|112218652|Male|Hemangioblastoma|2012|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|274|113477293|Male|Hemangioblastoma|2013|0.2|0.3|0.2
20+|~|~|~|Malignant|~|113477293|Male|Hemangioblastoma|2013|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|1430|579536769|Male|Hemangioblastoma|2013-2017|0.2|0.3|0.2
20+|~|~|~|Malignant|~|579536769|Male|Hemangioblastoma|2013-2017|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|275|114741253|Male|Hemangioblastoma|2014|0.2|0.3|0.2
20+|~|~|~|Malignant|~|114741253|Male|Hemangioblastoma|2014|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|285|115974555|Male|Hemangioblastoma|2015|0.2|0.3|0.2
20+|~|~|~|Malignant|~|115974555|Male|Hemangioblastoma|2015|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|272|117142413|Male|Hemangioblastoma|2016|0.2|0.3|0.2
20+|~|~|~|Malignant|~|117142413|Male|Hemangioblastoma|2016|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|324|118201255|Male|Hemangioblastoma|2017|0.2|0.3|0.3
20+|~|~|~|Malignant|~|118201255|Male|Hemangioblastoma|2017|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|139|101938779|Male|Hemangioma|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|199|103190694|Male|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|103190694|Male|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|232|104488268|Male|Hemangioma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|104488268|Male|Hemangioma|2006|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|267|105697783|Male|Hemangioma|2007|0.2|0.3|0.3
20+|~|~|~|Malignant|~|105697783|Male|Hemangioma|2007|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|325|106947980|Male|Hemangioma|2008|0.3|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|424|108197539|Male|Hemangioma|2009|0.4|0.4|0.4
20+|~|~|~|Malignant|~|108197539|Male|Hemangioma|2009|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|445|109527917|Male|Hemangioma|2010|0.4|0.4|0.4
20+|~|~|~|Malignant|~|109527917|Male|Hemangioma|2010|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|503|110844094|Male|Hemangioma|2011|0.4|0.5|0.5
20+|~|~|~|Malignant|~|110844094|Male|Hemangioma|2011|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|509|112218652|Male|Hemangioma|2012|0.4|0.5|0.5
20+|~|~|~|Malignant|~|112218652|Male|Hemangioma|2012|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|504|113477293|Male|Hemangioma|2013|0.4|0.5|0.4
20+|~|~|~|Malignant|~|113477293|Male|Hemangioma|2013|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|2231|579536769|Male|Hemangioma|2013-2017|0.4|0.4|0.4
20+|~|~|~|Malignant|~|579536769|Male|Hemangioma|2013-2017|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|495|114741253|Male|Hemangioma|2014|0.4|0.5|0.4
20+|~|~|~|Malignant|~|114741253|Male|Hemangioma|2014|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|441|115974555|Male|Hemangioma|2015|0.3|0.4|0.4
20+|~|~|~|Malignant|~|115974555|Male|Hemangioma|2015|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|398|117142413|Male|Hemangioma|2016|0.3|0.4|0.3
20+|~|~|~|Malignant|~|117142413|Male|Hemangioma|2016|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|393|118201255|Male|Hemangioma|2017|0.3|0.4|0.3
20+|~|~|~|Malignant|~|118201255|Male|Hemangioma|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|26|101938779|Male|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|103190694|Male|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|35|104488268|Male|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|30|106947980|Male|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|29|108197539|Male|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109527917|Male|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|30|109527917|Male|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110844094|Male|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|22|110844094|Male|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112218652|Male|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|28|112218652|Male|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113477293|Male|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|29|113477293|Male|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|579536769|Male|Local Extensions from Regional Tumors|2013-2017|~|~|~
20+|0.0|0.0|0.0|Malignant|123|579536769|Male|Local Extensions from Regional Tumors|2013-2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114741253|Male|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|25|114741253|Male|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115974555|Male|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|23|115974555|Male|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117142413|Male|Local Extensions from Regional Tumors|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|26|117142413|Male|Local Extensions from Regional Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118201255|Male|Local Extensions from Regional Tumors|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|20|118201255|Male|Local Extensions from Regional Tumors|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.7|0.8|0.8|Malignant|749|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.7|0.8|0.8|Malignant|778|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|0.7|0.8|0.8
20+|~|~|~|Benign/Borderline|~|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.7|0.8|0.8|Malignant|761|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.7|0.8|0.7|Malignant|737|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.7|0.8|0.8|Malignant|774|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.7|0.8|0.7|Malignant|763|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|109527917|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.7|Malignant|757|109527917|Male|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|110844094|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.7|0.8|0.7|Malignant|810|110844094|Male|Lymphomas and Hematopoietic Neoplasms|2011|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|112218652|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|757|112218652|Male|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|113477293|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.6|0.7|0.6|Malignant|730|113477293|Male|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|579536769|Male|Lymphomas and Hematopoietic Neoplasms|2013-2017|~|~|~
20+|0.7|0.7|0.7|Malignant|4065|579536769|Male|Lymphomas and Hematopoietic Neoplasms|2013-2017|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|114741253|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.6|0.7|0.7|Malignant|818|114741253|Male|Lymphomas and Hematopoietic Neoplasms|2014|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|115974555|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.6|0.7|0.7|Malignant|820|115974555|Male|Lymphomas and Hematopoietic Neoplasms|2015|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|117142413|Male|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
20+|0.6|0.7|0.7|Malignant|819|117142413|Male|Lymphomas and Hematopoietic Neoplasms|2016|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|118201255|Male|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
20+|0.7|0.7|0.7|Malignant|878|118201255|Male|Lymphomas and Hematopoietic Neoplasms|2017|0.7|0.8|0.7
20+|5.1|5.4|5.2|Benign/Borderline|4893|101938779|Male|Meningioma|2004|4.7|4.9|4.8
20+|0.2|0.2|0.2|Malignant|170|101938779|Male|Meningioma|2004|0.1|0.2|0.2
20+|5.6|5.9|5.7|Benign/Borderline|5468|103190694|Male|Meningioma|2005|5.2|5.4|5.3
20+|0.1|0.2|0.2|Malignant|155|103190694|Male|Meningioma|2005|0.1|0.2|0.2
20+|5.9|6.2|6.1|Benign/Borderline|5877|104488268|Male|Meningioma|2006|5.5|5.8|5.6
20+|0.1|0.2|0.2|Malignant|154|104488268|Male|Meningioma|2006|0.1|0.2|0.1
20+|6.0|6.3|6.1|Benign/Borderline|6089|105697783|Male|Meningioma|2007|5.6|5.9|5.8
20+|0.1|0.2|0.2|Malignant|175|105697783|Male|Meningioma|2007|0.1|0.2|0.2
20+|6.4|6.7|6.6|Benign/Borderline|6682|106947980|Male|Meningioma|2008|6.1|6.4|6.2
20+|0.1|0.2|0.1|Malignant|148|106947980|Male|Meningioma|2008|0.1|0.2|0.1
20+|6.9|7.2|7.0|Benign/Borderline|7240|108197539|Male|Meningioma|2009|6.5|6.8|6.7
20+|0.1|0.2|0.1|Malignant|150|108197539|Male|Meningioma|2009|0.1|0.2|0.1
20+|6.7|7.1|6.9|Benign/Borderline|7259|109527917|Male|Meningioma|2010|6.5|6.8|6.6
20+|0.1|0.1|0.1|Malignant|121|109527917|Male|Meningioma|2010|0.1|0.1|0.1
20+|6.7|7.1|6.9|Benign/Borderline|7445|110844094|Male|Meningioma|2011|6.6|6.9|6.7
20+|0.1|0.2|0.1|Malignant|141|110844094|Male|Meningioma|2011|0.1|0.2|0.1
20+|6.8|7.1|6.9|Benign/Borderline|7623|112218652|Male|Meningioma|2012|6.6|6.9|6.8
20+|0.1|0.2|0.1|Malignant|152|112218652|Male|Meningioma|2012|0.1|0.2|0.1
20+|7.0|7.4|7.2|Benign/Borderline|8108|113477293|Male|Meningioma|2013|7.0|7.3|7.1
20+|0.1|0.2|0.1|Malignant|155|113477293|Male|Meningioma|2013|0.1|0.2|0.1
20+|7.2|7.4|7.3|Benign/Borderline|42870|579536769|Male|Meningioma|2013-2017|7.3|7.5|7.4
20+|0.1|0.1|0.1|Malignant|764|579536769|Male|Meningioma|2013-2017|0.1|0.1|0.1
20+|7.0|7.3|7.1|Benign/Borderline|8222|114741253|Male|Meningioma|2014|7.0|7.3|7.2
20+|0.1|0.2|0.1|Malignant|164|114741253|Male|Meningioma|2014|0.1|0.2|0.1
20+|7.2|7.5|7.4|Benign/Borderline|8672|115974555|Male|Meningioma|2015|7.3|7.6|7.5
20+|0.1|0.1|0.1|Malignant|148|115974555|Male|Meningioma|2015|0.1|0.1|0.1
20+|7.2|7.5|7.3|Benign/Borderline|8802|117142413|Male|Meningioma|2016|7.4|7.7|7.5
20+|0.1|0.1|0.1|Malignant|155|117142413|Male|Meningioma|2016|0.1|0.2|0.1
20+|7.2|7.5|7.4|Benign/Borderline|9066|118201255|Male|Meningioma|2017|7.5|7.8|7.7
20+|0.1|0.1|0.1|Malignant|142|118201255|Male|Meningioma|2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Mixed glioma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|295|101938779|Male|Mixed glioma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Mixed glioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|329|103190694|Male|Mixed glioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Mixed glioma|2006|~|~|~
20+|0.3|0.4|0.4|Malignant|364|104488268|Male|Mixed glioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Mixed glioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|348|105697783|Male|Mixed glioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Mixed glioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|339|106947980|Male|Mixed glioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Mixed glioma|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|392|108197539|Male|Mixed glioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109527917|Male|Mixed glioma|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|341|109527917|Male|Mixed glioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110844094|Male|Mixed glioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|363|110844094|Male|Mixed glioma|2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112218652|Male|Mixed glioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|331|112218652|Male|Mixed glioma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113477293|Male|Mixed glioma|2013|~|~|~
20+|0.3|0.4|0.3|Malignant|369|113477293|Male|Mixed glioma|2013|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|579536769|Male|Mixed glioma|2013-2017|~|~|~
20+|0.1|0.2|0.2|Malignant|873|579536769|Male|Mixed glioma|2013-2017|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114741253|Male|Mixed glioma|2014|~|~|~
20+|0.2|0.3|0.2|Malignant|267|114741253|Male|Mixed glioma|2014|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|115974555|Male|Mixed glioma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|143|115974555|Male|Mixed glioma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117142413|Male|Mixed glioma|2016|~|~|~
20+|0.0|0.1|0.1|Malignant|64|117142413|Male|Mixed glioma|2016|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|118201255|Male|Mixed glioma|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|30|118201255|Male|Mixed glioma|2017|0.0|0.0|0.0
20+|0.5|0.6|0.6|Benign/Borderline|507|101938779|Male|Neoplasm, unspecified|2004|0.5|0.5|0.5
20+|0.6|0.7|0.7|Malignant|609|101938779|Male|Neoplasm, unspecified|2004|0.6|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|626|103190694|Male|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.7|Malignant|603|103190694|Male|Neoplasm, unspecified|2005|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|615|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|565|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|588|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|565|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|607|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.7|Malignant|618|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|608|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.7|Malignant|642|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|664|109527917|Male|Neoplasm, unspecified|2010|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|600|109527917|Male|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|631|110844094|Male|Neoplasm, unspecified|2011|0.5|0.6|0.6
20+|0.5|0.6|0.6|Malignant|610|110844094|Male|Neoplasm, unspecified|2011|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|709|112218652|Male|Neoplasm, unspecified|2012|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|619|112218652|Male|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|679|113477293|Male|Neoplasm, unspecified|2013|0.6|0.6|0.6
20+|0.5|0.6|0.6|Malignant|610|113477293|Male|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|0.5|0.6|0.5|Benign/Borderline|3042|579536769|Male|Neoplasm, unspecified|2013-2017|0.5|0.5|0.5
20+|0.5|0.6|0.5|Malignant|3048|579536769|Male|Neoplasm, unspecified|2013-2017|0.5|0.5|0.5
20+|0.5|0.6|0.6|Benign/Borderline|635|114741253|Male|Neoplasm, unspecified|2014|0.5|0.6|0.6
20+|0.6|0.6|0.6|Malignant|662|114741253|Male|Neoplasm, unspecified|2014|0.5|0.6|0.6
20+|0.5|0.6|0.5|Benign/Borderline|622|115974555|Male|Neoplasm, unspecified|2015|0.5|0.6|0.5
20+|0.5|0.6|0.6|Malignant|623|115974555|Male|Neoplasm, unspecified|2015|0.5|0.6|0.5
20+|0.5|0.5|0.5|Benign/Borderline|565|117142413|Male|Neoplasm, unspecified|2016|0.4|0.5|0.5
20+|0.5|0.6|0.5|Malignant|613|117142413|Male|Neoplasm, unspecified|2016|0.5|0.6|0.5
20+|0.4|0.5|0.5|Benign/Borderline|541|118201255|Male|Neoplasm, unspecified|2017|0.4|0.5|0.5
20+|0.4|0.5|0.5|Malignant|540|118201255|Male|Neoplasm, unspecified|2017|0.4|0.5|0.5
20+|2.2|2.4|2.3|Benign/Borderline|2327|101938779|Male|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2674|103190694|Male|Nerve sheath, benign and malignant|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|30|103190694|Male|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2653|104488268|Male|Nerve sheath, benign and malignant|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2734|105697783|Male|Nerve sheath, benign and malignant|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2704|106947980|Male|Nerve sheath, benign and malignant|2008|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2885|108197539|Male|Nerve sheath, benign and malignant|2009|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2889|109527917|Male|Nerve sheath, benign and malignant|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|23|109527917|Male|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2995|110844094|Male|Nerve sheath, benign and malignant|2011|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|17|110844094|Male|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3175|112218652|Male|Nerve sheath, benign and malignant|2012|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|24|112218652|Male|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3238|113477293|Male|Nerve sheath, benign and malignant|2013|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|21|113477293|Male|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|16605|579536769|Male|Nerve sheath, benign and malignant|2013-2017|2.8|2.9|2.9
20+|0.0|0.0|0.0|Malignant|105|579536769|Male|Nerve sheath, benign and malignant|2013-2017|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3489|114741253|Male|Nerve sheath, benign and malignant|2014|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|22|114741253|Male|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3428|115974555|Male|Nerve sheath, benign and malignant|2015|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|16|115974555|Male|Nerve sheath, benign and malignant|2015|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3292|117142413|Male|Nerve sheath, benign and malignant|2016|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|21|117142413|Male|Nerve sheath, benign and malignant|2016|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3158|118201255|Male|Nerve sheath, benign and malignant|2017|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|25|118201255|Male|Nerve sheath, benign and malignant|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|29|101938779|Male|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|32|105697783|Male|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|18|106947980|Male|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|24|108197539|Male|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109527917|Male|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|109527917|Male|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110844094|Male|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|29|110844094|Male|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112218652|Male|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|28|112218652|Male|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113477293|Male|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|27|113477293|Male|Neuroepithelial|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|18|579536769|Male|Neuroepithelial|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|137|579536769|Male|Neuroepithelial|2013-2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114741253|Male|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|35|114741253|Male|Neuroepithelial|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115974555|Male|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|32|115974555|Male|Neuroepithelial|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117142413|Male|Neuroepithelial|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|24|117142413|Male|Neuroepithelial|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118201255|Male|Neuroepithelial|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|19|118201255|Male|Neuroepithelial|2017|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|161|101938779|Male|Neuronal/glial, neuronal|2004|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|101938779|Male|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|191|103190694|Male|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|35|103190694|Male|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|201|104488268|Male|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|184|105697783|Male|Neuronal/glial, neuronal|2007|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|218|106947980|Male|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|106947980|Male|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|217|108197539|Male|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|234|109527917|Male|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109527917|Male|Neuronal/glial, neuronal|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|187|110844094|Male|Neuronal/glial, neuronal|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|110844094|Male|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|205|112218652|Male|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|112218652|Male|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|215|113477293|Male|Neuronal/glial, neuronal|2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|113477293|Male|Neuronal/glial, neuronal|2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1173|579536769|Male|Neuronal/glial, neuronal|2013-2017|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|86|579536769|Male|Neuronal/glial, neuronal|2013-2017|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|223|114741253|Male|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|114741253|Male|Neuronal/glial, neuronal|2014|0.0|0.0|0.0
20+|0.2|0.3|0.2|Benign/Borderline|264|115974555|Male|Neuronal/glial, neuronal|2015|0.2|0.3|0.2
20+|0.0|0.0|0.0|Malignant|16|115974555|Male|Neuronal/glial, neuronal|2015|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|238|117142413|Male|Neuronal/glial, neuronal|2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|117142413|Male|Neuronal/glial, neuronal|2016|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|233|118201255|Male|Neuronal/glial, neuronal|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|118201255|Male|Neuronal/glial, neuronal|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Oligodendroglioma|2004|~|~|~
20+|0.4|0.5|0.5|Malignant|477|101938779|Male|Oligodendroglioma|2004|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|103190694|Male|Oligodendroglioma|2005|~|~|~
20+|0.4|0.5|0.4|Malignant|440|103190694|Male|Oligodendroglioma|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Oligodendroglioma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|467|104488268|Male|Oligodendroglioma|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Oligodendroglioma|2007|~|~|~
20+|0.4|0.5|0.4|Malignant|438|105697783|Male|Oligodendroglioma|2007|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|106947980|Male|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|408|106947980|Male|Oligodendroglioma|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Oligodendroglioma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|473|108197539|Male|Oligodendroglioma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109527917|Male|Oligodendroglioma|2010|~|~|~
20+|0.4|0.5|0.4|Malignant|470|109527917|Male|Oligodendroglioma|2010|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|110844094|Male|Oligodendroglioma|2011|~|~|~
20+|0.4|0.4|0.4|Malignant|441|110844094|Male|Oligodendroglioma|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112218652|Male|Oligodendroglioma|2012|~|~|~
20+|0.3|0.4|0.3|Malignant|367|112218652|Male|Oligodendroglioma|2012|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|113477293|Male|Oligodendroglioma|2013|~|~|~
20+|0.3|0.4|0.3|Malignant|367|113477293|Male|Oligodendroglioma|2013|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|579536769|Male|Oligodendroglioma|2013-2017|~|~|~
20+|0.3|0.4|0.4|Malignant|1963|579536769|Male|Oligodendroglioma|2013-2017|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114741253|Male|Oligodendroglioma|2014|~|~|~
20+|0.3|0.4|0.4|Malignant|410|114741253|Male|Oligodendroglioma|2014|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|115974555|Male|Oligodendroglioma|2015|~|~|~
20+|0.3|0.4|0.4|Malignant|403|115974555|Male|Oligodendroglioma|2015|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|117142413|Male|Oligodendroglioma|2016|~|~|~
20+|0.3|0.4|0.3|Malignant|395|117142413|Male|Oligodendroglioma|2016|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|118201255|Male|Oligodendroglioma|2017|~|~|~
20+|0.3|0.4|0.3|Malignant|388|118201255|Male|Oligodendroglioma|2017|0.3|0.4|0.3
20+|0.1|0.1|0.1|Benign/Borderline|82|101938779|Male|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|101938779|Male|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|73|103190694|Male|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|103190694|Male|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|68|104488268|Male|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|104488268|Male|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|105697783|Male|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|39|105697783|Male|Other mesenchymal|2007|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|103|106947980|Male|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|46|106947980|Male|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|104|108197539|Male|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|48|108197539|Male|Other mesenchymal|2009|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|77|109527917|Male|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|109527917|Male|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|67|110844094|Male|Other mesenchymal|2011|0.0|0.1|0.1
20+|0.0|0.1|0.0|Malignant|45|110844094|Male|Other mesenchymal|2011|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|93|112218652|Male|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|112218652|Male|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|74|113477293|Male|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|43|113477293|Male|Other mesenchymal|2013|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|418|579536769|Male|Other mesenchymal|2013-2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|223|579536769|Male|Other mesenchymal|2013-2017|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|85|114741253|Male|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|48|114741253|Male|Other mesenchymal|2014|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|109|115974555|Male|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|45|115974555|Male|Other mesenchymal|2015|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|77|117142413|Male|Other mesenchymal|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|41|117142413|Male|Other mesenchymal|2016|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|73|118201255|Male|Other mesenchymal|2017|0.0|0.1|0.1
20+|0.0|0.1|0.0|Malignant|46|118201255|Male|Other mesenchymal|2017|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|150|101938779|Male|Pilocytic astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|155|103190694|Male|Pilocytic astrocytoma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|158|104488268|Male|Pilocytic astrocytoma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|142|105697783|Male|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|145|106947980|Male|Pilocytic astrocytoma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|137|108197539|Male|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109527917|Male|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|163|109527917|Male|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|110844094|Male|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|172|110844094|Male|Pilocytic astrocytoma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|112218652|Male|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|146|112218652|Male|Pilocytic astrocytoma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|113477293|Male|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|144|113477293|Male|Pilocytic astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|579536769|Male|Pilocytic astrocytoma|2013-2017|~|~|~
20+|0.1|0.1|0.1|Malignant|734|579536769|Male|Pilocytic astrocytoma|2013-2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114741253|Male|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.2|0.1|Malignant|150|114741253|Male|Pilocytic astrocytoma|2014|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|115974555|Male|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.2|0.1|Malignant|148|115974555|Male|Pilocytic astrocytoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117142413|Male|Pilocytic astrocytoma|2016|~|~|~
20+|0.1|0.2|0.1|Malignant|157|117142413|Male|Pilocytic astrocytoma|2016|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|118201255|Male|Pilocytic astrocytoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|135|118201255|Male|Pilocytic astrocytoma|2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|18|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|105697783|Male|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|105697783|Male|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|23|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pineal parenchymal|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|18|108197539|Male|Pineal parenchymal|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109527917|Male|Pineal parenchymal|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|18|109527917|Male|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|110844094|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|110844094|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|112218652|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|112218652|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113477293|Male|Pineal parenchymal|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|36|113477293|Male|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|87|579536769|Male|Pineal parenchymal|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|143|579536769|Male|Pineal parenchymal|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|22|114741253|Male|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|19|114741253|Male|Pineal parenchymal|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115974555|Male|Pineal parenchymal|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|28|115974555|Male|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|117142413|Male|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|34|117142413|Male|Pineal parenchymal|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118201255|Male|Pineal parenchymal|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|26|118201255|Male|Pineal parenchymal|2017|0.0|0.0|0.0
20+|3.3|3.6|3.5|Benign/Borderline|3435|101938779|Male|Pituitary|2004|3.3|3.5|3.4
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Pituitary|2004|0.0|0.0|0.0
20+|3.6|3.9|3.8|Benign/Borderline|3783|103190694|Male|Pituitary|2005|3.6|3.8|3.7
20+|~|~|~|Malignant|~|103190694|Male|Pituitary|2005|~|~|~
20+|3.8|4.1|4.0|Benign/Borderline|4067|104488268|Male|Pituitary|2006|3.8|4.0|3.9
20+|0.0|0.0|0.0|Malignant|17|104488268|Male|Pituitary|2006|0.0|0.0|0.0
20+|4.1|4.4|4.2|Benign/Borderline|4453|105697783|Male|Pituitary|2007|4.1|4.3|4.2
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Pituitary|2007|0.0|0.0|0.0
20+|4.4|4.7|4.6|Benign/Borderline|4851|106947980|Male|Pituitary|2008|4.4|4.7|4.5
20+|~|~|~|Malignant|~|106947980|Male|Pituitary|2008|~|~|~
20+|4.7|4.9|4.8|Benign/Borderline|5191|108197539|Male|Pituitary|2009|4.7|4.9|4.8
20+|~|~|~|Malignant|~|108197539|Male|Pituitary|2009|~|~|~
20+|4.7|5.0|4.9|Benign/Borderline|5373|109527917|Male|Pituitary|2010|4.8|5.0|4.9
20+|~|~|~|Malignant|~|109527917|Male|Pituitary|2010|~|~|~
20+|4.8|5.0|4.9|Benign/Borderline|5472|110844094|Male|Pituitary|2011|4.8|5.1|4.9
20+|0.0|0.0|0.0|Malignant|21|110844094|Male|Pituitary|2011|0.0|0.0|0.0
20+|5.1|5.4|5.3|Benign/Borderline|5967|112218652|Male|Pituitary|2012|5.2|5.5|5.3
20+|0.0|0.0|0.0|Malignant|19|112218652|Male|Pituitary|2012|0.0|0.0|0.0
20+|5.1|5.3|5.2|Benign/Borderline|6006|113477293|Male|Pituitary|2013|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|25|113477293|Male|Pituitary|2013|0.0|0.0|0.0
20+|5.1|5.2|5.2|Benign/Borderline|30829|579536769|Male|Pituitary|2013-2017|5.3|5.4|5.3
20+|0.0|0.0|0.0|Malignant|85|579536769|Male|Pituitary|2013-2017|0.0|0.0|0.0
20+|5.1|5.3|5.2|Benign/Borderline|6092|114741253|Male|Pituitary|2014|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|21|114741253|Male|Pituitary|2014|0.0|0.0|0.0
20+|5.2|5.4|5.3|Benign/Borderline|6298|115974555|Male|Pituitary|2015|5.3|5.6|5.4
20+|0.0|0.0|0.0|Malignant|16|115974555|Male|Pituitary|2015|0.0|0.0|0.0
20+|5.0|5.3|5.2|Benign/Borderline|6268|117142413|Male|Pituitary|2016|5.2|5.5|5.4
20+|~|~|~|Malignant|~|117142413|Male|Pituitary|2016|~|~|~
20+|4.9|5.2|5.0|Benign/Borderline|6165|118201255|Male|Pituitary|2017|5.1|5.3|5.2
20+|~|~|~|Malignant|~|118201255|Male|Pituitary|2017|~|~|~
20+|12.4|12.8|12.6|Benign/Borderline|12291|101938779|Male|Total|2004|11.8|12.3|12.1
20+|10.7|11.1|10.9|Malignant|10648|101938779|Male|Total|2004|10.2|10.6|10.4
20+|13.8|14.3|14.0|Benign/Borderline|13897|103190694|Male|Total|2005|13.2|13.7|13.5
20+|10.7|11.1|10.9|Malignant|10806|103190694|Male|Total|2005|10.3|10.7|10.5
20+|14.2|14.7|14.4|Benign/Borderline|14573|104488268|Male|Total|2006|13.7|14.2|13.9
20+|10.5|10.9|10.7|Malignant|10832|104488268|Male|Total|2006|10.2|10.6|10.4
20+|14.6|15.1|14.8|Benign/Borderline|15230|105697783|Male|Total|2007|14.2|14.6|14.4
20+|10.5|10.9|10.7|Malignant|11066|105697783|Male|Total|2007|10.3|10.7|10.5
20+|15.4|15.9|15.7|Benign/Borderline|16384|106947980|Male|Total|2008|15.1|15.6|15.3
20+|10.6|11.0|10.8|Malignant|11371|106947980|Male|Total|2008|10.4|10.8|10.6
20+|16.3|16.8|16.6|Benign/Borderline|17557|108197539|Male|Total|2009|16.0|16.5|16.2
20+|10.5|10.9|10.7|Malignant|11436|108197539|Male|Total|2009|10.4|10.8|10.6
20+|16.3|16.8|16.5|Benign/Borderline|17889|109527917|Male|Total|2010|16.1|16.6|16.3
20+|10.2|10.6|10.4|Malignant|11407|109527917|Male|Total|2010|10.2|10.6|10.4
20+|16.3|16.7|16.5|Benign/Borderline|18220|110844094|Male|Total|2011|16.2|16.7|16.4
20+|10.2|10.6|10.4|Malignant|11646|110844094|Male|Total|2011|10.3|10.7|10.5
20+|16.9|17.4|17.1|Benign/Borderline|19235|112218652|Male|Total|2012|16.9|17.4|17.1
20+|10.0|10.4|10.2|Malignant|11675|112218652|Male|Total|2012|10.2|10.6|10.4
20+|17.0|17.5|17.2|Benign/Borderline|19752|113477293|Male|Total|2013|17.2|17.7|17.4
20+|10.0|10.4|10.2|Malignant|11850|113477293|Male|Total|2013|10.3|10.6|10.4
20+|17.1|17.3|17.2|Benign/Borderline|102066|579536769|Male|Total|2013-2017|17.5|17.7|17.6
20+|10.0|10.1|10.0|Malignant|60667|579536769|Male|Total|2013-2017|10.4|10.6|10.5
20+|17.1|17.6|17.3|Benign/Borderline|20206|114741253|Male|Total|2014|17.4|17.9|17.6
20+|10.1|10.5|10.3|Malignant|12161|114741253|Male|Total|2014|10.4|10.8|10.6
20+|17.3|17.8|17.5|Benign/Borderline|20801|115974555|Male|Total|2015|17.7|18.2|17.9
20+|9.8|10.1|9.9|Malignant|12015|115974555|Male|Total|2015|10.2|10.5|10.4
20+|16.9|17.4|17.2|Benign/Borderline|20658|117142413|Male|Total|2016|17.4|17.9|17.6
20+|9.8|10.2|10.0|Malignant|12359|117142413|Male|Total|2016|10.4|10.7|10.6
20+|16.6|17.1|16.8|Benign/Borderline|20649|118201255|Male|Total|2017|17.2|17.7|17.5
20+|9.6|10.0|9.8|Malignant|12282|118201255|Male|Total|2017|10.2|10.6|10.4
20+|2.2|2.4|2.3|Benign/Borderline|2327|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2674|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|30|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2654|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2735|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2706|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2889|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2890|109527917|Male|Tumors of Cranial and Spinal Nerves|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|23|109527917|Male|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2998|110844094|Male|Tumors of Cranial and Spinal Nerves|2011|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|17|110844094|Male|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3177|112218652|Male|Tumors of Cranial and Spinal Nerves|2012|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|24|112218652|Male|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3242|113477293|Male|Tumors of Cranial and Spinal Nerves|2013|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|21|113477293|Male|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|16627|579536769|Male|Tumors of Cranial and Spinal Nerves|2013-2017|2.8|2.9|2.9
20+|0.0|0.0|0.0|Malignant|105|579536769|Male|Tumors of Cranial and Spinal Nerves|2013-2017|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3492|114741253|Male|Tumors of Cranial and Spinal Nerves|2014|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|22|114741253|Male|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3435|115974555|Male|Tumors of Cranial and Spinal Nerves|2015|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|16|115974555|Male|Tumors of Cranial and Spinal Nerves|2015|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3296|117142413|Male|Tumors of Cranial and Spinal Nerves|2016|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|21|117142413|Male|Tumors of Cranial and Spinal Nerves|2016|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3162|118201255|Male|Tumors of Cranial and Spinal Nerves|2017|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|25|118201255|Male|Tumors of Cranial and Spinal Nerves|2017|0.0|0.0|0.0
20+|0.4|0.5|0.4|Benign/Borderline|448|101938779|Male|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.4
20+|8.9|9.3|9.1|Malignant|8968|101938779|Male|Tumors of Neuroepthelial Tissue|2004|8.6|9.0|8.8
20+|0.5|0.5|0.5|Benign/Borderline|524|103190694|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.5
20+|8.9|9.3|9.1|Malignant|9102|103190694|Male|Tumors of Neuroepthelial Tissue|2005|8.6|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|560|104488268|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9192|104488268|Male|Tumors of Neuroepthelial Tissue|2006|8.6|9.0|8.8
20+|0.4|0.5|0.5|Benign/Borderline|520|105697783|Male|Tumors of Neuroepthelial Tissue|2007|0.5|0.5|0.5
20+|8.8|9.2|9.0|Malignant|9394|105697783|Male|Tumors of Neuroepthelial Tissue|2007|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|586|106947980|Male|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
20+|8.9|9.3|9.1|Malignant|9657|106947980|Male|Tumors of Neuroepthelial Tissue|2008|8.9|9.2|9.0
20+|0.5|0.6|0.5|Benign/Borderline|588|108197539|Male|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9729|108197539|Male|Tumors of Neuroepthelial Tissue|2009|8.8|9.2|9.0
20+|0.5|0.6|0.6|Benign/Borderline|646|109527917|Male|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
20+|8.7|9.0|8.8|Malignant|9755|109527917|Male|Tumors of Neuroepthelial Tissue|2010|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|604|110844094|Male|Tumors of Neuroepthelial Tissue|2011|0.5|0.6|0.5
20+|8.6|9.0|8.8|Malignant|9902|110844094|Male|Tumors of Neuroepthelial Tissue|2011|8.8|9.1|8.9
20+|0.5|0.6|0.6|Benign/Borderline|627|112218652|Male|Tumors of Neuroepthelial Tissue|2012|0.5|0.6|0.6
20+|8.5|8.9|8.7|Malignant|9990|112218652|Male|Tumors of Neuroepthelial Tissue|2012|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|609|113477293|Male|Tumors of Neuroepthelial Tissue|2013|0.5|0.6|0.5
20+|8.5|8.9|8.7|Malignant|10181|113477293|Male|Tumors of Neuroepthelial Tissue|2013|8.8|9.1|9.0
20+|0.6|0.6|0.6|Benign/Borderline|3336|579536769|Male|Tumors of Neuroepthelial Tissue|2013-2017|0.6|0.6|0.6
20+|8.5|8.6|8.5|Malignant|51901|579536769|Male|Tumors of Neuroepthelial Tissue|2013-2017|8.9|9.0|9.0
20+|0.5|0.6|0.6|Benign/Borderline|678|114741253|Male|Tumors of Neuroepthelial Tissue|2014|0.5|0.6|0.6
20+|8.5|8.9|8.7|Malignant|10323|114741253|Male|Tumors of Neuroepthelial Tissue|2014|8.8|9.2|9.0
20+|0.5|0.6|0.6|Benign/Borderline|688|115974555|Male|Tumors of Neuroepthelial Tissue|2015|0.5|0.6|0.6
20+|8.3|8.6|8.4|Malignant|10260|115974555|Male|Tumors of Neuroepthelial Tissue|2015|8.7|9.0|8.8
20+|0.6|0.6|0.6|Benign/Borderline|708|117142413|Male|Tumors of Neuroepthelial Tissue|2016|0.6|0.7|0.6
20+|8.4|8.7|8.5|Malignant|10591|117142413|Male|Tumors of Neuroepthelial Tissue|2016|8.9|9.2|9.0
20+|0.5|0.6|0.6|Benign/Borderline|653|118201255|Male|Tumors of Neuroepthelial Tissue|2017|0.5|0.6|0.6
20+|8.2|8.5|8.4|Malignant|10546|118201255|Male|Tumors of Neuroepthelial Tissue|2017|8.8|9.1|8.9
20+|3.5|3.8|3.6|Benign/Borderline|3620|101938779|Male|Tumors of Sellar Region|2004|3.4|3.7|3.6
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.8|4.1|4.0|Benign/Borderline|4014|103190694|Male|Tumors of Sellar Region|2005|3.8|4.0|3.9
20+|~|~|~|Malignant|~|103190694|Male|Tumors of Sellar Region|2005|~|~|~
20+|4.0|4.3|4.1|Benign/Borderline|4258|104488268|Male|Tumors of Sellar Region|2006|4.0|4.2|4.1
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.3|4.6|4.4|Benign/Borderline|4653|105697783|Male|Tumors of Sellar Region|2007|4.3|4.5|4.4
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.6|4.9|4.8|Benign/Borderline|5049|106947980|Male|Tumors of Sellar Region|2008|4.6|4.9|4.7
20+|~|~|~|Malignant|~|106947980|Male|Tumors of Sellar Region|2008|~|~|~
20+|4.8|5.1|5.0|Benign/Borderline|5393|108197539|Male|Tumors of Sellar Region|2009|4.9|5.1|5.0
20+|~|~|~|Malignant|~|108197539|Male|Tumors of Sellar Region|2009|~|~|~
20+|4.9|5.2|5.1|Benign/Borderline|5575|109527917|Male|Tumors of Sellar Region|2010|5.0|5.2|5.1
20+|~|~|~|Malignant|~|109527917|Male|Tumors of Sellar Region|2010|~|~|~
20+|4.9|5.2|5.1|Benign/Borderline|5668|110844094|Male|Tumors of Sellar Region|2011|5.0|5.2|5.1
20+|0.0|0.0|0.0|Malignant|22|110844094|Male|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|5.3|5.6|5.4|Benign/Borderline|6183|112218652|Male|Tumors of Sellar Region|2012|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|19|112218652|Male|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|6233|113477293|Male|Tumors of Sellar Region|2013|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|25|113477293|Male|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|5.3|5.4|5.4|Benign/Borderline|31957|579536769|Male|Tumors of Sellar Region|2013-2017|5.5|5.6|5.5
20+|0.0|0.0|0.0|Malignant|89|579536769|Male|Tumors of Sellar Region|2013-2017|0.0|0.0|0.0
20+|5.2|5.5|5.4|Benign/Borderline|6295|114741253|Male|Tumors of Sellar Region|2014|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|24|114741253|Male|Tumors of Sellar Region|2014|0.0|0.0|0.0
20+|5.3|5.6|5.5|Benign/Borderline|6519|115974555|Male|Tumors of Sellar Region|2015|5.5|5.8|5.6
20+|0.0|0.0|0.0|Malignant|16|115974555|Male|Tumors of Sellar Region|2015|0.0|0.0|0.0
20+|5.2|5.5|5.4|Benign/Borderline|6508|117142413|Male|Tumors of Sellar Region|2016|5.4|5.7|5.6
20+|~|~|~|Malignant|~|117142413|Male|Tumors of Sellar Region|2016|~|~|~
20+|5.1|5.3|5.2|Benign/Borderline|6402|118201255|Male|Tumors of Sellar Region|2017|5.3|5.6|5.4
20+|~|~|~|Malignant|~|118201255|Male|Tumors of Sellar Region|2017|~|~|~
20+|5.4|5.7|5.5|Benign/Borderline|5225|101938779|Male|Tumors of the Meninges|2004|5.0|5.3|5.1
20+|0.2|0.2|0.2|Malignant|202|101938779|Male|Tumors of the Meninges|2004|0.2|0.2|0.2
20+|5.9|6.3|6.1|Benign/Borderline|5827|103190694|Male|Tumors of the Meninges|2005|5.5|5.8|5.6
20+|0.2|0.2|0.2|Malignant|193|103190694|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
20+|6.2|6.5|6.4|Benign/Borderline|6221|104488268|Male|Tumors of the Meninges|2006|5.8|6.1|6.0
20+|0.2|0.2|0.2|Malignant|186|104488268|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|6.3|6.6|6.5|Benign/Borderline|6429|105697783|Male|Tumors of the Meninges|2007|5.9|6.2|6.1
20+|0.2|0.2|0.2|Malignant|219|105697783|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
20+|6.8|7.1|6.9|Benign/Borderline|7073|106947980|Male|Tumors of the Meninges|2008|6.5|6.8|6.6
20+|0.2|0.2|0.2|Malignant|199|106947980|Male|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|7.2|7.6|7.4|Benign/Borderline|7617|108197539|Male|Tumors of the Meninges|2009|6.9|7.2|7.0
20+|0.2|0.2|0.2|Malignant|199|108197539|Male|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|7.1|7.4|7.2|Benign/Borderline|7640|109527917|Male|Tumors of the Meninges|2010|6.8|7.1|7.0
20+|0.1|0.2|0.1|Malignant|158|109527917|Male|Tumors of the Meninges|2010|0.1|0.2|0.1
20+|7.1|7.4|7.2|Benign/Borderline|7789|110844094|Male|Tumors of the Meninges|2011|6.9|7.2|7.0
20+|0.1|0.2|0.2|Malignant|187|110844094|Male|Tumors of the Meninges|2011|0.1|0.2|0.2
20+|7.1|7.4|7.2|Benign/Borderline|7998|112218652|Male|Tumors of the Meninges|2012|7.0|7.3|7.1
20+|0.1|0.2|0.2|Malignant|184|112218652|Male|Tumors of the Meninges|2012|0.1|0.2|0.2
20+|7.3|7.7|7.5|Benign/Borderline|8456|113477293|Male|Tumors of the Meninges|2013|7.3|7.6|7.5
20+|0.1|0.2|0.2|Malignant|198|113477293|Male|Tumors of the Meninges|2013|0.2|0.2|0.2
20+|7.5|7.7|7.6|Benign/Borderline|44718|579536769|Male|Tumors of the Meninges|2013-2017|7.6|7.8|7.7
20+|0.2|0.2|0.2|Malignant|999|579536769|Male|Tumors of the Meninges|2013-2017|0.2|0.2|0.2
20+|7.3|7.6|7.5|Benign/Borderline|8582|114741253|Male|Tumors of the Meninges|2014|7.3|7.6|7.5
20+|0.2|0.2|0.2|Malignant|214|114741253|Male|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|7.5|7.8|7.7|Benign/Borderline|9066|115974555|Male|Tumors of the Meninges|2015|7.7|8.0|7.8
20+|0.1|0.2|0.2|Malignant|194|115974555|Male|Tumors of the Meninges|2015|0.1|0.2|0.2
20+|7.5|7.8|7.6|Benign/Borderline|9151|117142413|Male|Tumors of the Meninges|2016|7.7|8.0|7.8
20+|0.1|0.2|0.2|Malignant|201|117142413|Male|Tumors of the Meninges|2016|0.1|0.2|0.2
20+|7.6|7.9|7.7|Benign/Borderline|9463|118201255|Male|Tumors of the Meninges|2017|7.8|8.2|8.0
20+|0.1|0.2|0.2|Malignant|192|118201255|Male|Tumors of the Meninges|2017|0.1|0.2|0.2
20+|0.6|0.8|0.7|Benign/Borderline|648|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.6|0.8|0.7|Malignant|616|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.8|0.9|0.9|Benign/Borderline|826|103190694|Male|Unclassified Tumors|2005|0.7|0.9|0.8
20+|0.6|0.7|0.7|Malignant|612|103190694|Male|Unclassified Tumors|2005|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|849|104488268|Male|Unclassified Tumors|2006|0.8|0.9|0.8
20+|0.6|0.7|0.6|Malignant|576|104488268|Male|Unclassified Tumors|2006|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|857|105697783|Male|Unclassified Tumors|2007|0.8|0.9|0.8
20+|0.6|0.7|0.6|Malignant|573|105697783|Male|Unclassified Tumors|2007|0.5|0.6|0.5
20+|0.9|1.0|0.9|Benign/Borderline|936|106947980|Male|Unclassified Tumors|2008|0.8|0.9|0.9
20+|0.6|0.7|0.7|Malignant|628|106947980|Male|Unclassified Tumors|2008|0.5|0.6|0.6
20+|0.9|1.1|1.0|Benign/Borderline|1034|108197539|Male|Unclassified Tumors|2009|0.9|1.0|1.0
20+|0.6|0.7|0.7|Malignant|653|108197539|Male|Unclassified Tumors|2009|0.6|0.7|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1111|109527917|Male|Unclassified Tumors|2010|1.0|1.1|1.0
20+|0.6|0.7|0.6|Malignant|613|109527917|Male|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1136|110844094|Male|Unclassified Tumors|2011|1.0|1.1|1.0
20+|0.6|0.7|0.6|Malignant|626|110844094|Male|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.0|1.2|1.1|Benign/Borderline|1218|112218652|Male|Unclassified Tumors|2012|1.0|1.1|1.1
20+|0.6|0.7|0.6|Malignant|631|112218652|Male|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|1186|113477293|Male|Unclassified Tumors|2013|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|620|113477293|Male|Unclassified Tumors|2013|0.5|0.6|0.5
20+|0.9|0.9|0.9|Benign/Borderline|5284|579536769|Male|Unclassified Tumors|2013-2017|0.9|0.9|0.9
20+|0.5|0.6|0.5|Malignant|3096|579536769|Male|Unclassified Tumors|2013-2017|0.5|0.6|0.5
20+|0.9|1.1|1.0|Benign/Borderline|1132|114741253|Male|Unclassified Tumors|2014|0.9|1.0|1.0
20+|0.6|0.7|0.6|Malignant|673|114741253|Male|Unclassified Tumors|2014|0.5|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|1064|115974555|Male|Unclassified Tumors|2015|0.9|1.0|0.9
20+|0.5|0.6|0.6|Malignant|631|115974555|Male|Unclassified Tumors|2015|0.5|0.6|0.5
20+|0.8|0.9|0.8|Benign/Borderline|964|117142413|Male|Unclassified Tumors|2016|0.8|0.9|0.8
20+|0.5|0.6|0.5|Malignant|623|117142413|Male|Unclassified Tumors|2016|0.5|0.6|0.5
20+|0.7|0.8|0.8|Benign/Borderline|938|118201255|Male|Unclassified Tumors|2017|0.7|0.8|0.8
20+|0.4|0.5|0.5|Malignant|549|118201255|Male|Unclassified Tumors|2017|0.4|0.5|0.5
20+|0.1|0.1|0.1|Benign/Borderline|100|101938779|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|113|103190694|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|103190694|Male|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|138|104488268|Male|Unique astrocytoma variants|2006|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|24|104488268|Male|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|122|105697783|Male|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|105697783|Male|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|150|106947980|Male|Unique astrocytoma variants|2008|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|35|106947980|Male|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|159|108197539|Male|Unique astrocytoma variants|2009|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|37|108197539|Male|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|184|109527917|Male|Unique astrocytoma variants|2010|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|26|109527917|Male|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|187|110844094|Male|Unique astrocytoma variants|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|31|110844094|Male|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|174|112218652|Male|Unique astrocytoma variants|2012|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|27|112218652|Male|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|169|113477293|Male|Unique astrocytoma variants|2013|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|39|113477293|Male|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|888|579536769|Male|Unique astrocytoma variants|2013-2017|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|176|579536769|Male|Unique astrocytoma variants|2013-2017|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|178|114741253|Male|Unique astrocytoma variants|2014|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|40|114741253|Male|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|172|115974555|Male|Unique astrocytoma variants|2015|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|27|115974555|Male|Unique astrocytoma variants|2015|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|195|117142413|Male|Unique astrocytoma variants|2016|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|29|117142413|Male|Unique astrocytoma variants|2016|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|174|118201255|Male|Unique astrocytoma variants|2017|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|41|118201255|Male|Unique astrocytoma variants|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|24|211050944|Male and Female|All other|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|213511339|Male and Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|216055494|Male and Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|218481776|Male and Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|220975702|Male and Female|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|223491138|Male and Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|226144182|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|32|226144182|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|228752299|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|45|228752299|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|231390637|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|35|231390637|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|33|233810936|Male and Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|50|233810936|Male and Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|245|1192790502|Male and Female|All other|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|257|1192790502|Male and Female|All other|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|28|236278334|Male and Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|49|236278334|Male and Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|45|238659768|Male and Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|53|238659768|Male and Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|73|240960373|Male and Female|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|52|240960373|Male and Female|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|66|243081091|Male and Female|All other|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|53|243081091|Male and Female|All other|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.6|0.6|Malignant|1237|211050944|Male and Female|Anaplastic astrocytoma|2004|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1214|213511339|Male and Female|Anaplastic astrocytoma|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1210|216055494|Male and Female|Anaplastic astrocytoma|2006|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1202|218481776|Male and Female|Anaplastic astrocytoma|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.5|0.6|0.5|Malignant|1212|220975702|Male and Female|Anaplastic astrocytoma|2008|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|1214|223491138|Male and Female|Anaplastic astrocytoma|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|226144182|Male and Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|1279|226144182|Male and Female|Anaplastic astrocytoma|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|228752299|Male and Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|1280|228752299|Male and Female|Anaplastic astrocytoma|2011|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|231390637|Male and Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.5|0.6|0.6|Malignant|1337|231390637|Male and Female|Anaplastic astrocytoma|2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|233810936|Male and Female|Anaplastic astrocytoma|2013|~|~|~
20+|0.6|0.6|0.6|Malignant|1428|233810936|Male and Female|Anaplastic astrocytoma|2013|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|1192790502|Male and Female|Anaplastic astrocytoma|2013-2017|~|~|~
20+|0.6|0.6|0.6|Malignant|7194|1192790502|Male and Female|Anaplastic astrocytoma|2013-2017|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|236278334|Male and Female|Anaplastic astrocytoma|2014|~|~|~
20+|0.6|0.6|0.6|Malignant|1399|236278334|Male and Female|Anaplastic astrocytoma|2014|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|238659768|Male and Female|Anaplastic astrocytoma|2015|~|~|~
20+|0.6|0.6|0.6|Malignant|1477|238659768|Male and Female|Anaplastic astrocytoma|2015|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|240960373|Male and Female|Anaplastic astrocytoma|2016|~|~|~
20+|0.6|0.6|0.6|Malignant|1460|240960373|Male and Female|Anaplastic astrocytoma|2016|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|243081091|Male and Female|Anaplastic astrocytoma|2017|~|~|~
20+|0.5|0.6|0.6|Malignant|1430|243081091|Male and Female|Anaplastic astrocytoma|2017|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|394|211050944|Male and Female|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|376|213511339|Male and Female|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.2|0.2|Malignant|354|216055494|Male and Female|Anaplastic oligodendroglioma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|341|218481776|Male and Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|359|220975702|Male and Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|334|223491138|Male and Female|Anaplastic oligodendroglioma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|226144182|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|328|226144182|Male and Female|Anaplastic oligodendroglioma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|228752299|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|335|228752299|Male and Female|Anaplastic oligodendroglioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|231390637|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.2|Malignant|357|231390637|Male and Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|233810936|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.1|0.2|0.2|Malignant|373|233810936|Male and Female|Anaplastic oligodendroglioma|2013|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|1192790502|Male and Female|Anaplastic oligodendroglioma|2013-2017|~|~|~
20+|0.1|0.2|0.2|Malignant|1857|1192790502|Male and Female|Anaplastic oligodendroglioma|2013-2017|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|236278334|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.1|0.2|0.1|Malignant|353|236278334|Male and Female|Anaplastic oligodendroglioma|2014|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|238659768|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.1|Malignant|353|238659768|Male and Female|Anaplastic oligodendroglioma|2015|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|240960373|Male and Female|Anaplastic oligodendroglioma|2016|~|~|~
20+|0.1|0.2|0.2|Malignant|369|240960373|Male and Female|Anaplastic oligodendroglioma|2016|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|243081091|Male and Female|Anaplastic oligodendroglioma|2017|~|~|~
20+|0.2|0.2|0.2|Malignant|409|243081091|Male and Female|Anaplastic oligodendroglioma|2017|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.6|Malignant|1207|211050944|Male and Female|Astrocytoma, NOS|2004|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1198|213511339|Male and Female|Astrocytoma, NOS|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Astrocytoma, NOS|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1188|216055494|Male and Female|Astrocytoma, NOS|2006|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Astrocytoma, NOS|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1159|218481776|Male and Female|Astrocytoma, NOS|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.5|0.5|Malignant|1120|220975702|Male and Female|Astrocytoma, NOS|2008|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.5|Malignant|1054|223491138|Male and Female|Astrocytoma, NOS|2009|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|226144182|Male and Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|1092|226144182|Male and Female|Astrocytoma, NOS|2010|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|228752299|Male and Female|Astrocytoma, NOS|2011|~|~|~
20+|0.4|0.5|0.5|Malignant|1042|228752299|Male and Female|Astrocytoma, NOS|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|231390637|Male and Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|1050|231390637|Male and Female|Astrocytoma, NOS|2012|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|233810936|Male and Female|Astrocytoma, NOS|2013|~|~|~
20+|0.4|0.5|0.4|Malignant|1011|233810936|Male and Female|Astrocytoma, NOS|2013|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|1192790502|Male and Female|Astrocytoma, NOS|2013-2017|~|~|~
20+|0.5|0.5|0.5|Malignant|5715|1192790502|Male and Female|Astrocytoma, NOS|2013-2017|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|236278334|Male and Female|Astrocytoma, NOS|2014|~|~|~
20+|0.4|0.5|0.5|Malignant|1086|236278334|Male and Female|Astrocytoma, NOS|2014|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|238659768|Male and Female|Astrocytoma, NOS|2015|~|~|~
20+|0.5|0.5|0.5|Malignant|1188|238659768|Male and Female|Astrocytoma, NOS|2015|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|240960373|Male and Female|Astrocytoma, NOS|2016|~|~|~
20+|0.5|0.5|0.5|Malignant|1245|240960373|Male and Female|Astrocytoma, NOS|2016|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|243081091|Male and Female|Astrocytoma, NOS|2017|~|~|~
20+|0.5|0.5|0.5|Malignant|1185|243081091|Male and Female|Astrocytoma, NOS|2017|0.5|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|63|211050944|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|75|213511339|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|68|216055494|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|Choroid plexus|2006|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|89|218481776|Male and Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|76|220975702|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|74|223491138|Male and Female|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|86|226144182|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|226144182|Male and Female|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|84|228752299|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|228752299|Male and Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|74|231390637|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|231390637|Male and Female|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|78|233810936|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|233810936|Male and Female|Choroid plexus|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|407|1192790502|Male and Female|Choroid plexus|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|1192790502|Male and Female|Choroid plexus|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|88|236278334|Male and Female|Choroid plexus|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|236278334|Male and Female|Choroid plexus|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|83|238659768|Male and Female|Choroid plexus|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|238659768|Male and Female|Choroid plexus|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|72|240960373|Male and Female|Choroid plexus|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|240960373|Male and Female|Choroid plexus|2016|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|86|243081091|Male and Female|Choroid plexus|2017|0.0|0.0|0.0
20+|~|~|~|Malignant|~|243081091|Male and Female|Choroid plexus|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|389|211050944|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|416|213511339|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|392|216055494|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|420|218481776|Male and Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|423|220975702|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|432|223491138|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|440|226144182|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226144182|Male and Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|417|228752299|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|228752299|Male and Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|440|231390637|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|231390637|Male and Female|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|471|233810936|Male and Female|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|233810936|Male and Female|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2276|1192790502|Male and Female|Craniopharyngioma|2013-2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|1192790502|Male and Female|Craniopharyngioma|2013-2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|426|236278334|Male and Female|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|236278334|Male and Female|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|456|238659768|Male and Female|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|238659768|Male and Female|Craniopharyngioma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|455|240960373|Male and Female|Craniopharyngioma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|240960373|Male and Female|Craniopharyngioma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|468|243081091|Male and Female|Craniopharyngioma|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|243081091|Male and Female|Craniopharyngioma|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|258|211050944|Male and Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|280|213511339|Male and Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|294|216055494|Male and Female|Diffuse astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|318|218481776|Male and Female|Diffuse astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|340|220975702|Male and Female|Diffuse astrocytoma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|369|223491138|Male and Female|Diffuse astrocytoma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|226144182|Male and Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|349|226144182|Male and Female|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|228752299|Male and Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|251|228752299|Male and Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|231390637|Male and Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|207|231390637|Male and Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233810936|Male and Female|Diffuse astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|174|233810936|Male and Female|Diffuse astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1192790502|Male and Female|Diffuse astrocytoma|2013-2017|~|~|~
20+|0.0|0.0|0.0|Malignant|449|1192790502|Male and Female|Diffuse astrocytoma|2013-2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|236278334|Male and Female|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|132|236278334|Male and Female|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238659768|Male and Female|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|84|238659768|Male and Female|Diffuse astrocytoma|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|240960373|Male and Female|Diffuse astrocytoma|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|35|240960373|Male and Female|Diffuse astrocytoma|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|243081091|Male and Female|Diffuse astrocytoma|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|24|243081091|Male and Female|Diffuse astrocytoma|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|167|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|190|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|171|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|216|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|212|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|237|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226144182|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|198|226144182|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|228752299|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|187|228752299|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|231390637|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|174|231390637|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233810936|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|185|233810936|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1192790502|Male and Female|Embryonal/primitive/medulloblastoma|2013-2017|~|~|~
20+|0.1|0.1|0.1|Malignant|873|1192790502|Male and Female|Embryonal/primitive/medulloblastoma|2013-2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236278334|Male and Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|179|236278334|Male and Female|Embryonal/primitive/medulloblastoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238659768|Male and Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|167|238659768|Male and Female|Embryonal/primitive/medulloblastoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|240960373|Male and Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|182|240960373|Male and Female|Embryonal/primitive/medulloblastoma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|243081091|Male and Female|Embryonal/primitive/medulloblastoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|160|243081091|Male and Female|Embryonal/primitive/medulloblastoma|2017|0.1|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|246|211050944|Male and Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|211050944|Male and Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|270|213511339|Male and Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|213511339|Male and Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|310|216055494|Male and Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|216055494|Male and Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|250|218481776|Male and Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|218481776|Male and Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|255|220975702|Male and Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|220975702|Male and Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|260|223491138|Male and Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|223491138|Male and Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|277|226144182|Male and Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|226144182|Male and Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|269|228752299|Male and Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|228752299|Male and Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|293|231390637|Male and Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|231390637|Male and Female|Ependymoma variants|2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|275|233810936|Male and Female|Ependymoma variants|2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|233810936|Male and Female|Ependymoma variants|2013|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|1418|1192790502|Male and Female|Ependymoma variants|2013-2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|25|1192790502|Male and Female|Ependymoma variants|2013-2017|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|298|236278334|Male and Female|Ependymoma variants|2014|0.1|0.1|0.1
20+|~|~|~|Malignant|~|236278334|Male and Female|Ependymoma variants|2014|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|291|238659768|Male and Female|Ependymoma variants|2015|0.1|0.1|0.1
20+|~|~|~|Malignant|~|238659768|Male and Female|Ependymoma variants|2015|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|291|240960373|Male and Female|Ependymoma variants|2016|0.1|0.1|0.1
20+|~|~|~|Malignant|~|240960373|Male and Female|Ependymoma variants|2016|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|263|243081091|Male and Female|Ependymoma variants|2017|0.1|0.1|0.1
20+|~|~|~|Malignant|~|243081091|Male and Female|Ependymoma variants|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|595|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|602|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|585|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|584|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|633|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|682|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|16|226144182|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|627|226144182|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|17|228752299|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|594|228752299|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|231390637|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|630|231390637|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|233810936|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.2|Malignant|576|233810936|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|108|1192790502|Male and Female|Ependymoma/anaplastic ependymoma|2013-2017|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|2877|1192790502|Male and Female|Ependymoma/anaplastic ependymoma|2013-2017|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|29|236278334|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|565|236278334|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|27|238659768|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|580|238659768|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|19|240960373|Male and Female|Ependymoma/anaplastic ependymoma|2016|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|587|240960373|Male and Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|21|243081091|Male and Female|Ependymoma/anaplastic ependymoma|2017|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|569|243081091|Male and Female|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|38|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|56|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|68|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|65|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|65|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|61|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|70|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|81|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|66|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|78|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|226144182|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|226144182|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|61|228752299|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|69|228752299|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|64|231390637|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|52|231390637|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|50|233810936|Male and Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|52|233810936|Male and Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|275|1192790502|Male and Female|Germ Cell Tumors|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|320|1192790502|Male and Female|Germ Cell Tumors|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|236278334|Male and Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|69|236278334|Male and Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|60|238659768|Male and Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|59|238659768|Male and Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|59|240960373|Male and Female|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|76|240960373|Male and Female|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|243081091|Male and Female|Germ Cell Tumors|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|243081091|Male and Female|Germ Cell Tumors|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioblastoma|2004|~|~|~
20+|4.4|4.6|4.5|Malignant|9562|211050944|Male and Female|Glioblastoma|2004|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioblastoma|2005|~|~|~
20+|4.4|4.5|4.5|Malignant|9705|213511339|Male and Female|Glioblastoma|2005|4.5|4.6|4.5
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioblastoma|2006|~|~|~
20+|4.3|4.5|4.4|Malignant|9801|216055494|Male and Female|Glioblastoma|2006|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioblastoma|2007|~|~|~
20+|4.4|4.6|4.5|Malignant|10191|218481776|Male and Female|Glioblastoma|2007|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Glioblastoma|2008|~|~|~
20+|4.4|4.6|4.5|Malignant|10413|220975702|Male and Female|Glioblastoma|2008|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Glioblastoma|2009|~|~|~
20+|4.4|4.5|4.4|Malignant|10495|223491138|Male and Female|Glioblastoma|2009|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|226144182|Male and Female|Glioblastoma|2010|~|~|~
20+|4.4|4.5|4.4|Malignant|10738|226144182|Male and Female|Glioblastoma|2010|4.7|4.8|4.7
20+|~|~|~|Benign/Borderline|~|228752299|Male and Female|Glioblastoma|2011|~|~|~
20+|4.3|4.5|4.4|Malignant|10891|228752299|Male and Female|Glioblastoma|2011|4.7|4.9|4.8
20+|~|~|~|Benign/Borderline|~|231390637|Male and Female|Glioblastoma|2012|~|~|~
20+|4.4|4.6|4.5|Malignant|11390|231390637|Male and Female|Glioblastoma|2012|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|233810936|Male and Female|Glioblastoma|2013|~|~|~
20+|4.4|4.6|4.5|Malignant|11554|233810936|Male and Female|Glioblastoma|2013|4.9|5.0|4.9
20+|~|~|~|Benign/Borderline|~|1192790502|Male and Female|Glioblastoma|2013-2017|~|~|~
20+|4.4|4.5|4.5|Malignant|59876|1192790502|Male and Female|Glioblastoma|2013-2017|5.0|5.1|5.0
20+|~|~|~|Benign/Borderline|~|236278334|Male and Female|Glioblastoma|2014|~|~|~
20+|4.3|4.5|4.4|Malignant|11584|236278334|Male and Female|Glioblastoma|2014|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|238659768|Male and Female|Glioblastoma|2015|~|~|~
20+|4.4|4.6|4.5|Malignant|12000|238659768|Male and Female|Glioblastoma|2015|4.9|5.1|5.0
20+|~|~|~|Benign/Borderline|~|240960373|Male and Female|Glioblastoma|2016|~|~|~
20+|4.4|4.6|4.5|Malignant|12367|240960373|Male and Female|Glioblastoma|2016|5.0|5.2|5.1
20+|~|~|~|Benign/Borderline|~|243081091|Male and Female|Glioblastoma|2017|~|~|~
20+|4.3|4.5|4.4|Malignant|12371|243081091|Male and Female|Glioblastoma|2017|5.0|5.2|5.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|845|211050944|Male and Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|834|213511339|Male and Female|Glioma malignant, NOS|2005|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|18|216055494|Male and Female|Glioma malignant, NOS|2006|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|843|216055494|Male and Female|Glioma malignant, NOS|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|876|218481776|Male and Female|Glioma malignant, NOS|2007|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|24|220975702|Male and Female|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|923|220975702|Male and Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|24|223491138|Male and Female|Glioma malignant, NOS|2009|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|968|223491138|Male and Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|19|226144182|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|820|226144182|Male and Female|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|27|228752299|Male and Female|Glioma malignant, NOS|2011|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|940|228752299|Male and Female|Glioma malignant, NOS|2011|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|30|231390637|Male and Female|Glioma malignant, NOS|2012|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|923|231390637|Male and Female|Glioma malignant, NOS|2012|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|30|233810936|Male and Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|916|233810936|Male and Female|Glioma malignant, NOS|2013|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|210|1192790502|Male and Female|Glioma malignant, NOS|2013-2017|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|4987|1192790502|Male and Female|Glioma malignant, NOS|2013-2017|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|40|236278334|Male and Female|Glioma malignant, NOS|2014|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|940|236278334|Male and Female|Glioma malignant, NOS|2014|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|48|238659768|Male and Female|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|995|238659768|Male and Female|Glioma malignant, NOS|2015|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|48|240960373|Male and Female|Glioma malignant, NOS|2016|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|1045|240960373|Male and Female|Glioma malignant, NOS|2016|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|44|243081091|Male and Female|Glioma malignant, NOS|2017|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|1091|243081091|Male and Female|Glioma malignant, NOS|2017|0.4|0.5|0.4
20+|0.2|0.2|0.2|Benign/Borderline|456|211050944|Male and Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|516|213511339|Male and Female|Hemangioblastoma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|498|216055494|Male and Female|Hemangioblastoma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|474|218481776|Male and Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|527|220975702|Male and Female|Hemangioblastoma|2008|0.2|0.3|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|510|223491138|Male and Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|529|226144182|Male and Female|Hemangioblastoma|2010|0.2|0.3|0.2
20+|~|~|~|Malignant|~|226144182|Male and Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|523|228752299|Male and Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|228752299|Male and Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|539|231390637|Male and Female|Hemangioblastoma|2012|0.2|0.3|0.2
20+|~|~|~|Malignant|~|231390637|Male and Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|509|233810936|Male and Female|Hemangioblastoma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|233810936|Male and Female|Hemangioblastoma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2597|1192790502|Male and Female|Hemangioblastoma|2013-2017|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|30|1192790502|Male and Female|Hemangioblastoma|2013-2017|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|492|236278334|Male and Female|Hemangioblastoma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|236278334|Male and Female|Hemangioblastoma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|528|238659768|Male and Female|Hemangioblastoma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|238659768|Male and Female|Hemangioblastoma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|533|240960373|Male and Female|Hemangioblastoma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|240960373|Male and Female|Hemangioblastoma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|535|243081091|Male and Female|Hemangioblastoma|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|243081091|Male and Female|Hemangioblastoma|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|374|211050944|Male and Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|485|213511339|Male and Female|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|551|216055494|Male and Female|Hemangioma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioma|2006|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|635|218481776|Male and Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioma|2007|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|794|220975702|Male and Female|Hemangioma|2008|0.3|0.4|0.4
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|950|223491138|Male and Female|Hemangioma|2009|0.4|0.5|0.4
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioma|2009|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1100|226144182|Male and Female|Hemangioma|2010|0.5|0.5|0.5
20+|~|~|~|Malignant|~|226144182|Male and Female|Hemangioma|2010|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|1218|228752299|Male and Female|Hemangioma|2011|0.5|0.6|0.5
20+|~|~|~|Malignant|~|228752299|Male and Female|Hemangioma|2011|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|1224|231390637|Male and Female|Hemangioma|2012|0.5|0.6|0.5
20+|~|~|~|Malignant|~|231390637|Male and Female|Hemangioma|2012|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1227|233810936|Male and Female|Hemangioma|2013|0.5|0.6|0.5
20+|~|~|~|Malignant|~|233810936|Male and Female|Hemangioma|2013|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|5168|1192790502|Male and Female|Hemangioma|2013-2017|0.4|0.4|0.4
20+|0.0|0.0|0.0|Malignant|22|1192790502|Male and Female|Hemangioma|2013-2017|0.0|0.0|0.0
20+|0.4|0.5|0.5|Benign/Borderline|1143|236278334|Male and Female|Hemangioma|2014|0.5|0.5|0.5
20+|~|~|~|Malignant|~|236278334|Male and Female|Hemangioma|2014|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|1007|238659768|Male and Female|Hemangioma|2015|0.4|0.4|0.4
20+|~|~|~|Malignant|~|238659768|Male and Female|Hemangioma|2015|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|924|240960373|Male and Female|Hemangioma|2016|0.4|0.4|0.4
20+|~|~|~|Malignant|~|240960373|Male and Female|Hemangioma|2016|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|867|243081091|Male and Female|Hemangioma|2017|0.3|0.4|0.4
20+|~|~|~|Malignant|~|243081091|Male and Female|Hemangioma|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|50|211050944|Male and Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|45|213511339|Male and Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|53|216055494|Male and Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|52|220975702|Male and Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|53|223491138|Male and Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226144182|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|54|226144182|Male and Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|228752299|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|42|228752299|Male and Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|231390637|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|48|231390637|Male and Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|233810936|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|44|233810936|Male and Female|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|1192790502|Male and Female|Local Extensions from Regional Tumors|2013-2017|~|~|~
20+|0.0|0.0|0.0|Malignant|213|1192790502|Male and Female|Local Extensions from Regional Tumors|2013-2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|236278334|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|51|236278334|Male and Female|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|238659768|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|42|238659768|Male and Female|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|240960373|Male and Female|Local Extensions from Regional Tumors|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|42|240960373|Male and Female|Local Extensions from Regional Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|243081091|Male and Female|Local Extensions from Regional Tumors|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|34|243081091|Male and Female|Local Extensions from Regional Tumors|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|1340|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|1440|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|1435|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|1377|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|1475|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.6|0.7|0.6|Malignant|1428|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|226144182|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|1506|226144182|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|228752299|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|1528|228752299|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|231390637|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.6|0.6|Malignant|1462|231390637|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|233810936|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.6|0.6|0.6|Malignant|1471|233810936|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|1192790502|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013-2017|~|~|~
20+|0.6|0.6|0.6|Malignant|8038|1192790502|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013-2017|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|236278334|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.6|0.7|0.6|Malignant|1634|236278334|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|238659768|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.6|0.6|0.6|Malignant|1577|238659768|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|240960373|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
20+|0.6|0.6|0.6|Malignant|1650|240960373|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|243081091|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
20+|0.6|0.7|0.6|Malignant|1706|243081091|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017|0.7|0.7|0.7
20+|8.8|9.1|9.0|Benign/Borderline|19047|211050944|Male and Female|Meningioma|2004|8.9|9.2|9.0
20+|0.2|0.2|0.2|Malignant|442|211050944|Male and Female|Meningioma|2004|0.2|0.2|0.2
20+|9.9|10.2|10.0|Benign/Borderline|21692|213511339|Male and Female|Meningioma|2005|10.0|10.3|10.2
20+|0.2|0.2|0.2|Malignant|435|213511339|Male and Female|Meningioma|2005|0.2|0.2|0.2
20+|10.4|10.7|10.5|Benign/Borderline|23145|216055494|Male and Female|Meningioma|2006|10.6|10.9|10.7
20+|0.2|0.2|0.2|Malignant|406|216055494|Male and Female|Meningioma|2006|0.2|0.2|0.2
20+|10.7|11.0|10.8|Benign/Borderline|24268|218481776|Male and Female|Meningioma|2007|11.0|11.2|11.1
20+|0.2|0.2|0.2|Malignant|445|218481776|Male and Female|Meningioma|2007|0.2|0.2|0.2
20+|11.3|11.6|11.4|Benign/Borderline|26126|220975702|Male and Female|Meningioma|2008|11.7|12.0|11.8
20+|0.1|0.2|0.2|Malignant|365|220975702|Male and Female|Meningioma|2008|0.1|0.2|0.2
20+|12.0|12.3|12.2|Benign/Borderline|28290|223491138|Male and Female|Meningioma|2009|12.5|12.8|12.7
20+|0.1|0.2|0.1|Malignant|350|223491138|Male and Female|Meningioma|2009|0.1|0.2|0.2
20+|11.7|11.9|11.8|Benign/Borderline|27893|226144182|Male and Female|Meningioma|2010|12.2|12.5|12.3
20+|0.1|0.2|0.1|Malignant|327|226144182|Male and Female|Meningioma|2010|0.1|0.2|0.1
20+|11.7|12.0|11.8|Benign/Borderline|28463|228752299|Male and Female|Meningioma|2011|12.3|12.6|12.4
20+|0.1|0.2|0.1|Malignant|327|228752299|Male and Female|Meningioma|2011|0.1|0.2|0.1
20+|11.8|12.1|12.0|Benign/Borderline|29410|231390637|Male and Female|Meningioma|2012|12.6|12.9|12.7
20+|0.1|0.2|0.1|Malignant|354|231390637|Male and Female|Meningioma|2012|0.1|0.2|0.2
20+|12.0|12.3|12.1|Benign/Borderline|30297|233810936|Male and Female|Meningioma|2013|12.8|13.1|13.0
20+|0.1|0.2|0.1|Malignant|378|233810936|Male and Female|Meningioma|2013|0.1|0.2|0.2
20+|12.3|12.4|12.4|Benign/Borderline|160205|1192790502|Male and Female|Meningioma|2013-2017|13.4|13.5|13.4
20+|0.1|0.1|0.1|Malignant|1738|1192790502|Male and Female|Meningioma|2013-2017|0.1|0.2|0.1
20+|12.1|12.4|12.3|Benign/Borderline|31214|236278334|Male and Female|Meningioma|2014|13.1|13.4|13.2
20+|0.1|0.2|0.1|Malignant|382|236278334|Male and Female|Meningioma|2014|0.1|0.2|0.2
20+|12.4|12.7|12.5|Benign/Borderline|32513|238659768|Male and Female|Meningioma|2015|13.5|13.8|13.6
20+|0.1|0.1|0.1|Malignant|344|238659768|Male and Female|Meningioma|2015|0.1|0.2|0.1
20+|12.4|12.7|12.5|Benign/Borderline|32991|240960373|Male and Female|Meningioma|2016|13.5|13.8|13.7
20+|0.1|0.1|0.1|Malignant|319|240960373|Male and Female|Meningioma|2016|0.1|0.1|0.1
20+|12.2|12.5|12.3|Benign/Borderline|33190|243081091|Male and Female|Meningioma|2017|13.5|13.8|13.7
20+|0.1|0.1|0.1|Malignant|315|243081091|Male and Female|Meningioma|2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Mixed glioma|2004|~|~|~
20+|0.2|0.3|0.2|Malignant|492|211050944|Male and Female|Mixed glioma|2004|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|565|213511339|Male and Female|Mixed glioma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Mixed glioma|2006|~|~|~
20+|0.3|0.3|0.3|Malignant|637|216055494|Male and Female|Mixed glioma|2006|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Mixed glioma|2007|~|~|~
20+|0.3|0.3|0.3|Malignant|587|218481776|Male and Female|Mixed glioma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Mixed glioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|602|220975702|Male and Female|Mixed glioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Mixed glioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|678|223491138|Male and Female|Mixed glioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226144182|Male and Female|Mixed glioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|611|226144182|Male and Female|Mixed glioma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|228752299|Male and Female|Mixed glioma|2011|~|~|~
20+|0.3|0.3|0.3|Malignant|635|228752299|Male and Female|Mixed glioma|2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|231390637|Male and Female|Mixed glioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|573|231390637|Male and Female|Mixed glioma|2012|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|233810936|Male and Female|Mixed glioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|617|233810936|Male and Female|Mixed glioma|2013|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|1192790502|Male and Female|Mixed glioma|2013-2017|~|~|~
20+|0.1|0.1|0.1|Malignant|1523|1192790502|Male and Female|Mixed glioma|2013-2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236278334|Male and Female|Mixed glioma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|466|236278334|Male and Female|Mixed glioma|2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|238659768|Male and Female|Mixed glioma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|273|238659768|Male and Female|Mixed glioma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|240960373|Male and Female|Mixed glioma|2016|~|~|~
20+|0.0|0.1|0.0|Malignant|106|240960373|Male and Female|Mixed glioma|2016|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|243081091|Male and Female|Mixed glioma|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|61|243081091|Male and Female|Mixed glioma|2017|0.0|0.0|0.0
20+|0.5|0.6|0.6|Benign/Borderline|1194|211050944|Male and Female|Neoplasm, unspecified|2004|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|1312|211050944|Male and Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.7|0.7|Benign/Borderline|1495|213511339|Male and Female|Neoplasm, unspecified|2005|0.7|0.7|0.7
20+|0.6|0.7|0.6|Malignant|1322|213511339|Male and Female|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|1418|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1286|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1424|218481776|Male and Female|Neoplasm, unspecified|2007|0.6|0.7|0.7
20+|0.5|0.6|0.5|Malignant|1217|218481776|Male and Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1442|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1369|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|1527|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1427|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1483|226144182|Male and Female|Neoplasm, unspecified|2010|0.6|0.7|0.7
20+|0.5|0.6|0.5|Malignant|1250|226144182|Male and Female|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1470|228752299|Male and Female|Neoplasm, unspecified|2011|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1257|228752299|Male and Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.7|0.7|Benign/Borderline|1581|231390637|Male and Female|Neoplasm, unspecified|2012|0.6|0.7|0.7
20+|0.5|0.5|0.5|Malignant|1273|231390637|Male and Female|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|1476|233810936|Male and Female|Neoplasm, unspecified|2013|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1274|233810936|Male and Female|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|7000|1192790502|Male and Female|Neoplasm, unspecified|2013-2017|0.6|0.6|0.6
20+|0.5|0.5|0.5|Malignant|6430|1192790502|Male and Female|Neoplasm, unspecified|2013-2017|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|1503|236278334|Male and Female|Neoplasm, unspecified|2014|0.6|0.7|0.6
20+|0.5|0.6|0.5|Malignant|1400|236278334|Male and Female|Neoplasm, unspecified|2014|0.6|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|1459|238659768|Male and Female|Neoplasm, unspecified|2015|0.6|0.6|0.6
20+|0.5|0.5|0.5|Malignant|1349|238659768|Male and Female|Neoplasm, unspecified|2015|0.5|0.6|0.6
20+|0.5|0.5|0.5|Benign/Borderline|1322|240960373|Male and Female|Neoplasm, unspecified|2016|0.5|0.6|0.5
20+|0.4|0.5|0.5|Malignant|1214|240960373|Male and Female|Neoplasm, unspecified|2016|0.5|0.5|0.5
20+|0.4|0.5|0.5|Benign/Borderline|1240|243081091|Male and Female|Neoplasm, unspecified|2017|0.5|0.5|0.5
20+|0.4|0.5|0.4|Malignant|1193|243081091|Male and Female|Neoplasm, unspecified|2017|0.5|0.5|0.5
20+|2.2|2.3|2.3|Benign/Borderline|4882|211050944|Male and Female|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5501|213511339|Male and Female|Nerve sheath, benign and malignant|2005|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|52|213511339|Male and Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5602|216055494|Male and Female|Nerve sheath, benign and malignant|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5687|218481776|Male and Female|Nerve sheath, benign and malignant|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5783|220975702|Male and Female|Nerve sheath, benign and malignant|2008|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.6|2.7|2.6|Benign/Borderline|6120|223491138|Male and Female|Nerve sheath, benign and malignant|2009|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|36|223491138|Male and Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5923|226144182|Male and Female|Nerve sheath, benign and malignant|2010|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|45|226144182|Male and Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.6|2.7|2.6|Benign/Borderline|6273|228752299|Male and Female|Nerve sheath, benign and malignant|2011|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|37|228752299|Male and Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|6647|231390637|Male and Female|Nerve sheath, benign and malignant|2012|2.8|2.9|2.9
20+|0.0|0.0|0.0|Malignant|50|231390637|Male and Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.7|2.8|2.8|Benign/Borderline|6864|233810936|Male and Female|Nerve sheath, benign and malignant|2013|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|43|233810936|Male and Female|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|34796|1192790502|Male and Female|Nerve sheath, benign and malignant|2013-2017|2.9|2.9|2.9
20+|0.0|0.0|0.0|Malignant|211|1192790502|Male and Female|Nerve sheath, benign and malignant|2013-2017|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|7236|236278334|Male and Female|Nerve sheath, benign and malignant|2014|3.0|3.1|3.1
20+|0.0|0.0|0.0|Malignant|39|236278334|Male and Female|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.8|2.9|2.8|Benign/Borderline|7200|238659768|Male and Female|Nerve sheath, benign and malignant|2015|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|39|238659768|Male and Female|Nerve sheath, benign and malignant|2015|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|6936|240960373|Male and Female|Nerve sheath, benign and malignant|2016|2.8|2.9|2.9
20+|0.0|0.0|0.0|Malignant|46|240960373|Male and Female|Nerve sheath, benign and malignant|2016|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|6560|243081091|Male and Female|Nerve sheath, benign and malignant|2017|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|44|243081091|Male and Female|Nerve sheath, benign and malignant|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|41|213511339|Male and Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|41|216055494|Male and Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|52|218481776|Male and Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|45|220975702|Male and Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|45|223491138|Male and Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226144182|Male and Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|52|226144182|Male and Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|228752299|Male and Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|52|228752299|Male and Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|231390637|Male and Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|55|231390637|Male and Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|233810936|Male and Female|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|48|233810936|Male and Female|Neuroepithelial|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|36|1192790502|Male and Female|Neuroepithelial|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|254|1192790502|Male and Female|Neuroepithelial|2013-2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|236278334|Male and Female|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|57|236278334|Male and Female|Neuroepithelial|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|238659768|Male and Female|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|69|238659768|Male and Female|Neuroepithelial|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|240960373|Male and Female|Neuroepithelial|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|46|240960373|Male and Female|Neuroepithelial|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|243081091|Male and Female|Neuroepithelial|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|34|243081091|Male and Female|Neuroepithelial|2017|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|315|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|37|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|375|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|54|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|388|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|43|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|389|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|46|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|421|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|47|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|439|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|41|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|482|226144182|Male and Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|34|226144182|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|426|228752299|Male and Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|40|228752299|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|416|231390637|Male and Female|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|42|231390637|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|397|233810936|Male and Female|Neuronal/glial, neuronal|2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|31|233810936|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|2301|1192790502|Male and Female|Neuronal/glial, neuronal|2013-2017|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|174|1192790502|Male and Female|Neuronal/glial, neuronal|2013-2017|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|457|236278334|Male and Female|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|33|236278334|Male and Female|Neuronal/glial, neuronal|2014|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|490|238659768|Male and Female|Neuronal/glial, neuronal|2015|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|30|238659768|Male and Female|Neuronal/glial, neuronal|2015|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|474|240960373|Male and Female|Neuronal/glial, neuronal|2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|48|240960373|Male and Female|Neuronal/glial, neuronal|2016|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|483|243081091|Male and Female|Neuronal/glial, neuronal|2017|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|32|243081091|Male and Female|Neuronal/glial, neuronal|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Oligodendroglioma|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|832|211050944|Male and Female|Oligodendroglioma|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Oligodendroglioma|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|801|213511339|Male and Female|Oligodendroglioma|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Oligodendroglioma|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|846|216055494|Male and Female|Oligodendroglioma|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Oligodendroglioma|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|811|218481776|Male and Female|Oligodendroglioma|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|772|220975702|Male and Female|Oligodendroglioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Oligodendroglioma|2009|~|~|~
20+|0.4|0.4|0.4|Malignant|837|223491138|Male and Female|Oligodendroglioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|226144182|Male and Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.4|0.4|Malignant|800|226144182|Male and Female|Oligodendroglioma|2010|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|228752299|Male and Female|Oligodendroglioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|762|228752299|Male and Female|Oligodendroglioma|2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|231390637|Male and Female|Oligodendroglioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|663|231390637|Male and Female|Oligodendroglioma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|233810936|Male and Female|Oligodendroglioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|710|233810936|Male and Female|Oligodendroglioma|2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|1192790502|Male and Female|Oligodendroglioma|2013-2017|~|~|~
20+|0.3|0.3|0.3|Malignant|3555|1192790502|Male and Female|Oligodendroglioma|2013-2017|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|236278334|Male and Female|Oligodendroglioma|2014|~|~|~
20+|0.3|0.3|0.3|Malignant|715|236278334|Male and Female|Oligodendroglioma|2014|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|238659768|Male and Female|Oligodendroglioma|2015|~|~|~
20+|0.3|0.3|0.3|Malignant|710|238659768|Male and Female|Oligodendroglioma|2015|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|240960373|Male and Female|Oligodendroglioma|2016|~|~|~
20+|0.3|0.3|0.3|Malignant|724|240960373|Male and Female|Oligodendroglioma|2016|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|243081091|Male and Female|Oligodendroglioma|2017|~|~|~
20+|0.3|0.3|0.3|Malignant|696|243081091|Male and Female|Oligodendroglioma|2017|0.3|0.3|0.3
20+|0.1|0.1|0.1|Benign/Borderline|150|211050944|Male and Female|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|211050944|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|156|213511339|Male and Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|62|213511339|Male and Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|155|216055494|Male and Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|216055494|Male and Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|166|218481776|Male and Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|77|218481776|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|206|220975702|Male and Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|97|220975702|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|200|223491138|Male and Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|73|223491138|Male and Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|172|226144182|Male and Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|70|226144182|Male and Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|159|228752299|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|76|228752299|Male and Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|201|231390637|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|71|231390637|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|178|233810936|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|83|233810936|Male and Female|Other mesenchymal|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|888|1192790502|Male and Female|Other mesenchymal|2013-2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|432|1192790502|Male and Female|Other mesenchymal|2013-2017|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|179|236278334|Male and Female|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|81|236278334|Male and Female|Other mesenchymal|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|200|238659768|Male and Female|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|82|238659768|Male and Female|Other mesenchymal|2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|155|240960373|Male and Female|Other mesenchymal|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|80|240960373|Male and Female|Other mesenchymal|2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|176|243081091|Male and Female|Other mesenchymal|2017|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|106|243081091|Male and Female|Other mesenchymal|2017|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|275|211050944|Male and Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|305|213511339|Male and Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|306|216055494|Male and Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|307|218481776|Male and Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|290|220975702|Male and Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|272|223491138|Male and Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226144182|Male and Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|329|226144182|Male and Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|228752299|Male and Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|333|228752299|Male and Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|231390637|Male and Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|268|231390637|Male and Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233810936|Male and Female|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|300|233810936|Male and Female|Pilocytic astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1192790502|Male and Female|Pilocytic astrocytoma|2013-2017|~|~|~
20+|0.1|0.1|0.1|Malignant|1442|1192790502|Male and Female|Pilocytic astrocytoma|2013-2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236278334|Male and Female|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|297|236278334|Male and Female|Pilocytic astrocytoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238659768|Male and Female|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|293|238659768|Male and Female|Pilocytic astrocytoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|240960373|Male and Female|Pilocytic astrocytoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|293|240960373|Male and Female|Pilocytic astrocytoma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|243081091|Male and Female|Pilocytic astrocytoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|259|243081091|Male and Female|Pilocytic astrocytoma|2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|25|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|46|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|68|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|43|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|47|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|55|226144182|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|226144182|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|228752299|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|228752299|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|231390637|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|231390637|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|68|233810936|Male and Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|70|233810936|Male and Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|307|1192790502|Male and Female|Pineal parenchymal|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|279|1192790502|Male and Female|Pineal parenchymal|2013-2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|66|236278334|Male and Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|37|236278334|Male and Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|238659768|Male and Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|59|238659768|Male and Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|61|240960373|Male and Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|62|240960373|Male and Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|50|243081091|Male and Female|Pineal parenchymal|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|51|243081091|Male and Female|Pineal parenchymal|2017|0.0|0.0|0.0
20+|3.5|3.7|3.6|Benign/Borderline|7562|211050944|Male and Female|Pituitary|2004|3.5|3.7|3.6
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Pituitary|2004|0.0|0.0|0.0
20+|3.9|4.1|4.0|Benign/Borderline|8591|213511339|Male and Female|Pituitary|2005|3.9|4.1|4.0
20+|0.0|0.0|0.0|Malignant|37|213511339|Male and Female|Pituitary|2005|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|9358|216055494|Male and Female|Pituitary|2006|4.2|4.4|4.3
20+|0.0|0.0|0.0|Malignant|31|216055494|Male and Female|Pituitary|2006|0.0|0.0|0.0
20+|4.4|4.6|4.5|Benign/Borderline|9946|218481776|Male and Female|Pituitary|2007|4.5|4.6|4.6
20+|0.0|0.0|0.0|Malignant|33|218481776|Male and Female|Pituitary|2007|0.0|0.0|0.0
20+|4.8|5.0|4.9|Benign/Borderline|10774|220975702|Male and Female|Pituitary|2008|4.8|5.0|4.9
20+|~|~|~|Malignant|~|220975702|Male and Female|Pituitary|2008|~|~|~
20+|5.1|5.3|5.2|Benign/Borderline|11711|223491138|Male and Female|Pituitary|2009|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|24|223491138|Male and Female|Pituitary|2009|0.0|0.0|0.0
20+|5.1|5.3|5.2|Benign/Borderline|11889|226144182|Male and Female|Pituitary|2010|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|31|226144182|Male and Female|Pituitary|2010|0.0|0.0|0.0
20+|5.2|5.4|5.3|Benign/Borderline|12175|228752299|Male and Female|Pituitary|2011|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|34|228752299|Male and Female|Pituitary|2011|0.0|0.0|0.0
20+|5.5|5.7|5.6|Benign/Borderline|13093|231390637|Male and Female|Pituitary|2012|5.6|5.8|5.7
20+|0.0|0.0|0.0|Malignant|34|231390637|Male and Female|Pituitary|2012|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|13057|233810936|Male and Female|Pituitary|2013|5.5|5.7|5.6
20+|0.0|0.0|0.0|Malignant|40|233810936|Male and Female|Pituitary|2013|0.0|0.0|0.0
20+|5.5|5.6|5.5|Benign/Borderline|67108|1192790502|Male and Female|Pituitary|2013-2017|5.6|5.7|5.6
20+|0.0|0.0|0.0|Malignant|139|1192790502|Male and Female|Pituitary|2013-2017|0.0|0.0|0.0
20+|5.5|5.7|5.6|Benign/Borderline|13261|236278334|Male and Female|Pituitary|2014|5.5|5.7|5.6
20+|0.0|0.0|0.0|Malignant|34|236278334|Male and Female|Pituitary|2014|0.0|0.0|0.0
20+|5.6|5.8|5.7|Benign/Borderline|13706|238659768|Male and Female|Pituitary|2015|5.6|5.8|5.7
20+|0.0|0.0|0.0|Malignant|30|238659768|Male and Female|Pituitary|2015|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|13599|240960373|Male and Female|Pituitary|2016|5.5|5.7|5.6
20+|0.0|0.0|0.0|Malignant|18|240960373|Male and Female|Pituitary|2016|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|13485|243081091|Male and Female|Pituitary|2017|5.5|5.6|5.5
20+|0.0|0.0|0.0|Malignant|17|243081091|Male and Female|Pituitary|2017|0.0|0.0|0.0
20+|16.3|16.6|16.4|Benign/Borderline|34930|211050944|Male and Female|Total|2004|16.4|16.7|16.6
20+|9.0|9.3|9.1|Malignant|19387|211050944|Male and Female|Total|2004|9.1|9.3|9.2
20+|18.3|18.7|18.5|Benign/Borderline|39896|213511339|Male and Female|Total|2005|18.5|18.9|18.7
20+|9.0|9.3|9.1|Malignant|19725|213511339|Male and Female|Total|2005|9.1|9.4|9.2
20+|19.1|19.5|19.3|Benign/Borderline|42242|216055494|Male and Female|Total|2006|19.4|19.7|19.6
20+|8.9|9.2|9.0|Malignant|19815|216055494|Male and Female|Total|2006|9.0|9.3|9.2
20+|19.6|20.0|19.8|Benign/Borderline|44105|218481776|Male and Female|Total|2007|20.0|20.4|20.2
20+|8.9|9.2|9.0|Malignant|20143|218481776|Male and Female|Total|2007|9.1|9.3|9.2
20+|20.7|21.1|20.9|Benign/Borderline|47232|220975702|Male and Female|Total|2008|21.2|21.6|21.4
20+|8.9|9.2|9.1|Malignant|20598|220975702|Male and Female|Total|2008|9.2|9.4|9.3
20+|22.0|22.4|22.2|Benign/Borderline|50932|223491138|Male and Female|Total|2009|22.6|23.0|22.8
20+|8.9|9.1|9.0|Malignant|20808|223491138|Male and Female|Total|2009|9.2|9.4|9.3
20+|21.5|21.9|21.7|Benign/Borderline|50691|226144182|Male and Female|Total|2010|22.2|22.6|22.4
20+|8.7|8.9|8.8|Malignant|20724|226144182|Male and Female|Total|2010|9.0|9.3|9.2
20+|21.7|22.1|21.9|Benign/Borderline|51935|228752299|Male and Female|Total|2011|22.5|22.9|22.7
20+|8.6|8.8|8.7|Malignant|20853|228752299|Male and Female|Total|2011|9.0|9.2|9.1
20+|22.4|22.7|22.6|Benign/Borderline|54374|231390637|Male and Female|Total|2012|23.3|23.7|23.5
20+|8.5|8.8|8.6|Malignant|21146|231390637|Male and Female|Total|2012|9.0|9.3|9.1
20+|22.4|22.7|22.6|Benign/Borderline|55276|233810936|Male and Female|Total|2013|23.4|23.8|23.6
20+|8.5|8.7|8.6|Malignant|21477|233810936|Male and Female|Total|2013|9.1|9.3|9.2
20+|22.6|22.7|22.6|Benign/Borderline|286577|1192790502|Male and Female|Total|2013-2017|23.9|24.1|24.0
20+|8.4|8.5|8.4|Malignant|109077|1192790502|Male and Female|Total|2013-2017|9.1|9.2|9.1
20+|22.6|23.0|22.8|Benign/Borderline|56796|236278334|Male and Female|Total|2014|23.8|24.2|24.0
20+|8.4|8.7|8.5|Malignant|21653|236278334|Male and Female|Total|2014|9.0|9.3|9.2
20+|22.9|23.3|23.1|Benign/Borderline|58435|238659768|Male and Female|Total|2015|24.3|24.7|24.5
20+|8.4|8.6|8.5|Malignant|21882|238659768|Male and Female|Total|2015|9.0|9.3|9.2
20+|22.5|22.9|22.7|Benign/Borderline|58265|240960373|Male and Female|Total|2016|24.0|24.4|24.2
20+|8.3|8.5|8.4|Malignant|22111|240960373|Male and Female|Total|2016|9.1|9.3|9.2
20+|21.9|22.3|22.1|Benign/Borderline|57805|243081091|Male and Female|Total|2017|23.6|24.0|23.8
20+|8.1|8.3|8.2|Malignant|21954|243081091|Male and Female|Total|2017|8.9|9.2|9.0
20+|2.2|2.3|2.3|Benign/Borderline|4882|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5504|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|52|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5604|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5689|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5787|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.6|2.7|2.6|Benign/Borderline|6127|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|36|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5927|226144182|Male and Female|Tumors of Cranial and Spinal Nerves|2010|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|45|226144182|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.6|2.7|2.6|Benign/Borderline|6278|228752299|Male and Female|Tumors of Cranial and Spinal Nerves|2011|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|37|228752299|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|6649|231390637|Male and Female|Tumors of Cranial and Spinal Nerves|2012|2.8|2.9|2.9
20+|0.0|0.0|0.0|Malignant|50|231390637|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.7|2.8|2.8|Benign/Borderline|6869|233810936|Male and Female|Tumors of Cranial and Spinal Nerves|2013|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|43|233810936|Male and Female|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|34833|1192790502|Male and Female|Tumors of Cranial and Spinal Nerves|2013-2017|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|211|1192790502|Male and Female|Tumors of Cranial and Spinal Nerves|2013-2017|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|7245|236278334|Male and Female|Tumors of Cranial and Spinal Nerves|2014|3.0|3.1|3.1
20+|0.0|0.0|0.0|Malignant|39|236278334|Male and Female|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.8|2.9|2.8|Benign/Borderline|7210|238659768|Male and Female|Tumors of Cranial and Spinal Nerves|2015|3.0|3.1|3.0
20+|0.0|0.0|0.0|Malignant|39|238659768|Male and Female|Tumors of Cranial and Spinal Nerves|2015|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|6944|240960373|Male and Female|Tumors of Cranial and Spinal Nerves|2016|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|46|240960373|Male and Female|Tumors of Cranial and Spinal Nerves|2016|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|6565|243081091|Male and Female|Tumors of Cranial and Spinal Nerves|2017|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|44|243081091|Male and Female|Tumors of Cranial and Spinal Nerves|2017|0.0|0.0|0.0
20+|0.4|0.4|0.4|Benign/Borderline|829|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.4|0.4
20+|7.4|7.7|7.5|Malignant|16027|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|966|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16249|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1044|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16422|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|1004|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16788|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1075|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|17079|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1101|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|17351|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|7.6|7.9|7.8
20+|0.5|0.6|0.5|Benign/Borderline|1193|226144182|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.5
20+|7.2|7.5|7.4|Malignant|17355|226144182|Male and Female|Tumors of Neuroepthelial Tissue|2010|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1164|228752299|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.5|0.5
20+|7.2|7.4|7.3|Malignant|17458|228752299|Male and Female|Tumors of Neuroepthelial Tissue|2011|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1168|231390637|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.5|0.5|0.5
20+|7.2|7.4|7.3|Malignant|17785|231390637|Male and Female|Tumors of Neuroepthelial Tissue|2012|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1134|233810936|Male and Female|Tumors of Neuroepthelial Tissue|2013|0.5|0.5|0.5
20+|7.2|7.4|7.3|Malignant|18073|233810936|Male and Female|Tumors of Neuroepthelial Tissue|2013|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|6193|1192790502|Male and Female|Tumors of Neuroepthelial Tissue|2013-2017|0.5|0.5|0.5
20+|7.0|7.1|7.1|Malignant|91437|1192790502|Male and Female|Tumors of Neuroepthelial Tissue|2013-2017|7.6|7.7|7.7
20+|0.5|0.6|0.5|Benign/Borderline|1271|236278334|Male and Female|Tumors of Neuroepthelial Tissue|2014|0.5|0.6|0.5
20+|7.0|7.2|7.1|Malignant|17934|236278334|Male and Female|Tumors of Neuroepthelial Tissue|2014|7.5|7.7|7.6
20+|0.5|0.6|0.6|Benign/Borderline|1290|238659768|Male and Female|Tumors of Neuroepthelial Tissue|2015|0.5|0.6|0.5
20+|7.0|7.2|7.1|Malignant|18338|238659768|Male and Female|Tumors of Neuroepthelial Tissue|2015|7.6|7.8|7.7
20+|0.5|0.6|0.5|Benign/Borderline|1278|240960373|Male and Female|Tumors of Neuroepthelial Tissue|2016|0.5|0.6|0.5
20+|7.0|7.2|7.1|Malignant|18641|240960373|Male and Female|Tumors of Neuroepthelial Tissue|2016|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1220|243081091|Male and Female|Tumors of Neuroepthelial Tissue|2017|0.5|0.5|0.5
20+|6.8|7.0|6.9|Malignant|18451|243081091|Male and Female|Tumors of Neuroepthelial Tissue|2017|7.5|7.7|7.6
20+|3.7|3.8|3.8|Benign/Borderline|7951|211050944|Male and Female|Tumors of Sellar Region|2004|3.7|3.9|3.8
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.1|4.3|4.2|Benign/Borderline|9007|213511339|Male and Female|Tumors of Sellar Region|2005|4.1|4.3|4.2
20+|0.0|0.0|0.0|Malignant|39|213511339|Male and Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.4|4.6|4.5|Benign/Borderline|9750|216055494|Male and Female|Tumors of Sellar Region|2006|4.4|4.6|4.5
20+|0.0|0.0|0.0|Malignant|33|216055494|Male and Female|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.6|4.8|4.7|Benign/Borderline|10366|218481776|Male and Female|Tumors of Sellar Region|2007|4.7|4.8|4.7
20+|0.0|0.0|0.0|Malignant|33|218481776|Male and Female|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|5.0|5.1|5.0|Benign/Borderline|11197|220975702|Male and Female|Tumors of Sellar Region|2008|5.0|5.2|5.1
20+|0.0|0.0|0.0|Malignant|16|220975702|Male and Female|Tumors of Sellar Region|2008|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|12143|223491138|Male and Female|Tumors of Sellar Region|2009|5.3|5.5|5.4
20+|0.0|0.0|0.0|Malignant|25|223491138|Male and Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|12329|226144182|Male and Female|Tumors of Sellar Region|2010|5.4|5.5|5.5
20+|0.0|0.0|0.0|Malignant|31|226144182|Male and Female|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|12592|228752299|Male and Female|Tumors of Sellar Region|2011|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|36|228752299|Male and Female|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|5.7|5.9|5.8|Benign/Borderline|13533|231390637|Male and Female|Tumors of Sellar Region|2012|5.8|5.9|5.8
20+|0.0|0.0|0.0|Malignant|34|231390637|Male and Female|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|5.6|5.8|5.7|Benign/Borderline|13528|233810936|Male and Female|Tumors of Sellar Region|2013|5.7|5.9|5.8
20+|0.0|0.0|0.0|Malignant|41|233810936|Male and Female|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|5.7|5.8|5.7|Benign/Borderline|69384|1192790502|Male and Female|Tumors of Sellar Region|2013-2017|5.8|5.9|5.8
20+|0.0|0.0|0.0|Malignant|147|1192790502|Male and Female|Tumors of Sellar Region|2013-2017|0.0|0.0|0.0
20+|5.6|5.8|5.7|Benign/Borderline|13687|236278334|Male and Female|Tumors of Sellar Region|2014|5.7|5.9|5.8
20+|0.0|0.0|0.0|Malignant|38|236278334|Male and Female|Tumors of Sellar Region|2014|0.0|0.0|0.0
20+|5.8|6.0|5.9|Benign/Borderline|14162|238659768|Male and Female|Tumors of Sellar Region|2015|5.8|6.0|5.9
20+|0.0|0.0|0.0|Malignant|31|238659768|Male and Female|Tumors of Sellar Region|2015|0.0|0.0|0.0
20+|5.6|5.8|5.7|Benign/Borderline|14054|240960373|Male and Female|Tumors of Sellar Region|2016|5.7|5.9|5.8
20+|0.0|0.0|0.0|Malignant|19|240960373|Male and Female|Tumors of Sellar Region|2016|0.0|0.0|0.0
20+|5.5|5.7|5.6|Benign/Borderline|13953|243081091|Male and Female|Tumors of Sellar Region|2017|5.6|5.8|5.7
20+|0.0|0.0|0.0|Malignant|18|243081091|Male and Female|Tumors of Sellar Region|2017|0.0|0.0|0.0
20+|9.1|9.4|9.2|Benign/Borderline|19653|211050944|Male and Female|Tumors of the Meninges|2004|9.2|9.4|9.3
20+|0.2|0.3|0.2|Malignant|500|211050944|Male and Female|Tumors of the Meninges|2004|0.2|0.3|0.2
20+|10.2|10.5|10.4|Benign/Borderline|22364|213511339|Male and Female|Tumors of the Meninges|2005|10.3|10.6|10.5
20+|0.2|0.3|0.2|Malignant|500|213511339|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
20+|10.7|11.0|10.8|Benign/Borderline|23798|216055494|Male and Female|Tumors of the Meninges|2006|10.9|11.2|11.0
20+|0.2|0.2|0.2|Malignant|469|216055494|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|11.0|11.3|11.1|Benign/Borderline|24908|218481776|Male and Female|Tumors of the Meninges|2007|11.3|11.5|11.4
20+|0.2|0.3|0.2|Malignant|529|218481776|Male and Female|Tumors of the Meninges|2007|0.2|0.3|0.2
20+|11.6|11.9|11.8|Benign/Borderline|26859|220975702|Male and Female|Tumors of the Meninges|2008|12.0|12.3|12.2
20+|0.2|0.2|0.2|Malignant|468|220975702|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|12.4|12.6|12.5|Benign/Borderline|29000|223491138|Male and Female|Tumors of the Meninges|2009|12.8|13.1|13.0
20+|0.2|0.2|0.2|Malignant|426|223491138|Male and Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|12.0|12.2|12.1|Benign/Borderline|28594|226144182|Male and Female|Tumors of the Meninges|2010|12.5|12.8|12.6
20+|0.2|0.2|0.2|Malignant|399|226144182|Male and Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|12.0|12.3|12.1|Benign/Borderline|29145|228752299|Male and Female|Tumors of the Meninges|2011|12.6|12.9|12.7
20+|0.2|0.2|0.2|Malignant|404|228752299|Male and Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|12.2|12.4|12.3|Benign/Borderline|30150|231390637|Male and Female|Tumors of the Meninges|2012|12.9|13.2|13.0
20+|0.2|0.2|0.2|Malignant|425|231390637|Male and Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|12.3|12.6|12.4|Benign/Borderline|30984|233810936|Male and Female|Tumors of the Meninges|2013|13.1|13.4|13.3
20+|0.2|0.2|0.2|Malignant|465|233810936|Male and Female|Tumors of the Meninges|2013|0.2|0.2|0.2
20+|12.6|12.7|12.6|Benign/Borderline|163690|1192790502|Male and Female|Tumors of the Meninges|2013-2017|13.7|13.8|13.7
20+|0.2|0.2|0.2|Malignant|2200|1192790502|Male and Female|Tumors of the Meninges|2013-2017|0.2|0.2|0.2
20+|12.4|12.7|12.5|Benign/Borderline|31885|236278334|Male and Female|Tumors of the Meninges|2014|13.3|13.6|13.5
20+|0.2|0.2|0.2|Malignant|470|236278334|Male and Female|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|12.7|13.0|12.8|Benign/Borderline|33241|238659768|Male and Female|Tumors of the Meninges|2015|13.8|14.1|13.9
20+|0.2|0.2|0.2|Malignant|431|238659768|Male and Female|Tumors of the Meninges|2015|0.2|0.2|0.2
20+|12.7|12.9|12.8|Benign/Borderline|33679|240960373|Male and Female|Tumors of the Meninges|2016|13.8|14.1|14.0
20+|0.1|0.2|0.2|Malignant|407|240960373|Male and Female|Tumors of the Meninges|2016|0.2|0.2|0.2
20+|12.5|12.8|12.6|Benign/Borderline|33901|243081091|Male and Female|Tumors of the Meninges|2017|13.8|14.1|13.9
20+|0.1|0.2|0.2|Malignant|427|243081091|Male and Female|Tumors of the Meninges|2017|0.2|0.2|0.2
20+|0.7|0.8|0.7|Benign/Borderline|1574|211050944|Male and Female|Unclassified Tumors|2004|0.7|0.8|0.7
20+|0.6|0.7|0.6|Malignant|1325|211050944|Male and Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|0.9|Benign/Borderline|1985|213511339|Male and Female|Unclassified Tumors|2005|0.9|1.0|0.9
20+|0.6|0.7|0.6|Malignant|1335|213511339|Male and Female|Unclassified Tumors|2005|0.6|0.7|0.6
20+|0.9|1.0|0.9|Benign/Borderline|1979|216055494|Male and Female|Unclassified Tumors|2006|0.9|1.0|0.9
20+|0.6|0.6|0.6|Malignant|1302|216055494|Male and Female|Unclassified Tumors|2006|0.6|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|2065|218481776|Male and Female|Unclassified Tumors|2007|0.9|1.0|0.9
20+|0.5|0.6|0.6|Malignant|1228|218481776|Male and Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.0|1.0|Benign/Borderline|2246|220975702|Male and Female|Unclassified Tumors|2008|1.0|1.1|1.0
20+|0.6|0.6|0.6|Malignant|1393|220975702|Male and Female|Unclassified Tumors|2008|0.6|0.7|0.6
20+|1.0|1.1|1.1|Benign/Borderline|2480|223491138|Male and Female|Unclassified Tumors|2009|1.1|1.2|1.1
20+|0.6|0.7|0.6|Malignant|1445|223491138|Male and Female|Unclassified Tumors|2009|0.6|0.7|0.6
20+|1.1|1.2|1.1|Benign/Borderline|2588|226144182|Male and Female|Unclassified Tumors|2010|1.1|1.2|1.1
20+|0.5|0.6|0.5|Malignant|1270|226144182|Male and Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.1|1.2|1.2|Benign/Borderline|2694|228752299|Male and Female|Unclassified Tumors|2011|1.1|1.2|1.2
20+|0.5|0.6|0.5|Malignant|1279|228752299|Male and Female|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.1|1.2|1.2|Benign/Borderline|2806|231390637|Male and Female|Unclassified Tumors|2012|1.2|1.3|1.2
20+|0.5|0.6|0.5|Malignant|1290|231390637|Male and Female|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|2710|233810936|Male and Female|Unclassified Tumors|2013|1.1|1.2|1.2
20+|0.5|0.5|0.5|Malignant|1288|233810936|Male and Female|Unclassified Tumors|2013|0.5|0.6|0.6
20+|1.0|1.0|1.0|Benign/Borderline|12191|1192790502|Male and Female|Unclassified Tumors|2013-2017|1.0|1.0|1.0
20+|0.5|0.5|0.5|Malignant|6511|1192790502|Male and Female|Unclassified Tumors|2013-2017|0.5|0.6|0.5
20+|1.0|1.1|1.1|Benign/Borderline|2649|236278334|Male and Female|Unclassified Tumors|2014|1.1|1.2|1.1
20+|0.5|0.6|0.5|Malignant|1418|236278334|Male and Female|Unclassified Tumors|2014|0.6|0.6|0.6
20+|1.0|1.0|1.0|Benign/Borderline|2470|238659768|Male and Female|Unclassified Tumors|2015|1.0|1.1|1.0
20+|0.5|0.5|0.5|Malignant|1365|238659768|Male and Female|Unclassified Tumors|2015|0.5|0.6|0.6
20+|0.9|0.9|0.9|Benign/Borderline|2249|240960373|Male and Female|Unclassified Tumors|2016|0.9|1.0|0.9
20+|0.4|0.5|0.5|Malignant|1230|240960373|Male and Female|Unclassified Tumors|2016|0.5|0.5|0.5
20+|0.8|0.9|0.8|Benign/Borderline|2113|243081091|Male and Female|Unclassified Tumors|2017|0.8|0.9|0.9
20+|0.4|0.5|0.4|Malignant|1210|243081091|Male and Female|Unclassified Tumors|2017|0.5|0.5|0.5
20+|0.1|0.1|0.1|Benign/Borderline|154|211050944|Male and Female|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|211050944|Male and Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|156|213511339|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|40|213511339|Male and Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|187|216055494|Male and Female|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|216055494|Male and Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|184|218481776|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|209|220975702|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|220975702|Male and Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|234|223491138|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|66|223491138|Male and Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|254|226144182|Male and Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|46|226144182|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|268|228752299|Male and Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|60|228752299|Male and Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|275|231390637|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|58|231390637|Male and Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|265|233810936|Male and Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|69|233810936|Male and Female|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|1378|1192790502|Male and Female|Unique astrocytoma variants|2013-2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|331|1192790502|Male and Female|Unique astrocytoma variants|2013-2017|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|278|236278334|Male and Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|78|236278334|Male and Female|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|275|238659768|Male and Female|Unique astrocytoma variants|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|50|238659768|Male and Female|Unique astrocytoma variants|2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|299|240960373|Male and Female|Unique astrocytoma variants|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|65|240960373|Male and Female|Unique astrocytoma variants|2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|261|243081091|Male and Female|Unique astrocytoma variants|2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|69|243081091|Male and Female|Unique astrocytoma variants|2017|0.0|0.0|0.0
